Modelling evolving clinical practice guidelines: a case of Malawi by Msosa, Yamiko Joseph
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
The University of Cape Town
Doctoral Thesis
Modelling evolving clinical practice
guidelines: A case of Malawi
Author:
Yamiko Joseph Msosa
Supervisors:
Dr. C. Maria Keet
Dr. Melissa Densmore
A thesis submitted in fulfilment of the requirements
for the degree of Doctor of Philosophy
in the
Research Centre in ICT4D
The Department of Computer Science
June 2018
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 
 
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
Declaration of Authorship
I, Yamiko Joseph Msosa, declare that this thesis titled, ‘Modelling evolving clinical
practice guidelines: A case of Malawi’ and the work presented in it are my own. I
confirm that:
 This work was done wholly or mainly while in candidature for a research degree
at this University.
 Where any part of this thesis has previously been submitted for a degree or any
other qualification at this University or any other institution, this has been clearly
stated.
 Where I have consulted the published work of others, this is always clearly at-
tributed.
 Where I have quoted from the work of others, the source is always given. With
the exception of such quotations, this thesis is entirely my own work.
 I have acknowledged all main sources of help.
 Where the thesis is based on work done by myself jointly with others, I have made
clear exactly what was done by others and what I have contributed myself.
Signed:
Date: 18th February 2018
i
Prior Publications
Some early versions of the content in this thesis appeared in the following publications:
 Msosa, Yamiko Joseph, Melissa Densmore, and C. Maria Keet. ”Charac-
terisation of Clinical Practice Guideline Changes.” Proceedings of the 9th Inter-
national Joint Conference on Biomedical Engineering Systems and Technologies
(BIOSTEC). 2016.
 Msosa, Yamiko Joseph, Melissa Densmore, and C. Maria Keet. ”Towards an
architectural design of a guideline-driven EMR system: a contextual inquiry of
Malawi.” Proceedings of the Seventh International Conference on Information and
Communication Technologies and Development. ACM, 2015.
“An aspiration achieved without effort doesn’t build wisdom.”
Kentaro Toyama
Abstract
Electronic medical record (EMR) systems are increasingly being adopted in low- and
middle-income countries. This provides an opportunity to support task-shifted health
workers with guideline-based clinical decision support to improve the quality of health-
care delivery. However, the formalization of clinical practice guidelines (CPGs) into
computer-interpretable guidelines (CIGs) for clinical decision support in such a setting
is a very challenging task due to the evolving nature of CPGs and limited healthcare bud-
gets. This study proposed that a CIG modelling language that considers CPG change
requirements in their representation models could enable semi-automated support of
CPG change operations thereby reducing the burden of maintaining CIGs.
Characteristics of CPG changes were investigated to elucidate CPG change requirements
using CPG documents from Malawi where EMR systems are routinely used. Thereafter,
a model-driven engineering approach was taken to design a CIG modelling framework
that has a novel domain-specific modelling language called FCIG for the modelling of
evolving CIGs. The CIG modelling framework was implemented using the Xtext frame-
work. The national antiretroviral therapy EMR system for Malawi was extended into
a prototype with FCIG support for experimentation. Further studies were conducted
with CIG modellers. The evaluations were conducted to answer the following research
questions: i) What are the CPG change requirements for modelling an evolving CIG?
ii) Can a model-driven engineering approach adequately support the modelling of an
evolving CIG? iii) What is the effect of modelling an evolving CIG using FCIG in com-
parison with the Health Level Seven (HL7) standard for modelling CIGs? Data was
collected using questionnaires, logs and observations. The results indicated that fine-
grained components of a CPG are affected by CPG changes and that those components
are not included explicitly in current executable CIG language models. The results
also showed that by including explicit semantics for elements that are affected by CPG
changes in a language model, smart-editing features for supporting CPG change opera-
tions can be enabled in a language-aware code editor. The results further showed that
both experienced and CIG modellers perceived FCIG as highly usable. Furthermore,
the results suggested that FCIG performs significantly better at CIG modelling tasks
as compared to the HL7 standard, Arden Syntax.
This study provides empirical evidence that a model-driven engineering approach to
clinical guideline formalization supports the authoring and maintenance of evolving CIGs
to provide up-to-date clinical decision support in low- and middle-income countries.
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Chapter 1
Introduction
1.1 Background
Malawi, one of the least developed countries in sub-Saharan Africa, faces a double disease
burden of communicable and non-communicable diseases [3]. In addition, the country
is facing a crisis in human health resources due to a shortage of health workers [4].
Malawi has one of the lowest doctor to patient ratios estimated at about two for every
100,000 [5].
Electronic medical records (EMRs) are the future of documenting and delivering health-
care as such systems can decrease medical errors and improve quality of care [6]. The
potential of EMR systems to transform medical care practice has been recognised over
the past decades, including the enhancement of healthcare delivery and facilitation of
decision-making processes [7]. Improving the quality of care through an EMR system
depends on effective clinical decision support as a recommendation can be provided at
the time of decision-making as part of the clinician’s workflow, which reduces practice
variation, and is based on best-practice guidelines [6].
Malawi, like most other low- and middle-income countries, has adopted task shifting
to cope with the human resource crisis for health. Task-shifting refers to a process of
delegation of tasks to health workers with lower qualifications [8]. The task-shifting
process requires the development of standardised protocols, including simplified clinical
practice guidelines (CPGs), simplified recording and reporting systems and simplified
monitoring and evaluation [4]. CPG representations that allow practitioners with limited
training to effectively manage the most prevalent manifestations of disease are essential
for national treatment programs like those in Malawi [9]. Several attempts have been
made as part of the general computerisation within healthcare to integrate CPGs in
1
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computer-supported clinical settings in form of computer-interpretable guidelines (CIGs)
[10]. CPG formalization as CIGs make it possible to develop guideline-based EMR
systems that have a better chance of impacting clinician behaviour than narrative CPGs
[11]. It can be argued that CIGs for clinical decision support are a necessary future of
medical decision making [12].
Clinical knowledge is often limited or partial, and it is not unusual for certain guidelines
to be revised or proved wrong. In such cases, clinical decision support systems designers
need to update their systems whenever new guidelines are introduced or old ones revised
[13]. Integrating CIGs with patient-specific data and clinical applications; and executing
CIGs in real-time to provide decision support and care planning still remain as challenges
in healthcare [14]. Evolving requirements from the medical field combined with the
properties of information systems demand advanced features in computer interpretable
guidelines (CIGs) to tackle problems emanating from CPG updates [15].
Malawi like most other low-resource regions, deploys paper-based CPGs for use by task-
shifted healthcare workers. But some of the CPGs have been integrated into national
EMR systems for guideline-based clinical decision support. In such situations, mainte-
nance of the EMR systems to support new and revised CPGs is a challenge. [16]
1.2 Problem statement
The aim of this work was to devise an appropriate framework for modelling and main-
taining CIGs in computer-supported clinical information systems for low- and middle-
income countries. In this work, I further sought to evaluate the effect of modelling and
maintaining CIGs using a newly devised CIG modelling framework that is based on
model-driven engineering techniques.
The scope of this study was on modelling evolving CIGs in clinical information systems
that support primary healthcare delivery in low- and middle-income countries. I con-
ducted the study within primary healthcare in Malawi. I chose Malawi because it is a
low- and middle-income country that routinely uses EMR systems in public health fa-
cilities. Furthermore, Malawi is facing a double crisis of high disease burden and severe
shortage of qualified health workers. This study focused on two CPGs, namely Integrated
Guidelines for the Management of HIV and Integrated Management of Child Illnesses,
because they are both adapted from the World Health Organisation (WHO) guidelines
and are mandated for use by frontline health workers in Malawi. Frontline health workers
are the first point of contact for medical care in many low- and middle-income countries
including Malawi [17, 18].
Chapter 1. Introduction 3
1.3 Research questions
In order to address the research problem, I posed three research questions.
1.3.1 What are the CPG change requirements for modelling an evolv-
ing CIG?
In order to address the first research question, I compared successive versions of CPGs
from Malawi. I analysed the changes that were identified in the comparison which
resulted in their classification into ten categories of CPG changes.
1.3.2 Can a model-driven engineering approach adequately support
the modelling of an evolving CIG?
I started by conceptualising a four-layer architecture for modelling evolving CIGs that
is discussed in Chapter 5. This four-layer architecture has at its core, a domain-specific
language (DSL) named FCIG, that has explicit semantics for specifying CPG structural
elements that are affected by CPG changes. In order to address this second research
question, I encoded a representative sample of CPGs from Malawi using FCIG and
further evaluated FCIG ’s language constructs for their evolving CIG representation
adequacy and usability.
1.3.3 What is the effect of modelling an evolving CIG using FCIG in
comparison with the HL7 standard for modelling CIGs?
In order to address the third research question, I conducted a study that measured the
effect of modelling evolving CIGs using FCIG. This was done by getting novice modellers
to model evolving CIGs using FCIG at one time and also using the HL7 standard Arden
Syntax at another time. Data from the two runs of the experiment was analysed in order
to measure the time on task, task success rate, error rate, number of errors encountered,
efficiency, lines of code (LOC), effective lines of code (ELOC) and system usability scale
(SUS) scores.
1.4 Research design and approach
In this research, I used a mixed-methods design in four studies. A mixed-methods
research design allows the collection and analysing of data using a mixture of quantitative
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and qualitative methods in a single study or a series of studies in order to understand a
particular phenomenon [19–21].
In order to address the first research question, I categorised CPG change requirements
for a typical low- and middle-income country. I started by collecting CPG documents for
HIV management from Malawi and elucidated CPG change requirements for a low- and
middle-income country through an inductive learning process. Through this process, I
identified ten categories of CPG changes that included related specifications of the CPG
structural elements that are affected by the changes.
In order to address the second research question, I used the CPG change requirements
for low- and middle-income country to systematically derive FCIG, an evolving CIG
modelling language that operates within a four-layer guideline modelling architecture.
I further evaluated FCIG ’s language constructs for their representation adequacy and
usability.
In order to address the third research question, I conducted a set of experiments with
two experimental conditions that allowed FCIG to be compared with the Health Level
Seven (HL7) standard for modelling CPGs, Arden Syntax.
1.5 Contributions
By addressing the research questions, this research resulted in the following contribu-
tions:
1. A systematic characterisation of CPG changes.
2. The concept of an evolving computer-interpretable guideline.
3. A four-layer computer-interpretable guideline modelling architecture.
4. A compact and usable CIG modelling language, FCIG.
5. Empirical evidence with regards to the effect of using the novel CIG modelling
framework on CIG modellers.
I anticipate that the above listed contributions will generate interest amongst guideline-
based clinical decision support systems designers and researchers, particularly those
that work in low- and middle-income countries. These contributions will enhance the
understanding of how sustainable guideline-based clinical decision support systems can
be conceptualised and operationalised in low- and middle-income countries.
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Furthermore, this research demonstrated a systematic and methodical process of design-
ing practical and usable CIG modelling framework that is particularly relevant in a low-
and middle-income countries.
1.6 Thesis outline
The rest of this thesis is structured into seven chapters as follows:
Chapter 2: Background
In this chapter, I explore and review literature relevant to this research. I further
discuss the context of this work in relation to current literature. I start by discussing
clinical practice guideline formalization and model-driven engineering. Thereafter, I give
a background of Malawi, which is the research context. And lastly, I discuss findings
from a contextual inquiry that I carried out to better understand the research context.
Chapter 3: Research design
This chapter discusses the overall approach and design to this work. I start by discussing
the aims of this research, followed by their related research questions that guided this
work. I further discuss the legal and ethical considerations that were taken during this
research study.
Chapter 4: Characterising clinical practice guideline changes
In this chapter, I use an inductive learning approach to characterise the changes that
occur when a CPG evolves over time. The characterisation in this chapter serves as a
foundation for grounding CPG change requirements for low-resource settings.
Chapter 5: Modelling evolving computer-interpretable guidelines
This chapter discusses the framework for modelling evolving CIGs. The framework aims
to address the CPG modelling challenges that were discussed in Chapter 4. I start by
discussing the theoretical foundations of a four-layer CIG modelling architecture. The
theoretical foundations are core to the evolving CIG modelling framework. Thereafter,
I evaluate the modelling language constructs of FCIG, the CIG modelling language that
is central to the four-layer CIG modelling architecture, for their CPG representation
adequacy.
Chapter 6: FCIG grammar evaluation of perceived usability
This chapter discusses the evaluation of the language constructs of FCIG for their us-
ability. I start by discussing how the evaluation was conducted with both novice and
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experienced CIG modellers. Thereafter I discuss the results from the evaluation and
their implications.
Chapter 7: Experimental evaluation of FCIG
This chapter discusses the experiments that were carried to assess the effectiveness of
FCIG. I start by discussing how the experiments were carried out. Thereafter, I discuss
the results from the experiments in relation to the evaluation criteria that was derived
to address the research questions and their related hypotheses.
Chapter 8: Conclusion
In this chapter, I start by restating the proposition from this work in relation to its
research questions. I follow up with a synthesis of how the empirical results addressed
the research questions. Thereafter, I discuss the contributions from this work and their
implications. Finally, I discuss the limitations of this research and opportunities for
future work.
Chapter 2
Background
This chapter discusses related work and sets the context for this study. Section 2.1 and
Section 2.2 discuss related work, followed by a discussion that characterises Malawi in
Section 2.3. The chapter concludes, in Section 2.4, with a discussion of results from a
contextual inquiry that was carried out in Malawi, so as to get a deeper insight of the
context for this research work.
2.1 Clinical practice guidelines
Computer-interpretable guidelines have been used to support health workers in providing
care to patients in computer-supported settings. The aim of this research was to solve
the challenges of maintaining clinical knowledge for automated clinical decision support
using model-driven engineering techniques in low- and middle-income countries. Clinical
knowledge from the best evidence is typically available for clinical practice in the form
of clinical practice guidelines (CPGs) [22–25]. Therefore, this section starts with a
discussion on clinical practice guidelines and their formalization for clinical decision
support. CPG formalization languages can be regarded as domain-specific languages for
use in the clinical domain. Hence, this section concludes with a discussion on domain-
specific languages in the context of model-driven engineering.
2.1.1 Evidence-based medicine
Clinical practice guidelines are typically translated from the best evidence [23–25].
Hence, this section starts by discussing evidence-based medicine and its relation to
clinical practice guidelines. Thereafter, the formalization of clinical practice guidelines
7
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into computer-interpretable guidelines is discussed as this research work focused on au-
tomated clinical decision support.
Evidence-based medicine (EBM) has been defined by its proponents as the conscientious,
explicit and judicious use of the current best evidence in making decisions about clinical
care of individual patients in order to provide optimal clinical care [26–30]. Practitioners
of EBM go through a process of life-long and self-directed learning in which they con-
vert information needs about diagnosis, prognosis, therapy and other health care issues
into answerable questions when providing care to their patients [27]. Health workers
practising EBM identify and apply the most effective clinical interventions in order to
maximise the quantity and quality of life for individual patients [28].
EBM is particularly relevant to low- and middle-income countries where the global
burden of disease and illness is primarily situated [31–37]. If EBM is good for richer
countries, then the case is stronger in low- and middle-income countries [35–37] as it is
essential to know which interventions work and which ones do not [32]. Low- to middle-
income countries need appropriate technology such that their healthcare delivery systems
have practitioners and patients that have access to the most appropriate evidence they
deserve [32, 33].
Across most domains in medicine, findings consistently show that practice lags be-
hind knowledge that is usually available in the form of clinical practice guidelines [22].
Evidence exists that many CPGs, even those that are broadly accepted, are not fol-
lowed [22, 38, 39]. A core part of practising evidence-based medicine is considering
CPGs when they do exist [22]. Although EBM has had many benefits, it has also had
some negative outcomes as the evidence-based quality mark has been misappropriated
by vested interests [40–42]. Although this research did not focus on validation of the
source of evidence that is used in CPG development, it contributes towards filling of this
gap by promoting the adoption of national CPGs in low- and middle-income countries
that typically use validated best evidence. National CPGs in low- and middle-income
countries are usually adapted from evidence-based recommendations from World Health
Organization (WHO) CPGs [43, 44]. Another drawback of EBM is that the volume
of evidence in form of clinical practice guidelines has become unmanageable in clini-
cal practice [42, 45]. These reasons have necessitated the need to refocus on providing
usable evidence that can optimise care given to patients [42]. This asserts the need
to evermore experiment with usable guideline modelling frameworks that can support
automated clinical decision support and the maintenance of the computer-interpretable
guidelines deployed in such an environment.
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2.1.2 Clinical practice guidelines in low- and middle-income countries
Clinical practice guidelines are systematically developed statements that include recom-
mendations to assist practitioner and patient decisions in order to optimise patient care
for specific clinical circumstances [46, 47]. The term Clinical Practice Guideline can
serve as an umbrella label for practice standards, protocols, parameters, algorithms and
various other types of statements about appropriate clinical care [48].
CPGs are developed to support the introduction of new knowledge and assist health
practitioners in managing patients in order to improve the quality of care in clinical
practice. CPGs describe the evidence-based procedures to be followed during diagnosis,
treatment and decision making for a specific disease based on years of accumulated
medical experience [49]. The fundamental value of CPGs is to ensure that tasks are
carried out uniformly in addition to serving as a guide or reminder in situations in
which it is likely that steps will be forgotten, are difficult to follow, or where errors can
be expensive [50]. CPGs aim to improve the quality of care, reduce unjustified variations
and reduce healthcare costs [11]. Furthermore, CPGs contribute an important modality
that can reduce the delivery of inappropriate care and support the introduction of new
knowledge into clinical practice [51].
While CPGs assist health practitioners in managing their patients, there are several
factors that make it difficult for the health practitioners to follow and adhere to often
complex CPGs. CPGs can become a source of stress and increased complexity for
clinicians [52]. CPGs can also be difficult to use in practice as they can include tens or
even hundreds of pages of complex information, vocabulary and diagrams dealing with
multiple aspects of care and treatment [49]. Further to that, several factors limiting or
restricting complete adherence to clinical guidelines include lack of awareness with the
guidelines existence, lack of agreement, lack of physician self-efficacy, lack of outcome
expectancy or the inherent difficulty to change habits in daily behaviour [53].
CPGs that are intended for developing countries differ from those that are developed for
use in richer countries. CPGs for many conditions in low- and middle-income countries
are designed for use by health workers with limited training that may also have limited
access to diagnostic testing tools [54]. The WHO, by virtue of being a technical resource
for health systems globally, develops CPGs that can be adapted and adopted by indi-
vidual countries in the developing world for use in their national treatment programs
such as Malaria and HIV [31, 54, 55]. WHO guidelines are usually based on strate-
gies that are safe, simple, and inexpensive in order to support scaling up of national
treatment programs [56, 57]. These CPGs are often revised as new evidence emerge on
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how to manage the various conditions targeted in the CPGs [57–59]. This public health
approach leads to a high diagnostic sensitivity at the expense of specificity [60].
2.1.3 Computer-based clinical practice guidelines
Computer-based CPGs have been developed to facilitate the integration of clinical guide-
lines into clinical environments that are equipped with digital technology [49]. Lyng [10]
argues that three approaches have been promoted for computerising CPGs as part of the
general computerisation efforts within healthcare: i) where computer-based CPGs are
promoted as modelling languages independent of their execution environment, ii) where
computer-based CPGs are promoted as an execution environment, iii) where comput-
er-based CPGs are integrated into an Electronic Health Record (EHR) system.
Computer-interpretable guidelines (CIGs) are formalized models of CPGs that make
it possible develop guideline-based clinical decision support systems (CDSSs) [11, 12].
Furthermore, modelling CPGs in a computer interpretable form is a pre-requisite for var-
ious computer applications to support CPG application [61]. A CIG modelling formalism
should be supported by a formal language that has a complete set of vocabulary, syntax
and semantics [12]. The current and emerging standards for expressing CPGs have a
formal syntax but no formal semantics as there are no mathematical models that define
what specifications in these languages mean [11]. Furthermore, these CIG modelling lan-
guages and frameworks that aim at improving CPG application in computer-supported
settings are insufficient as they rely on informal processes and notations [62]. The work
presented in this thesis aimed at filling this gap by proposing a usable CIG modelling
framework that has a formal notation and clear semantics for expressing a CIG.
A CPG’s formalization into computer-based guidelines is necessary for automated medi-
cal decision support. CPG formalization as CIGs make it possible to develop CIG-based
CDSSs which have a better chance of impacting clinician behaviour than narrative guide-
lines [11]. In addition, the medical community has started to recognise that CIGs can
further increase CPG advantages by providing relevant benefits such as automatic linkage
to patient data and decision support to care providers and patients [63]. Guideline-based
CDSSs are deemed necessary for the future of medical decision making in general [12].
There are a number of challenges that make it difficult to formalize a CPG into a CIG.
Data and knowledge modelling of CPGs is a relatively neglected area, yet it has enor-
mous impact on the format and expressiveness of decision criteria, and the ease with
which guidelines can be formalised and integrated into decision-support services [64]. In
addition, the way data and medical concepts are represented and linked to Electronic
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Medical Record (EMR) systems have resulted in incompatibilities among CPG encod-
ings [64–67]. This asserts the need to follow a knowledge modelling approach that can
leverage an existing medical vocabulary when formalizing CPGs. Furthermore, existing
tools for encoding and maintaining CIG models are limited in their ease-of-use and the
support they offer to the CIG modeller [68]. The work presented in this thesis aimed
at filling this gap by proposing a usable guideline modelling framework that leverages
existing medical dictionaries when modelling CIGs.
Computerisation of CPGs for guideline-based CDSS at the point-of-care (POC) has the
potential to improve clinicians’ adherence to CPGs in routine clinical practice. The
automation and computerisation of the daily management of both clinical guidelines
and patient data can lead to improvement of physicians’ adherence to clinical guidelines
and makes this a basic step towards widespread use in medical practice [53]. Moreover,
implementing guidelines in active computer-based CDSSs promises to improve guideline
adherence because these systems are able to monitor the actions and observations of
care providers and to provide guideline-based advice at the POC [12]. This research
investigated the potential of addressing this gap by providing a comprehensive framework
for integrating a CIG into an Electronic Medical Record system to encourage CPG
application at the point-of-care.
The formalization of CPGs into CIGs is a complex task that can be categorised into
several approaches. Each approach for specifying computer-based guidelines has its own
motivations and features as some focus more on guideline standardisation and interoper-
ability while others focus more on guideline development and decision support [11]. This
formalization of CPGs can be classified into two main categories. The first category is
the document-based approach that uses the CPG document as a medium of represen-
tation based on markup text using markup languages like XML [11, 69]. Examples of
the document-based approach are Hypertext Guideline Markup Language (HGML) [70]
and Guideline Elements Model (GEM) [71]. The document-based approach was not
appropriate for this study as this study focused on executable CIGs that can be inte-
grated with clinical information systems to provide patient-specific recommendations.
The second category, which is the focus of this research, is whereby knowledge is ex-
tracted from CPGs and represented as executable constructs in a specific format [69].
Examples of the executable CIG constructs are Arden Syntax for Medical Logic Mod-
ules [72–74], GuideLine Interchange Format (GLIF) [75], Asbru [76] or PROforma [77].
The executable CPG formalization approaches can be further categorised into two kinds
of methods: i) case-based reasoning or chaining of individual rules; ii) task-network
models, where a CIG execution engine executes a CPG that is represented as a network
of component tasks that unfold over time [11].
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For the rest of this thesis, the term CIG shall mean an executable CIG. There are a
number of formalisms for expressing CIGs [11, 12, 78, 79]. Though most of the CIG
formalisms have advanced the state of knowledge on how CPGs can be represented
in computer interpretable format, they are experimental and lack proven validity in
practice [79]. Practical and technical limitations force researchers developing guideline
modelling formalisms and execution software to confine the use of their technology to
their home institutions [80]. The work in this thesis aimed at addressing this gap by
proposing an evolving CIG conceptual model that can serve as a basis of interoper-
able CIG modelling frameworks. The various existing CIG modelling formalisms are
discussed in the sections that follow.
2.1.3.1 Arden Syntax
Arden Syntax for Medical Logic Modules (MLMs), established in 1989 and subsequently
developed as a Health Level Seven (HL7) certified standard [73, 79], is a framework for
providing decision support in EMR systems [78]. Arden Syntax represents procedural
clinical knowledge in MLMs. Each MLM contains sufficient knowledge to make a single
decision that invokes a specific action [78]. Arden Syntax has been used for clinical
decision support by generating clinical alerts, diagnostic interpretations, management
messages and screening for research studies [81–83]. Though Arden Syntax has been
used for clinical decision support in clinical information systems, it sometimes requires
a clinical information exporting mechanism which introduces a substantial system load
with delays in event detection and data provision [82]. In addition, Arden Syntax re-
quires a specialised Arden Syntax engine to execute MLMs within a clinical information
system [83]. Though Arden Syntax supports a more human readable writing style [83],
it poses considerable challenges when it is required to integrate it with existing het-
erogeneous clinical information systems [84]. This research considered these challenges
by proposing a specialised CIG domain-specific language (DSL) within a layered and
lightweight model-driven engineering framework that can facilitate CIG integration with
heterogeneous clinical information systems.
2.1.3.2 EON
The EON model, introduced in 1996, came out of research carried out of Stanford
University [85]. The model is a component-based architecture for building protocol-
based decision support systems for therapy-planning. Using this model, system builders
define a domain ontology for concepts in the application area, configure a problem-
solving method that implements some control strategy, and map the concepts defined
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in the domain ontology to the data requirements of a problem solving method. The
researchers developed generic problem solvers for determining patients’ eligibility for
protocols and for establishing appropriate protocol-directed therapy [86]. EON uses a
task-based approach to define decision-support services using alternative solutions that
can be selected from a toolkit [87]. However, the EON model is inappropriate to the
public health approach to CPGs that is typically adopted by low- and middle-income
countries as the EON model requires knowledge of a particular institutional clinical
workflow.
2.1.3.3 Prodigy
The Prodigy model was developed at the University of Newcastle upon Tyne. It provides
support for chronic disease management by facilitating knowledge engineering through a
simple and understandable model that is sufficiently expressive [88]. The model divides
a clinical guideline in two sections. The first, describes the management of a chronic
disease over time and demonstrates available therapeutic choices for each recognisable
state of the disease being managed. The second, describes actions that may be taken
each time the patient is seen by a clinician. A high-level view of a guideline is represented
as a network of scenarios, action steps and subguidelines. Clinical interventions are split
into actions, which are instantaneous as far as primary care is concerned, and activities,
interventions that persist until they are modified or stopped. Criteria are implemented
as Boolean expressions to express preference for or against a choice of action steps,
scenarios or prescription items [89]. However, this model just like other process-centric
CIG modelling languages is inappropriate for a public health approach to CPGs which
was the focus of this research.
2.1.3.4 Standards-based Active Guideline Environment (SAGE)
Standards-based Active Guideline Environment (SAGE), developed and introduced in
2002 by a consortium consisting of research groups at GE Healthcare, University of
Nebraska Medical Center, Apelon Inc., Stanford Medical Informatics and Mayo Clinic,
is a technology platform for integrating guideline-based decision support into enterprise
clinical information systems [90]. The project builds on previous guideline modelling
work that includes Asbru, GEM, GLIF, EON, PROforma, GUIDE and PRODIGY.
The researchers in the SAGE project argue that for effectiveness of clinical decision
support to be maximised, a clinical decision support system must be invoked at an
opportune moment in the clinical care process and must facilitate clinical workflow non-
intrusively [80]. A central concept of SAGE, characterised by a triggering event, patient
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characteristics, organisational setting, roles specifying who responds to an event, and
needed resources, is context that coordinates the activation of guideline-based decision
support [11]. Guideline recommendations are modelled as either activity graphs repre-
senting guideline-directed processes or decision maps that represent recommendations
at a point in time [80]. SAGE still remains an experimental platform whereby SAGE-
encoded guidelines have not been used in practice [79]. To address this gap, the work in
this thesis aims at creating an acceptable CIG DSL to novice CIG modellers with the
aim of increasing its likelihood of being adopted.
2.1.3.5 PROforma
PROforma, an executable process modelling language [77], was developed at the Ad-
vanced Computational Laboratory of Cancer Research in the UK [79]. It is essentially a
first-order logic formalism extended to support decision making and plan execution [79].
In PROforma, a guideline is modelled as a set of tasks and data items that are organised
hierarchically into plans [77]. Tasks are divided into four classes [77, 91]. Actions repre-
sent a request for an external actor to do something, Enquiries represent points at which
information is requested from an external actor, Decisions are points at which choices
need to be made from a set of candidates [91], and Plans are collections of tasks grouped
together for a particular reason [77]. PROforma as process modelling language does not
suit the context of the work in this thesis. The work in this thesis focuses on public
health approach CPG formalization that necessitates no knowledge of institution-specific
clinical workflows such as those required when modelling CIGs with PROforma.
2.1.3.6 GUIDE
GUIDE, introduced in 1998, is a component-based and multi-level architecture developed
by the Laboratory for Medical Informatics in Italy [79]. This methodology allows CPG
implementation by means of a careflow management system [92]. The model allows
representation and execution of CPGs with both workflow management systems and
EMR systems [79], extending a CPG implementation from a simple reminder to an
organiser of healthcare processes [93]. In contrast, the work in this thesis aimed at a
public health approach to CPG application which requires little sensitivity to institution-
specific clinical workflows.
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2.1.3.7 Guideline-Interchange Format (GLIF)
Guideline-Interchange Format (GLIF), developed and introduced in 1998 by members of
Intermed Collaboratory at the Universities of Columbia, Havard, McGill and Stanford,
is a structured computer-interpretable language for modelling and executing CPGs [75,
79, 94]. The current version, GLIF3, allows a formal definition of decision criteria, ac-
tion specifications and patient data [75]. The model enables CPG encoding at three
levels: a conceptual flowchart, a logically verifiable and computable specification, and
an implementable specification that can be incorporated into a particular institutional
information system [75, 95]. GELLO, an HL7 standard object-oriented expression lan-
guage, is included in GLIF as a formal expression language for specifying decision criteria
and patient states [11, 96]. While GLIF is a more comprehensive guideline representation
ontology than most CIG models, it remains an experimental language with inadequate
support for automated execution and it lacks proven capacity of integration with in-
stitutional information systems [79]. The work in this thesis aimed to fill this gap by
proposing a comprehensive CIG modelling architecture with integration and execution
capabilities.
2.1.3.8 GASTON framework
The GASTON framework, introduced in 1997, was developed at the University of Maas-
tricht in the Netherlands [97]. The framework uses a guideline representation formalism
that combines a number of approaches based on the concepts of primitives, problem
solving methods (PSMs) and ontologies [11, 98]. The primitives construct a CPGs
control structure explicitly [98] based on Guideline Interchange Format (GLIF) version
2.0 [11]. The PSMs are used to model CPGs that perform stereotypical tasks [98]. The
ontologies are used to model the medical domain [11]. The GASTON framework is
unsuitable for a public health approach to CPG application as it requires knowledge of
institution-specific clinical workflows to model CIGs.
2.1.3.9 Asbru
The Asgaard project led by Vienna University of Technology and Stanford Medical
Informatics introduced Asbru in 1997. Asbru is a task-specific, intention-based and time-
oriented language for representing skeletal plans [76]. The researchers in the project view
clinical practice guidelines as a set of schematic plans for the management of patients
who have a particular condition. The researchers further argue that, when guidelines
are applied, a care provider interprets skeletal plans that have been designed by the
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guidelines author and that providing support to the guideline application process implies
an interactive process [99]. Asbru is also unsuitable for the context of the study in this
thesis as it requires knowledge of institution-specific clinical workflows.
2.1.3.10 Other CIG modelling approaches
Colombet et al. [100] and Seroussi et al. [101] propose the usage of decision trees and
probabilistic models to formalize CPGs into CIGs, where the optimal action strategy is
evaluated though a decision tree [11]. Microsoft Excel and Visio were used as editing
tools to author and visualise the decision trees respectively [100]. In contrast, the work
presented in this thesis differs in its focus as it aimed at proposing and evaluating CIG
modelling tools that can overcome the burden of authoring and maintaining oft-changing
CIGs.
Pe´rez and Porres [102] propose a different approach to CPG formalization by providing
a framework that aims at enabling authoring and verification of CPGs using model
checking and model-driven development techniques to verify CPGs against semantic
errors and inconsistencies in their definition. The Unified Modelling Language (UML)
and Statecharts were used to represent the dynamics of each CPG [102]. In contrast, this
study follows a rule-based approach to CIG modelling with a specialised domain-specific
language for modelling CIGs that follow a public health approach.
Kamsu-Foguem et al. [103] propose the use of a graph-based approach to CPG formal-
ization so that sound logical reasoning can be supported in a visual manner to enhance
CIG understandability by those that have no formal background. A conceptual graph is
constructed from a collection of a formal and detailed collection of nodes, relations and
questions [103]. In contrast, the focus of the work in this thesis targeted the formaliza-
tion of CPGs that are applied in a public health manner thereby requiring no knowledge
of institution-specific clinical workflows.
Semantic web technologies have been proposed as a method for formalizing CPGs [14,
104, 105]. A knowledge management approach can be taken to ontologically model
practice guidelines in terms of their content, structure and function. This can be done
by creating an ontology that entails a semantic abstraction of practice guidelines in
terms of practice-related knowledge structural elements and relationships between ele-
ments [14]. Hurley and Abidi [14] define a clinical pathway ontology that describes the
structure and function of clinical pathways. Abidi et al. [106] further extend the previous
work into a clinical decision-support framework for handling comorbidities by combining
and aligning ontology modelled CPGs using web ontology language (OWL). Abidi et al.
[106] use semantic web rule language (SWRL) rules to define all conditions related to
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the merging process, increasing the effort required to maintain resulting systems and
reducing the possibility of sharing knowledge [15].
Huang et al. [107] also used semantic web technologies to represent evidence-based CPGs
in order to address the interoperability barrier to adopting CIGs. They represent CPGs
using Resource Description Framework (RDF) and OWL [107]. Building on previous
work, Zamborlini et al. [108] specify a formal model for detecting interactions among
recommendations within CIGs. Zamborlini et al. [108] represent guidelines using RDF
graph structures in a semantic web framework for representing and reasoning about
guideline recommendations and beliefs building on the work of Hoekstra et al. [109],
Huang et al. [107] and Mons et al. [110]. But semantic web technologies such as RDF,
SWRL and OWL can be cumbersome to the CIG modeller when authoring and main-
taining CIGs.
Business Process Modelling Notation (BPMN) has also been used to formalize CPGs. Kaiser
and Marcos [111] propose an approach that encodes CPG knowledge using BPMN and
semi-automatically transforms the encoded CPG into an executable CIG using lan-
guages such as Asbru and PROforma. Rodriguez Loya et al. [112], Braun et al. [113]
and Aziz et al. [114] used BPMN to formalize and execute CPGs in their work. BPMN
requires knowledge of institution-specific clinical workflow processes which does not suit
the public health approach to CPGs that is typically adopted in low- and middle-income
countries.
2.1.4 Support for computer-interpretable guideline evolution
Peleg [11] argues that capacity for managing the complexities involved in supporting
CIGs that evolve over time should be provided in CPG formalization systems. There
have been a number of efforts that have tried to address the complexities involved in
supporting evolving CIGs [115–117].
Miller et al. [115] analysed the nature of the domain knowledge that is required to
perform automated validation after updates are applied to CIGs for child-hood immu-
nisation in the United States of America. The patterns identified by Miller et al. [115]
for possible automation cannot be generalised as they were specific to child-hood immu-
nisation CIGs in the United States of America.
Attempts have also been made to incorporate version management capabilities in CIG
systems to facilitate CIG maintenance for evolving CPGs. There are two approaches to
CIG versioning that have been proposed in literature. The first, is the model-centric
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approach, where a versioning tool is used to support the creation of new or the modi-
fication of existing CPGs by tracking change operations of basic structural components
of a CIG model [116, 117]. The second, is the document-centric approach, where CPG
changes are tracked in the original guideline document and systematically applied to its
corresponding formal or semi-formal CIG model [61].
Peleg and Kantor [118] propose logical models for version management of CIGs rep-
resented in GLIF. The intention of models that were proposed by Peleg and Kantor
[118] for version management is to ensure that reasoning functions are related to cor-
rect guideline recommendations in different versions of a CPG, that may be required by
different users at a single point in time [116].
Grandi et al. [117] propose a method of version management that enables multi-version
representation of a CPG to allow access to multiple temporal perspectives of a CIG
version that can be tailored to a specific use case. In this method, the DeGeL framework
is used to specify CPGs in different formalisms such as ASBRU, GEM and GLIF [117,
119]. Using the DeGeL framework, multiple representations of a CPG are provided at
different representation levels from semi-formal to formal [117].
Kaiser and Miksch [61] propose a different method of version management by updating
previously formalized CPGs in a series of steps that apply the changes from textual
form into Asbru using a document-centric approach. Though the version management
approaches proposed by Peleg et al. [116], Grandi et al. [117] and Kaiser and Miksch
[61] address how to access different versions of a CIG at a single point in time from a
single repository, their conceptual models do not precisely define what changes and how
a particular type of change should be handled within a CIG model when a new version
of a CPG is introduced.
2.1.5 Electronic Medical Record systems in low- and middle-income
countries
Guideline-based clinical decision support systems are a promising tool that can improve
healthcare delivery in task-shifted settings [120–122]. Clinical guideline formalization
for clinical decision support is normally discussed in the context of health informatics.
Health informatics can be defined as an interdisciplinary field that studies and supports
the effective use of biomedical data, information and knowledge for scientific inquiry and
to support healthcare and healthcare delivery for individuals, families, groups and com-
munities [123–125]. Health informatics draws from several scientific disciplines including
computer science, information science and health science disciplines due to its interdisci-
plinary nature [123, 124]. The terms ‘biomedical informatics’ and ‘medical informatics’
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have been used as alternative names due to the evolving nature of the discipline over
time and the perception others have had on the term ‘health informatics’ as one that
does not reflect the field’s broad range of applicability by excluding fields such as ba-
sic human biology [124, 125]. In this thesis, I consider the terms ‘health informatics’,
‘biomedical informatics’ and ‘medical informatics’ to be synonymous in line with the
previously given definition of the term ‘health informatics’.
An Electronic Medical Record system is the backbone of health informatics. An EMR
system is a set of computational tools that are used for managing a repository of electron-
ically maintained information about an individual’s health status and healthcare [124].
The term ‘Electronic Health Record (EHR) system’ has been used as an alternative
term to ‘EMR system’ though others have perceived an EMR system to be an inter-
organisational system [126, 127]. In this thesis, I consider the terms ‘EHR system’
and ‘EMR system’ to be synonymous. An EMR system is central to patient care ser-
vices as it contains active information management tools that can provide clinical re-
minders and alerts, and linkages with clinical knowledge sources for clinical decision
support [123, 124, 128]. These active information management tools can contain CPG
formalization tools which are a focus of this research.
Various EMR systems have been deployed in many low- and middle-income countries
with the aim of improving healthcare delivery [129, 130]. The EMR systems have been
adopted in these countries to support national programs for primary care and other
specialist treatment categories such as HIV, Tuberculosis, Maternal and Child Health,
Diabetes and Immunisation [131–136].
EMR systems are increasingly being equipped with functionality that can increase their
uptake. A number of researchers and practitioners have worked on patient identifier
management in EMR systems to support the continuity of care in low- and middle-
income countries [122, 135, 137, 138]. The usage of barcodes and local language searching
algorithms has also been proposed to support patient searching functionality in EMR
systems for low- and middle-income countries [122, 138].
Free and open source EMR systems are recommended in low- and middle-income coun-
tries due to limited budgets for healthcare in addition to supporting software develop-
ment and maintenance capacity [139–142]. Though free and open source EMR systems
are recommended and gaining ground in low- and middle-income countries, there still
remains a need to improve the skills that are needed to implement and use these systems
so that the realisation of their potential benefits can be maximised [143].
There are two categories of medical records that can be accessed from an EMR sys-
tem for clinical decision support. The first category pertains to those medical records
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that are collected on paper during a patient’s visit at a health centre and subsequently
entered into an EMR. Such a method is called retrospective data entry normally un-
dertaken by non-clinical personnel such as data entry clerks [138, 144, 145]. Though it
has been argued that retrospective entry limits clinical decision support capabilities in
EMR systems [122, 135], others have argued that delivery of care can still be improved
through clinical decision support provided through clinical summaries [146–148]. The
second category is where medical data is entered into an EMR system by a care provider
during a patient’s visit at a health centre. Such a method is called point-of-care data
entry [122, 135, 149]. An EMR system that uses the point-of-care data entry method can
be called a provider-entry or point-of-care EMR system [122, 150]. Point-of-care clinical
decision support in EMR systems can also improve the quality of care as patient-specific
advice can be given during a clinical visit [122, 151]. The availability of EMR systems
in low- and middle-income countries provide a unique opportunity that can be exploited
to improve healthcare delivery through efficient and effective guideline-based clinical
decision support.
2.2 Model-driven engineering
Model-driven engineering (MDE) refers to software development approaches in which
abstract models of software are created and systematically transformed into concrete
implementations. In MDE, the primary artefacts of development are prescriptive mod-
els [152, 153]. A prescriptive model is a model that is rigorous, formal, complete and
consistent such that it can be used to automatically construct a target system [153]. The
main engineering principle behind it, is that the inherent complexity of software devel-
opment can be mastered by building, analysing and manipulating system models [154].
This approach allows the reduction of the gap between problem and software implemen-
tation domains through the use of technologies that support systematic transformation
of problem-level abstractions to software implementations [152]. MDE allows the cre-
ation of formal, tool-processable representations of specific aspects of software systems
using a domain-specific language (DSL) that allows the representations to be trans-
formed into executable code [153]. CIG modelling languages can be regarded as DSLs
that provide basic abstractions that are required to model CIGs [155, 156]. The work in
this thesis experiments with a CIG modelling DSL that enables guideline-based clinical
decision support through an MDE approach in a low- and middle-income country. To fo-
cus the discussion on MDE, the discussion is segmented in two parts: i) Domain-specific
languages; ii) Model-driven domain-specific language development.
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2.2.1 Domain-specific languages
A DSL is a computer programming language of limited expressiveness that is focused
on a particular class of problems, called a domain [153, 157]. DSLs sacrifice some of the
flexibility to express any program in a general-purpose language (GPL) for productivity,
ease of use, and conciseness of relevant programs, with corresponding gains in produc-
tivity and reduced maintenance costs, in a particular domain [153, 158]. The process of
building a DSL can help deepen an understanding of a DSL and its domain [153]. DSLs
address issues of low-level syntax and lacking of expressiveness by enabling developers
or domain experts to program at a high-level abstraction [159]. Therefore, by building a
DSL that is specifically tailored towards CPG formalization in low- and middle-income
countries, one can gain a deeper understanding of the implications of formalizing CPGs
using a CIG DSL in low- and middle-income countries.
Many computer programming languages are domain-specific and have been called many
names over the years [158] such as application-oriented [160], special purpose [161],
forth-generation [162], little [163], task-specific [164] and specialised [165] languages.
Although DSL development is hard, requiring both domain knowledge and language
development expertise [158], designing and implementing a small DSL from scratch
is often relatively easy, enabling innovative designers to rapidly develop high-impact
solutions [166]. A DSL specifically tailored towards CPG formalization in low- and
middle-income countries can be developed with the potential of revolutionising clinical
decision support in regions that are burdened by disease.
2.2.2 Model-based domain-specific language development
There are several case studies and experience reports in literature that present DSL
development experiences using a model-driven engineering approach [167]. These reports
can be categorised into three groups. The first, report on experiences and lessons learnt
from development of individual projects (e.g. [168–170]). The second reports on DSL
development in the context of model-driven software development (MDSD) (e.g. [171–
174]). The third, report on particular techniques for specific aspects related to the design
and implementation of DSLs (e.g. [158, 170, 175–180]).
Voelter et al. [153] argues that the development of a DSL primarily requires the com-
position of an abstract syntax, a concrete syntax, constraints and type systems, and
execution semantics. But the systematic development of a DSL can be achieved by car-
rying out activities from the following categories: i) Definition of scope and purpose of
the DSL, ii) Definition of domain abstractions and core language model, iii) Definition of
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the behaviour of language elements, iv) Definition of DSL concrete syntax, v) Integration
of DSL artifacts with an information system platform, vi) Evaluation and refinement of
DSL [1, 153, 167]. The activities within a DSL development process should be tailored
to the nature of the intended DSL. The activities within such a process are typically
carried out iteratively as requirements become clearer during development [1]. Figure
2.1 illustrates a typical model-driven DSL development process.
Figure 2.1: An illustration of a model-driven DSL development process [1]
In practice, DSL development is exploratory whereby different DSLs are typically de-
veloped in different application contexts. Hence, the order in which activities are per-
formed and the exact steps with their associated guidelines that must be taken can vary
widely [1, 167]. In such cases, DSL designers should reflect upon the various guidelines
and adapt them if required [1]. Hence the general approach to DSL development consists
of two major tasks. The first, involves tailoring the DSL engineering process to the con-
text of a particular project. The second, involves applying the tailored DSL engineering
process to develop the DSL [167].
There are three main models of the types of DSL engineering processes [167]. The
first, language model driven approach, is whereby the language model definition drives
the DSL development. The second, mockup language model, is a DSL development
process that starts with concrete syntax design in order to raise the participation of
domain experts. The third, extracting a DSL from an existing system approach, entails
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a process whereby domain abstractions are extracted directly from an existing system.
Kosar et al. [179] argue that many DSL development communities advocate their DSL
implementation approaches and work on improving their techniques and supporting
tools.
A software language is any language that is created to describe and create software such
as programming, modelling and domain-specific languages [181]. DSLs can be regarded
as specification languages or programming languages because DSLs are usually declar-
ative [182]. Since DSLs are software languages, existing software language development
methods can be used on DSLs.
A formal software language can be developed by specifying its formal language model
and implementing a concrete syntax that conforms to the semantics of the language
model. The section that follows discusses software language models of DSLs.
2.2.3 Formal language model specification
A core language model of a particular DSL is created by identifying domain abstractions
and defining language model semantics. A language model contains language concepts
that are intended as abstractions over types of a particular conceptual model [1]. The
core language model semantics, also known as static semantics, express invariants on
language model concepts and relations between the concepts. The semantics of a lan-
guage concept should be invariant throughout a domain of interest and in time [167].
The static semantics consist of rules that dictate whether or not an expression of the
language is well formed or not [183].
Constraints and type systems can be used to validate static semantics of a particular
program. It can be argued that not all programs that conform to the structure of a
language are valid. Constraints aim to solve this problem by enabling specification
of restrictions that cannot be expressed purely by structure [153]. These constraints
are boolean expressions that must be true for every program expressed in a particular
language. Constraints can be implemented with any language that is able to query
a model and report errors to the user [153]. On the other hand, a type system is a
collection of type rules for a typed software language such as a DSL [184]. Type systems
are a subset of constraints. The type systems associate types with program elements
and then check whether these types conform to pre-defined typing rules [153].
Another form of semantics that can manifest when using a DSL are execution semantics
also known as dynamic semantics. Execution semantics denote the observable behaviour
of a program as it is executed [153]. These semantics define the effects that result from
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using a language concept. The behaviour of language elements can be specified though
a DSL behaviour specification which can take a form that ranges from high-level control
flow models to precise textual specifications [167]. Execution semantics add another
layer of meaning to the language concepts that are defined in the abstract syntax of
a DSL [183]. The observable behaviour of a DSL can be established with a sufficient
number of tests, or with model checking and proof [153].
The abstract syntax of a DSL is a data structure that holds the core information in
a program, but without any of the notational details contained in the concrete syn-
tax [153]. An abstract syntax specification defines the basic notions of model elements
in a language and their relations in a mathematically precise way, with structural con-
straints, multiplicities and implicit relationships [185]. On the other hand, the concrete
syntax of a DSL is what the user interacts with to create programs [153]. A concrete
syntax specification targets the actual visual appearance of a language by assigning a
visual symbol to model elements in a language [185].
Some notable work has been undertaken to propose formal theories for software language
specification. Software language specifications can be constructed from theories over
types. Reynolds [186] and Harper [187] propose a set of theories that can be used for
formal software language specification based on predicate logic. Turner [188] also propose
a conceptually similar set of theories that are based on typed predicate logic. Noting
that DSLs are software languages, existing software language theories can be used in the
formal specification of language models for DSLs.
Once a formal language model for a particular DSL has been established, a concrete
syntax that can be used by a domain expert should be developed. The section that
follows discusses the specification of a DSL’s concrete syntax.
2.2.4 Concrete syntax specification
A concrete syntax is a DSL’s interface that represents the abstractions defined in its
abstract syntax. This interface should be convenient for human users as well as being
easy to process by software components [167]. Most language specification experts focus
on semantics and abstract syntax, paying little care and consideration to the design and
specification of concrete syntax [1]. There are two major categories of DSL concrete
syntax: i) Textual DSLs that use linear textual notations based on ASCII, Unicode or
other extended set of symbols; ii) Graphical DSLs that use graphical shapes such as
box-and-line diagrams [153, 157, 167]. DSLs are easily adopted by their user community
when existing or familiar notations are adopted. Hence, a good choice of concrete syntax
is important for DSLs to be accepted by the DSL users [153].
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A DSL’s concrete syntax can be implemented using a language workbench. A lan-
guage workbench is a software engineering tool that helps its users to efficiently cre-
ate a language and enable integration with the tools to create models in these lan-
guages [153, 157, 189]. Language workbenches reduce the effort required to develop
DSLs and their IDEs [153]. Fowler [157] argues that a language workbench can be
treated as a parser when used to define concrete syntax with its model-aware tooling
against an existing semantic model. This prevents a semantic model from being locked
in a specific language workbench [157]. There are several language workbenches that
have been proposed to support the creation of DSLs [153, 157, 190, 191].
Erdweg et al. [191] compared ten language workbenches according to their language
engineering features that were classified into six categories: i) Notation – these are
features that determine how programs or models are presented to users; ii) Semantics –
these are features that support specification of language semantics; iii) Editor support
– these are feature that support syntactic and semantic editing of programs or models;
iv) Validation – these are features that support language-specific validation that are
semantic in nature; v) Testing – these are features that support the debugging of the
language definition and the construction of the debuggers; vi) Composability – these
are features that support extension of existing languages and unification of multiple
languages into a single language. They concluded that language workbenches provide
adequate abstractions for implementing DSLs though the extent at which individual
language workbenches support language engineering features vary widely [191]. Stoffel
[192] compares three separate language workbenches according to their features. In
another study, Vasudevan and Tratt [190] conducted a comparative analysis of four
language workbenches for internal textual DSLs. Ribeiro et al. [193] also conducted a
comparative analysis of three language workbenches for UML profile-based languages
using qualitative criteria in separate study. These studies came to a conclusion that
language workbench features vary widely such that selection of a particular language
workbench should be based on the nature of the project at hand [190, 192, 193]. Though
language workbenches vary in terms of their features and function, they present us with
a unique opportunity that can be exploited by supporting the efficient implementation
of a CIG DSL with its related tooling for authoring and maintaining CIGs.
Metaedit+, initially proposed by Smolander et al. [194] out of the MetaPHOR research
laboratory, is a commercially available language workbench that can be used for imple-
menting DSLs [195, 196]. Though Metaedit+ has been widely used in the industry for
over two decades [197], it uses a proprietary structure definition that makes the models
and languages constructed with not portable to other language workbenches and edi-
tors [198]. A further drawback of Metaedit+ is that it is a commercial platform that
requires a pricy licence to operate.
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Meta Programming System (MPS) is an open source language workbench, being de-
veloped by Jetbrains, that supports many advanced features for creating graphical
DSLs [153, 189]. MPS structure definition is proprietary though the language work-
bench is open source. Voelter et al. [153] argues that MPS’ structure definition does
not implement any acceptable industry standard though it is conceptually close to [199]
Ecore, a model structure definition standard of the Eclipse Modelling Framework (EMF).
Since MPS language workbench is limited to the creation of graphical DSLs [200], it may
not suit textual DSL use cases such as support for rule-based CIG modelling. Another
drawback of the MPS language workbench is that it currently only supports tooling for
the IntelliJ IDEA IDE as it uses a proprietary structure definition [153, 201].
Spoofax is an open source Eclipse-based language workbench, developed out of the
University of Delft, that can be used for creating textual DSLs and tooling for use with
the Eclipse IDE [153, 202]. Spoofax uses a structure definition called A Term that is
based on a generic tree structure whose textual notation can be used for exchanging data
between tools [153]. Spoofax lacks a mechanism that can easily reuse implementations
by referencing existing DSL definitions [192].
Intentional Domain Workbench (IDW) is a commercially available language workbench
that can be used for creating graphical DSLs that is conceptually similar to MPS [153,
203]. Not many details about IDW are available due to its commercial nature [204].
Xtext is a widely adopted open source language workbench for creating textual DSLs [153,
205, 206]. Xtext uses EMF [199] open standards for its structure definition which allows
its resulting DSL definitions and tooling to be highly interoperable with existing IDEs
such as Eclipse and Intellij IDEA [153, 207]. Xtext may not be as advanced as MPS but
its Eclipse Modelling Platform ecosystem avails a large number of addons that enable
sophisticated DSL environments [153]. Xtext can be exploited when creating a CIG
DSL due to its open source nature and the usage of open standards in its DSL structure
definitions.
A DSL needs to be properly integrated into its target information system platform in
order to be useful to its user community. The section that follows discusses the methods
that can be used to integrate a DSL with its target information system platform.
2.2.5 DSL integration
DSL artifacts can be integrated with their target information systems platform by map-
ping DSL artifacts to platform features, extending platform to support new features,
and defining a DSL execution environment through DSL-to-platform transformations
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or interpreters [153, 167]. In model-driven software development, DSL models can be
transformed into other models that tools can use to generate code through a process
called model transformation [153, 208]. Alternatively, DSL models can be transformed
into text such as source code or configuration files through a process called code gener-
ation [153, 174]. A completely different approach can be taken whereby an interpreter
traverses an AST of a DSL model to directly perform actions that correspond to the
contents of the AST via a process called interpretation [153].
2.2.6 DSL evaluation
DSL users need to know the inherent strengths and domain applicability of the languages
they use [209]. Since DSLs fall under the software language umbrella, applicable soft-
ware language evaluation methods can be used for DSL evaluation. Evaluation criteria
of software languages can be classified into four categories as follows: i) Application
domain; ii) Human factors; iii) Software engineering; iv) Language design and imple-
mentation [209].
Application domain evaluation concerns, also known as the philosophy of design [210],
entail such criteria that assess how well a language supports developing software for
a specific type of applications [211, 212]. Incompatible abstractions of the problem
domain between software language users and software language engineers are a constant
challenge to language usability [213]. Software language users need to know the inherent
strengths and domain applicability of the languages they use, in order to use the software
languages effectively [209].
Human factors come into play noting that software engineering is human-intensive, as
well as that such criteria can be used to assess the user-friendliness of a particular
DSL [214]. Factors such as naturalness and readability of software languages have not
been consistently endorsed by evidences in software language engineering [215]. DSLs
can be regarded as user interfaces as they provide a domain-expert with an interface to
a desired computation platform [216]. Like other software languages, DSLs have rarely
received usability or human factors evaluation which may have led to the deployment of
inadequate and unusable languages [217].
Software engineering concerns are those aspects that enable the development of good
software by evaluating a software language’s capacity to support such qualities as relia-
bility, portability, re-usability and maintainability [209, 218]. A number of researchers
have argued that DSLs can improve desirable attributes of resulting software [182, 219].
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Language design and implementation concerns are those aspects that assess how well a
language is designed to enable support of modelling tools such as editors, compilers and
interpreters [220]. Modelling tools for a particular DSL are key to the DSL’s acceptance
in its modelling community [221, 222]
Several studies have investigated quality characteristics of DSLs that can guide DSL eval-
uations. Though there have been some studies on DSL assessment, there is currently no
agreed standard for DSL evaluation [223]. Kolovos et al. [224] argue that characteristics
that are used for evaluating general-purpose programming languages can also be ap-
plied when evaluating DSLs though their relative importance may differ. Kahlaoui et al.
[225] propose an approach that identifies a set of success factors that be transformed
into a project-specific set of assessment criteria for DSL evaluation. Ka¨rna¨ et al. [226]
propose a DSL evaluation approach that evaluates a DSL against pre-set goals through
user experiments. Mohagheghi and Haugen [227] also propose a set of DSL assessment
criteria based on their experiences in practice. Haugen and Mohagheghi [228] propose a
multi-dimensional framework for characterising DSLs using a questionnaire across three
dimensions: expressiveness, formalization and transparency. Wu et al. [229] propose a
slightly different approach that can determine the level of effort required in developing
and using a DSL through metrics that can measure the effort. Karsai et al. [180] propose a
set of DSL design guidelines that can be considered when developing a DSL and classified
the guidelines using development phases as follows: i) Language Purpose – guidelines for
the early activities of the DSL development process; ii) Language Realization – guide-
lines which discuss DSL implementation methods; iii) Language Content – guidelines
which focus on characteristics of language elements; iv) Concrete Syntax – guidelines
that contribute to readability of a language; v) Abstract Syntax – guidelines that affect
the internal representation of a language. Frank [1] proposes generic requirements of a
DSL as follows: i) Concepts of a DSL should correspond to concepts that are familiar
to prospective DSL users; ii) A DSL should provide domain-specific concepts so long
as their semantics are invariant within the scope of the DSL’s application; iii) A DSL’s
concepts should allow for modelling that is sufficient for all foreseeable applications;
iv) A DSL should provide concepts that can clearly distinguish different abstraction
levels within a model; v) A clear mapping should exist between a DSL’s concepts to the
concepts of the relevant target representation. DSL developers can evaluate a particular
DSL against specific requirements that are derived from the generic requirements [1].
Kahraman and Bilgen [230] propose a qualitative framework for assessing DSLs that
guides the selection of key DSL quality characteristics to guide an evaluator. Bariˇsic
et al. [216] propose an experimental evaluation model for DSLs that focuses on usability
and is based on techniques for the experimental evaluation of user interfaces. These
previous studies highlight domain-appropriateness, simplicity, usability, formality and
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expressiveness as important criteria that should be considered when creating a DSL to
ensure that the resulting DSL is of high quality and that it can increase its likelihood of
being accepted by its users.
Perceived usability can be regarded as an important high-level construct of usability [231,
232]. The subjective measurements of usability and the objective measurements of
efficiency and effectiveness provide a comprehensive construct of usability [233, 234].
The International Standards Organization (ISO) defines usability as the extent to which
a product can be used by specified users to achieve specified goals with effectiveness,
efficiency, and satisfaction in a specified context of use [235, 236]. The next section
discusses standardised perceived usability measurement tools.
2.2.7 Standardised usability questionnaires
Standardised usability questionnaires (SUQs) are designed to assess a participant’s sat-
isfaction with the perceived usability of products during or immediately after usability
testing [231]. Hence, an SUQ can be used to assess the perceived usability of a software
language. An SUQ usually undergoes psychometric qualification that reports measure-
ments that can determine its reliability, validity and sensitivity [231, 237].
Nunnally [237] and Lewis [238] agree that among several other advantages, an SUQ
can offer the following benefits: i) Objectivity – a standardised measurement can allow
measurement statements of other practitioners to be independently verified by others;
ii) Replicability – an SUQ can make it easier to replicate a particular study through
the usage of standardised methods; iii) Quantification – notwithstanding that the ap-
plication of statistical methods to multipoint scale data is a point of controversy, stan-
dardised measurements allow usability practitioners and researchers to report results in
finer detail that use mathematical and statistical methods so that results can be better
understood; iv) Economy – in spite of the substantial amount of work that is required
when developing standardised measures, the measures in an SUQ becomes economical
to use once they have been developed; v) Communication – standardised measures allow
usability practitioners and researchers to efficiently and effectively communicate their
usability results; vi) Scientific generalisation – SUQs provide a platform for standardis-
ation that is essential for assessing the generalisability of results.
Several SUQs have been introduced over the past few decades [231, 238, 239]. These
SUQs have been introduced primarily to assist in the assessment of usability following
participation in scenario-based usability tests [231]. SUQs can be classified into two
categories. The first category of SUQs includes those that administered immediately
following the completion of a task or test-scenario within a study [231, 240, 241]. The
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second category of SUQs includes those that are used for administration at the end of a
study [231, 241]. A posttest SUQ can be used as a post-study questionnaire in a study
that evaluates a CIG modelling language. The rest of this section discusses some of the
post-test SUQs that have undergone a psychometric evaluation process.
The questionnaire for user interaction satisfaction (QUIS) is a post-study questionnaire
that was first published in 1988 [242]. The original version of QUIS had 90 items that
used a 10-step bipolar scale that was numbered from 0 to 9, and was aligned with
the negative response on the left in addition to an off-scale ‘NA’ response to indicate
non-availability [231]. A psychometric evaluation of the early version of the QUIS was
reported for a short-form version of the questionnaire with 27 items covering usability
aspects related to software, screen, terminology and system information, learning, and
system capabilities [231, 242]. The evaluation showed evidence of construct validity
and sensitivity although items in screen factor did not group as expected [231]. The
current version of the QUIS is available in five languages (English, German, Italian,
Portuguese, Spanish); in two lengths, short with 41 items and long with 122 items; and
using a nine-point bipolar scale with an off-scale ‘NA’ response similar to the initial
version [231]. A licence for the QUIS is required before usage of the questionnaire
as follows: i) A student licence requires 50 United States Dollars (USD50.00); ii) An
academic or non-profit license requires 200 United States Dollars (USD200.00); iii) A
commercial licence requires 750 United States Dollars (USD750.00) [231].
The software usability measurement inventory (SUMI) is a post-study SUQ that was
introduced in the 1990s by the Human Factors Research Group at the University Col-
lege Cork in Ireland [243, 244]. The SUMI is a 50-item questionnaire with a global
scale based on 25 of the items five subscales for measuring efficiency, effectiveness, help-
fulness, control and learnability [231, 244]. The SUMI contains a mixture of positive
and negative statements for its items that are measured on a three-scale step namely:
Agree, Undecided, and Disagree [244]. The SUMI is currently available in 12 lan-
guages (Dutch, English, Finnish, French, German, Greek, Italian, Norwegian, Polish,
Portuguese, Swedish, and Spanish) [231]. SUMI underwent a considerable amount of
psychometric evaluation which provided some evidence of construct validity and sensi-
tivity [231, 244]. Licences are required to allow one to use SUMI as follows: i) One
thousand Euros (EUR1000.00) for oﬄine usage; ii) Five hundred Euros (EUR500.00)
for online usage; iii) No fee for students [231].
The post-study system usability questionnaire (PSSUQ) is a post-study SUQ that was
introduced in the early 1990s as an internal project at International Business Machines
(IBM) Corporation [245]. The current version of the PSSUQ is a 19-item questionnaire
with a single global scale and three subscales that measure system quality, information
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quality and interface quality [246]. The items in PSSUQ are scored using values between
one and seven, with lower scores indicating a higher degree of satisfaction [245, 246]. The
PSSUQ underwent a considerable amount of psychometric testing that provided some
evidence of construct validity and sensitivity [245–247]. The PSSUQ does not require
any licence fee for its use [231].
The system usability scale (SUS) is a post-test SUQ that was developed in the 1980s [232,
248]. The SUS is 10-item questionnaire that is scored using a five-step scale [248]. The
scores from an SUS questionnaire are used to derive a single global scale [231, 248]. The
scores from an SUS questionnaire can also be used to reliably compute two subscales
that can measure usability and reliability [249]. Like other more prominent SUQs in
both research and practice, the SUS underwent a considerable amount of psychometric
evaluations [231, 250]. The 10 SUS items were selected from a pool of 50 potential
items [231, 248]. The psychometric tests provided evidence of reliability, sensitivity
and validity [231]. The SUS does not require a licence fee as a prerequisite for its
use [231, 248].
The usability metrics for user experience (UMUX) is a recently developed four-item post-
test SUQ that is based on a seven-point Likert scale designed to provide results on a single
global scale that is similar to SUS [251]. The UMUX is organised around the ISO9421-
11 definition of usability [252]. The UMUX has a shorter form variant UMUX-LITE
which only has two items that align it to the technology acceptance model [252, 253].
The UMUX has undergone limited psychometric evaluation. The validity, reliability and
sensitivity of UMUX as an SUQ has been criticised [253–255]. A recent study that was
conducted to evaluate the validity, reliability and sensitivity of UMUX provided some
evidence of construct validity and sensitivity of the UMUX questionnaire [252].
2.3 Context: Malawi
The sections that follow describe Malawi, which characterise the context of this research
work. The geography and population of Malawi are described in Section 2.3.1. That is
followed by a discussion of Malawi’s health sector in Section 2.3.2.
2.3.1 Geography, population and the economy of Malawi
Malawi is a landlocked country in the sub-Saharan Africa. The country covers an area
of approximately 118, 484 square kilometres, of which, 94, 276 square kilometres is land.
The country was colonised by the British from 1, 891 until its independence in 1964.
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Hence English is the official language in the country. The Central African country is
901 kilometres long, and 80 to 161 kilometres wide. Malawi is bordered by Mozam-
bique on both sides in the south, Tanzania in the north east, and Zambia in the north
west. [256] [257]
Malawi has an agro-based economy due to the fact that the country lies along the Rift
Valley. In the valley, and along the entire length of the country, lies Lake Malawi, which
has the Shire River draining water from it in the south. Hence there are fertile plains
and mountain ranges that stretch along the west and south of Lake Malawi, making the
region suitable for agricultural activities. [256]
Malawi is divided into three main regions. The regions are referred to as the northern,
central and southern regions in the north, central and south of Malawi respectively. The
regions have a total of 28 districts. The districts are administratively subdivided into
traditional authorities (TAs) that are managed by chiefs. Each TA has a number of
villages, which are the smallest administrative units that are managed by village head-
men [256]. In some instances, a group village headman (GVH) oversees several villages.
A village development committee (VDC), at GVH level, is responsible for development
activities. Development activities at TA level are coordinated by the area development
committee (ADC). Politically, each district is further divided into constituencies which
are represented by Members of Parliament (MPs). In some cases, these constituencies
can combine more than one TA [3].
Malawi has a tropical continental climate. The country’s rainfall and temperatures
vary depending on altitude and proximity to the lake. From May to August, Malawi
experiences its winter with cool and dry weather. From September to April, Malawi
experiences its summer with hot weather. And the rainy season begins around October
and continues until April [256]. Rainfall intensity is considered a key determinant of
pathogenic micro-organisms such that transmission of many parasitic diseases is confined
to the rainy season [258–260].
Malawi has a population of approximately 17.2 million people with an intercensal popu-
lation growth rate of 3.1% per year [5]. The country has a number of urban centres with
the four major ones being Blantyre and Zomba in the southern region, Lilongwe in the
central region and Mzuzu in the northern region. The percentage of urban population is
just above 15 percent, the rest being rural population [256]. The country has a moderate
life expectancy at birth of 64.8 for females and 62.9 for males [5]. Almost half of the
population is under 15 years of age and the dependency ratio rose from 0.92 in 1966
to 1.04 in 2008 [3, 261]. About 7% of the population are infants aged less than 1 year,
22% are children under five years of age and about 46% are aged 18 years and above.
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Malawi is predominantly a Christian country (83%), while 13% are Muslim, 2% of other
religions and 2% of no religion [3].
In 1994, Malawi adopted a National Population Policy, which was designed to reduce
population growth to a level compatible with Malawi’s social and economic goals. The
policy aims to reduce population growth, improve health and well-being, to improve
education, and to increase employment opportunities [256]. In the same year, the coun-
try also adopted a strategy to eradicate poverty, the Malawi Growth and Development
Strategy (MGDS) which was an initial five-year strategy that is now in its third instal-
ment as MGDS III [256, 261]. The MGDS is the overarching development strategy for
the country [261, 262].
Malawi has 13 African ethnic groups with the Chewas followed by the Nyanjas being the
biggest groups. Linguistically, each ethnic group has its own language. However, the
country has 16 listed living languages with English as the official and statutory national
working language. The majority of Malawians speak Chichewa, which is the national
language. [263]
The economy of Malawi is based primarily on agriculture, which accounts for 30 percent
of the gross domestic product (GDP). The country’s major exports are tobacco, tea,
and sugar. They account for approximately 85 percent of Malawi’s domestic exports.
Malawi, one of the poorest countries in Africa, has a GDP per capita of $1113. The
country is ranked at 170 out of 188 countries on the human development index (HDI).
Human development is about equal life chances for all that involves expanding capabili-
ties of people’s present choices - to live healthy, productive and safe lives. The available
statistics indicate that over ten million people live in multidimensional poverty. Over
61% live on less than $1.25 a day. [256] [261] [5] [257]
2.3.2 The health sector
In Malawi health care services are delivered by both the public and the private sectors.
The public sector includes all facilities under the Ministry of Health (MOH) and the
Ministry of Local Government and Rural Development, those of other ministries such
as Education, and the Police, the Prison Service and the Army. The private sector
consists of private-for-profit and private not-for-profit providers, mainly Christian Health
Association of Malawi (CHAM). The public sector provides services free of charge while
the private sector charges user fees for its services. [3, 257]
The MOH is a government agency that sets the agenda for health in Malawi in collabo-
ration with other stakeholders. The agency is responsible for developing, reviewing and
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enforcing health and related policies for the health sector; spearheading sector reforms.
It also regulates the health sector including the private sector in addition to develop-
ing and reviewing standards, norms and management protocols for service delivery and
ensuring that these are communicated to lower level institutions. Further to that, the
MOH is also responsible for planning and mobilizing of health resources for the health
sector; advising other stakeholders on health-related issues; providing technical support
for supervision; coordinating research; and monitoring and evaluation. [3]
The MOH established five Zonal Offices. The role of the Zonal Offices is to provide
technical support to District Health Management Teams (DHMTs) in the planning,
delivery and monitoring of health service delivery at the district level. The Zonal Offices
further facilitate central hospitals’ supervision of districts. [3]
Malawi has a high disease burden characterised by high prevalence of communicable dis-
eases, maternal and child health problems, and increasing burdens of non-communicable
and neglected tropical diseases. The Essential Health Package (EHP) that includes the
delivery of health services in Malawi, covers diseases and conditions affecting the major-
ity of the population and especially the poor. These services are offered free of charge
to Malawians. The services in the package are: vaccine preventable diseases; acute res-
piratory infections (ARIs); malaria; tuberculosis; sexually transmitted infections (STIs)
including HIV/AIDS; diarrhoeal diseases; Schistosomiasis; malnutrition; ear, nose, and
skin infections; perinatal conditions; common injuries; disability and mental illness; and
non-communicable diseases including hypertension and diabetes. [3] [257]
The health services are delivered at different levels, namely primary, secondary, and
tertiary. These different levels are linked to each other through a comprehensive referral
system that has been established within the health system. [3]
The primary care level in Malawi consists of community initiatives; health posts; dispen-
saries; maternity facilities; health centres; and community and rural hospitals. Health
surveillance assistants (HSAs), community-based distributing agents, village health com-
mittees and other volunteers provide most of the services at the community level. In
particular, the HSAs provide promotive and preventive health services such as immu-
nization services. In some instances, the HSAs have been trained and provide services
in community case management of diseases such as acute respiratory infections (ARIs),
diarrhoea and pneumonia among children under five years of age. Services at the commu-
nity level are conducted through door-to-door visits, village clinics and mobile clinics. [3]
Community health nurses and other health cadres also provide health services at the
community level through outreach programs. Village health committees promote pri-
mary health care activities through community participation and they work with HSAs
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on preventive and promotive health services such as hygiene and sanitation. [3]
At primary level, health centres support the HSAs. Each health centre has a health
centre advisory committee, and in collaboration with village health committees, helps
communities to demand the quantity and quality of services that are expected from
health centres. Health centres provide both curative and preventive healthcare services.
And at a higher level, community hospitals also known as rural hospitals, provide both
primary and secondary care with an admission capacity of 200 to 250 beds. [3]
The secondary level of health care is delivered from district hospitals in each district
throughout the country. With an admission capacity of 200 to 300 beds, the district
hospitals are referral facilities for both health centres and rural hospitals. The district
hospitals also deliver primary care services to the local town population. In addition to
the district hospitals, CHAM hospitals also provide secondary level health care services.
The district or CHAM hospitals provide general services, primary healthcare services and
technical supervision to lower healthcare service delivery units. District hospitals also
provide in-service training for various personnel in the provision of healthcare services
for community-based health programs. Health services within each district are managed
by the district health management team at the district hospital, which receives direct
technical support for supervision from Zonal Offices. [3]
This level consists of central hospitals that offer specialised services and in turn provide
referral health services for district hospitals in their respective regions. The four central
hospitals are Queen Elizabeth in Blantyre with 1250 beds, Kamuzu in Lilongwe with
1200 beds, Mzuzu in Mzimba District with 300 beds and Zomba in Zomba District with
450 beds. Tertiary care is also provided by Zomba Mental Hospital in Zomba. Queen
Elizabeth and Kamuzu Central Hospitals are also teaching hospitals, with links to the
College of Medicine and Kamuzu College of Nursing. Although the central hospitals also
provide healthcare services which ought to be delivered by district health services, they
are responsible for professional training, conducting research and providing support to
districts. There are plans to establish gateway clinics at all central hospitals in order to
decongest them. The gateway clinics will be run by the district health officers. [3]
CHAM, a non-profit health services provider, is the biggest partner for the MOH. It
provides healthcare services and trains health workers through its health training insti-
tutions. CHAM owns 11 of the 16 health-training institutions in Malawi, most of them
located in rural areas. CHAM facilities charge user fees to cover operational costs and
are also mostly located in rural areas. The Government of Malawi heavily subsidizes
CHAM by financing some Essential Medicines and all local staffing costs in CHAM
facilities. [3]
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The Malawi Traditional Medicine Policy guides the practice of traditional medicine in
Malawi. The health sector works with traditional healers through the Malawi Traditional
Healers Umbrella Organization (MTHUO). Although the relationship between the MOH
and traditional healers has been weak, the MOH and stakeholders in the health sector
have mainly engaged with traditional birth attendants (TBAs) with the intention of
expanding maternal and child health (MCH) services to the community. [3]
2.3.3 Electronic medical record systems in Malawi
The MOH in Malawi is increasingly deploying EMR systems for routine clinical practice
in both government and private health facilities with support from implementing part-
ners and donors. There have been significant efforts by the MOH to deploy the EMR
systems to support care delivery in primary care [136].
Malawi has developed EMR systems that support health workers through treatment,
diagnosis and cohort-reporting for a number of national treatment programs such as
antiretroviral therapy [122] and diabetes [264]. These disease-specific EMR systems
are designed to support health workers in-line with national clinical practice guide-
lines [122][264].
2.4 Contextual inquiry in Malawi
EMR systems integrated with CPGs are increasingly being deployed to support health-
care delivery in Malawi. To devise a lasting solution for CPG formalization, it was
essential to understand the challenges of operationalising guideline-based clinical deci-
sion support in EMR systems for Malawi. The challenges for Malawi were investigated
by means of a contextual inquiry with 13 health professionals in seven health facilities,
nine EMR system developers, and some of the implementation details of the national
EMR system in Malawi. [16]
2.4.1 Methods
One tertiary, one referral and five primary care health facilities were selected in Malawi
for observation of routine clinical practice. The observations were carried out for one
month in July 2014. Clinical encounters were observed during patient visits and ward
rounds for outpatients and inpatients respectively. In addition, semi-structured inter-
views were carried out with the health workers that were observed.
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Nine members of the software development team that develop and maintain the national
EMR systems for Malawi were also observed. In addition, semi-structured interviews
were carried out with the members of the EMR system developers that were observed.
Furthermore, code inspections of the national EMR systems were carried out through
a publicly accessible open source repository 1. The national ART and diabetes EMR
systems for Malawi were accessed and inspected.
2.4.2 Findings
Eighty minutes’ worth of interviews were recorded with thirteen healthcare workers in
the seven health facilities we observed. Of these healthcare workers, five were medical
doctors that had spent a minimum of six years in medical school; three were nurses that
had spent a minimum of three years in nursing school; and five were medical assistants
that had spent a minimum of a year in health sciences school. All of the healthcare
workers that were interviewed indicated that they use clinical practice guidelines during
routine clinical practice. Of the seven health facilities that were observed, four had a
version of the national EMR system deployed in at least some part of the health facility.
50.7% of the healthcare workers we interviewed indicated that they had used computers
since medical or nursing school. 30.8% of the healthcare workers indicated that they use
digital devices or computers routinely to support them during clinical consultation.
Eighty two minutes’ worth of interviews were also recorded with the members of the
software development team. Of the nine team members I observed and interviewed, four
were team leaders. The software developers that were interviewed had implemented CPG
rules in an EMR before and had varying experiences developing guideline-driven EMR
systems. From the interviews and the code inspections, it was indicated that there was no
uniform way of encoding CPG rules into the EMR systems. Furthermore, the CPG rules
that were encoded, were either hard-coded in software programs or encoded as records
in the database depending on developer preference. All the EMR system developers
found maintenance of CPG rules within the EMR systems challenging. The developers
indicated that CPGs are revised on a regular basis which necessitates updates to the
corresponding rules in the EMR systems. For instance, the Malawi clinical guidelines
for managing HIV services were revised in 2008, 2011 and 2014, warranting significant
efforts in maintaining the national ART EMR. One developer said that ‘changes in
guidelines require a deep understanding of the software implementation and it is hard to
maintain guidelines that apply across multiple EMR systems or multiple versions of a
particular EMR’. The developers also indicated that they are given very tight deadlines
to deliver working software. For instance, one software developer stated that ‘we get
1https://github.com/BaobabHealthTrust
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unrealistic demands from end-users’ and another developer further said that ‘we are
given unrealistic deadlines by product owners’. The developers preferred that CPG
rules be separated into their own layer or component on the software stack for ease of
maintenance. The raw data from the contextual inquiry is available in Appendix I.
2.4.3 Discussion
As Malawi seeks to scale up application of computerised guidelines, the current approach
that has been adopted requires a lot of software maintenance effort likely to make it
an unsustainable practice. In collaboration with the EMR system developers, health
workers, and other stakeholders, a viable direction would be one that allows generic
specification of CIGs for later integration with EMR systems. Such a direction may
enable generalised CPG support in EMR systems that would make it easier to support
new and revised CPGs for clinical decision support. The failure of large complex systems
such as EMR systems in meeting their deadlines, costs, and stakeholder expectations,
are not by and large failures of technology, rather, these projects fail because they do
not recognise the social and organisational complexity of the environment in which the
systems are deployed [265]. Implementing a sustainable guideline-based EMR system
needs a thorough understanding of the context such systems operate in.
Component-based software engineering is the process of defining, implementing, and
integrating or composing loosely coupled, independent components into systems [266].
As digital healthcare ecosystems are becoming larger and more complex, component-
based software engineering is becoming an important software development approach
that allows EMR systems to be built from reusable components [267, 268]. One way
that digital healthcare can cope with complexity and deliver better software more quickly
is to reuse rather than reimplement software components. In the same fashion, a CIG
can be specified once using a specialised CIG modelling environment that can transform
the CIG into an EMR platform specific CIG using model-driven engineering techniques.
Separating the CPG rules and their execution engine into a separate component of the
software architecture can improve the maintainability of the EMR systems. A healthcare
system adapting to the effects of growing expenditures and a diminishing primary work-
force needs the support of a flexible information infrastructure that facilitates innovation
in wellness, healthcare and public health [269]. Clinical guideline recommendations can
be encoded in a uniform way making it easier for CIG modellers to identify and update
specific recommendations every time corresponding national CPGs are revised. The
clinical guideline recommendations could be interpreted by a separate component, a
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guideline execution engine or evaluator, that could be part of the overall EMR archi-
tecture. A key characteristic of this approach to software design is that the system
components should be not only interoperable but substitutable [269].
Another key characteristic of a component-based approach to software design for a
flexible health information infrastructure is that the platform should be built to open
standards to facilitate customisation, extension and innovation [269]. Open standards
show promise as a means to achieving the true potential of EMR systems in improving
healthcare [270]. Any open standards initiative to develop EMR systems would draw
on the same ethos of peer review and open discovery that drives much of the research
component of the health industry [271][272]. An open standard CIG modelling platform
would allow the EMR system developer community to adopt, extend and integrate the
platform into their respective EMR systems fairly easily.
2.5 Chapter summary
This chapter has discussed related work to clinical guideline formalization for computer-
supported clinical decision support. The chapter further discussed the factors that char-
acterise Malawi as a context of this study. The last part of the chapter discusses results
from a contextual inquiry that was carried out in Malawi to gain a better understanding
of the context. The related work and the contextual inquiry highlighted some gaps that
motivated this research study. The gaps are summarised as follows:
i) There is need to support CPG application in task-shifted settings
ii) Most CIG formalization languages do not suit the modelling of public health CPGs
iii) Most existing CIG formalization environments are complex and still experimental,
hindering the likelihood of their adoption by CIG modellers
iv) There is inadequate support for evolving CIGs for clinical decision support in low-
and middle-income countries
. These gaps implied that there was a need to create a usable and effective evolving-CIG
modelling framework that can facilitate the provision of guideline-based clinical deci-
sion support in low- and middle-income countries. Therefore, the next logical question
was to ask what characterises CPG changes in low-resource settings. The literature
review also highlighted some opportunities that could be explored. The opportunities
are summarised below:
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i) The CIG modelling framework could consider a model-driven engineering approach
ii) Evaluation of the CIG modelling framework could consider the CIG modelling
language’s usability
iii) An experimental approach to the CIG DSL evaluation could be adopted
iv) The CIG modelling framework could leverage existing open standards in clinical
information systems that are widely adopted in low- and middle-income countries
v) Existing software language specification theories could be adopted during the CIG
DSL design phase
vi) A post-study standardised usability questionnaire could be used when evaluating
the novel CIG DSL
vii) The development of the CIG DSL proposed in this thesis could use the Xtext
modelling framework as it is based on open standards
viii) Existing usability evaluation approaches can be adopted during the CIG DSL
evaluation phase
ix ) The CIG DSL proposed in this thesis could be evaluated against the current HL7
standard for modelling CIGs
. Taking into account the afore summarised gaps and opportunities, as presented previ-
ously in Section 1.3, the following research questions were posed:
1. What are the CPG change requirements for modelling an evolving CIG?
2. Can a model-driven engineering approach adequately support the modelling of an
evolving CIG?
3. What is the effect of modelling an evolving CIG using FCIG in comparison with
the HL7 standard for modelling CIGs?
. The research in this thesis aimed to address these research questions. The detailed
methodologies for each of the four studies in this research discuss how the opportunities
summarised in this section were exploited. The next chapter discusses the research
approach that was undertaken in this study in order to answer the research questions.
Chapter 3
Research design
The work in this thesis was conducted over a series of four separate but related studies.
In this chapter I present and describe the overall approach that I adopted to carry out
the research presented in this thesis.
3.1 Research questions
The aim of this work was to devise an appropriate framework for modelling and maintain-
ing CIGs in computer-supported clinical information systems for low- and middle-income
countries.
In order to address the research problem, I formulated the following research questions:
1. RQ1 – “What are the CPG change requirements for modelling an evolving CIG?”
2. RQ2 – “Can a model-driven engineering approach adequately support the modelling
of an evolving CIG?”
3. RQ3 – “What is the effect of modelling an evolving CIG using FCIG in comparison
with the HL7 standard for modelling CIGs?”
3.2 Research approach
I developed and applied this research in the context of public health facilities in Malawi.
I used a mixed-methods approach that drew on a combination of methods that included
formal specification, software language design, experimental evaluation, and quantitative
and qualitative data analyses.
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I started by characterising changes that occur in CPGs using clinical guideline docu-
ments from Malawi. After characterising the CPG changes, I conceptualised a novel
evolving CIG modelling architecture that enables computational support for managing
CPG changes. At the centre of the CIG modelling architecture, I designed a domain-
specific language FCIG that conforms to an evolving CIG conceptual model that ex-
plicitly specifies the elements that are affected by CPG changes. Finally, I evaluated
FCIG and its modelling architecture for its adequacy, usability and effectiveness when
modelling evolving CIGs.
I segmented the research into four separate but related studies focusing on specific
concerns towards answering the research questions presented in Section 3.1. The detailed
methodologies for each of the studies are detailed in the respective chapters that discuss
the individual studies.
In order to answer the first research question RQ1, I carried out a study that elucidated
and categorised clinical practice guideline change requirements for low- and middle-
income countries in the context of Malawi. The detailed methodology and results from
that study are discussed in Chapter 4.
In order to answer the second research question RQ2, I carried out two studies that
focussed on the following: i) The second study evaluated whether FCIG could be used
to model an evolving CIG. The second study further evaluated whether FCIG could
directly support fine-grained CPG changes. The methodology and the results from the
study are detailed in Chapter 5; ii) The third study evaluated whether the language
constructs of FCIG were usable. The methodology and the results from the study are
detailed in Chapter 6.
In order to answer the third research question RQ3, I carried out a study that com-
pared FCIG with the HL7 standard Arden Syntax when modelling evolving CIGs. The
methodology and the results from the third study are detailed in Chapter 7.
3.3 Legal and ethical arrangements
I obtained ethical clearance for the research with approval number FSREC 018-2014
from the Science Faculty at the University of Cape Town. I further obtained ethical
clearance for the research with approval number NHSRC # 1293 from the National
Health Sciences Research Committee in Malawi. Furthermore, I obtained formal au-
thorisation to visit and carry out research work at specific health facilities from the
Lilongwe District Health Office. Refer to Sections A.1–A.4 of appendix A for copies of
the approval and authorisation letters.
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As the research involved working in the electronic health records domain, in all instances
where patient data was required, I used anonymised retrospective patient records to
protect the privacy of the patients and maintain confidentiality of the data.
3.4 Chapter summary
This chapter has outlined the approach that was undertaken to conduct this research.
The research was structured into four separate but related studies. Each of the four
studies, together with their detailed methodologies, are discussed in chapters that fol-
low.
Chapter 4
Characterising clinical practice
guideline changes
4.1 Introduction
In this chapter, I characterise CPG changes. I take a bottom-up inductive learning
approach to analyse successive sets of CPGs to elucidate and characterise the changes
that occur over time.
4.2 Materials and methods
I began by requesting and obtaining copies of guideline documents from the Central
Monitoring and Evaluation Division (CMED) of the Malawi Ministry of Health. I re-
quested only the guideline documents that had been used in the past or were still in use
by healthcare workers in public health facilities.
After obtaining the guideline documents, I selected a set of guideline documents span-
ning at least three successive versions of CPGs. I examined each guideline document
within the set to identify and extract candidate guideline recommendations. Thereafter,
I encoded the extracted candidate guideline recommendations into Guideline Elements
Model (GEM) using GEM Cutter version 3.0. I selected GEM Cutter because it for-
malizes CPGs into a structure that is close to the structure of published CPG text
from guideline documents through a documentary approach to CPG modelling [69]. I
encoded all candidate guideline recommendations whose conditions and actions were
clearly specified in the originating guideline document. I did not encode other clinical
facts and supporting information for CPGs.
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After extracting and encoding the candidate guideline recommendations, I compared
the first and the second version of CPGs from the selected set. Thereafter, I repeated
the process by comparing the second and third versions of the CPGs. For each com-
parison cycle, I adopted an inductive learning approach to extract and document the
guideline changes that I observed. Inductive learning allows people to discover patterns
in a seemingly chaotic collection of observations [273] making it a powerful strategy
for helping people deepen their understanding of content [274]. Following the inductive
learning approach, I begin by selecting a candidate guideline recommendation from the
GEM encoded sample. Thereafter, I analysed the candidate recommendation to identify
its equivalent guideline recommendation in a successive version of the CPG. In those
instances where an equivalent guideline recommendation was found, I compared the two
versions of the candidate guideline recommendation. For those guideline recommenda-
tion sets that were found to be different, I recorded the change by specifying the change
or refining an existing specification of the change. I repeated this process until all the
candidate guideline recommendations were analysed in each comparison cycle. Refer
to figure 4.1 for an overview of the comparison cycle within the change specification
process.
Finally, I analysed the recorded incidents of the changes between the first and the second
version of the CPGs. I repeated this analysis with the second and the third version of
the CPGs.
4.3 Types of CPG changes and their incidence
4.3.1 Encoding clinical practice guideline recommendations
Firstly, I obtained several copies of CPG documents from the Malawi the Ministry of
Health. I identified three successive versions of CPGs from the copies of the CPG
documents. The identified CPGs were used by health workers for the provision of HIV
services. The three versions of the CPGs were published by the Malawi Ministry of
Health in 2008, 2011 and 2014.
Secondly, I examined 114 pages of the 2008 version of the CPG text for managing HIV
services for the presence of candidate guideline recommendations within the CPGs. I
identified 13 CPGs from which I extracted and encoded 105 candidate guideline recom-
mendations into GEM.
Thirdly, I examined 79 pages of the 2011 version of the CPG text for managing HIV
services for the presence of candidate guideline recommendations within the CPGs. I
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Figure 4.1: Change specification process
identified 21 CPGs from which I extracted and encoded 85 candidate guideline recom-
mendations into GEM.
Finally, I repeated the previous process with the 2014 version of the CPG text. I
examined 95 pages of the guideline text for the presence of candidate guideline rec-
ommendations within the CPGs. I identified 19 CPGs from which I extracted and
encoded 98 candidate guideline recommendations into GEM. Refer to appendix A for
detailed report extracts of the 2008, 2011 and 2014 versions of GEM encoded CPGs for
the “Malawi Clinical Management of HIV”. For a summary of the totals of the GEM
encoded guidelines, refer to table 4.1.
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Table 4.1: Summary of the characteristics of the GEM encoded CPGs
Year No. of pages No. of CPGs No. of recommendations
2008 114 13 105
2011 79 21 85
2014 95 19 98
Totals 288 53 288
4.3.2 Comparing CPG versions
To begin with, I compared the 2008 with the 2011 version of the GEM encoded CPGs
to identify and specify the changes between the two. After analysing the 105 and 85
candidate guideline recommendations from the 2008 and 2011 CPG versions respectively,
I noted that 75 candidate guideline recommendations from the 2008 CPG version were
discontinued in the 2011 CPG version. Of the 30 candidate guideline recommendations
that were carried over from the 2008 CPG version to the 2011 CPG version, I noted
that 27 were changed with 41 individual changes in total. Furthermore, I noted that 55
new candidate guideline recommendations were introduced in the 2011 GEM encoded
sample.
Thereafter, I repeated the process with the 2011 and the 2014 versions of the GEM
encoded CPGs. I compared the candidate guideline recommendations in the two CPG
versions to identify and specify changes between the two. After analysing the 85 and
98 guideline recommendations from the 2011 and 2014 CPG versions respectively, I
noted that three candidate guideline recommendations from the 2011 CPG version were
discontinued in the 2014 CPG version. I also noted that, of the 82 candidate guideline
recommendations that were carried over from the 2011 CPG version to the 2014 CPG
version, 12 were changed with 17 individual changes in total. Furthermore, I noted that
16 new candidate guideline recommendations were introduced in the 2014 GEM encoded
sample. Table 4.2 shows a summary of the characteristics of the guideline changes that I
identified. The raw data regarding the CPG change incidents is available in Appendix J.
In the next section, I will categorise and describe the changes that I have identified
in this section using both an example of the actual changes—indicated in bold in the
examples—and a generalised specification of the change.
For this generalised specification, I use the following notation. Let the following deno-
tations hold for CPG structural elements: clinical practice guideline be CPG, guideline
recommendation be GR, condition be C, decision variable be DV, value for a decision
variable be DVV, recommended action be RA, action verb be AV, and a verb complement
for an action verb be AVC. Then the state before the change is indicated with a subscript
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time “t” and the changed CPG one chronon later, “t+1” (which for the examined CPGs
is 3 years). Anything unchanged is omitted from the notation to avoid clutter.
Table 4.2: Characteristics of CPG changes
Characteristic 2008/2011 2011/2014
No. of discontinued recommendations 75 3
No. of new recommendations 55 16
Instances of changes to recommendations 41 17
No. of recommendations with changes 27 12
Total number of changes in CPGs 171 36
4.3.3 CPG Change Categories
There are 10 categories in total. The changes are discussed in the following sections.
4.3.3.1 Addition of a decision variable to a guideline condition
A decision variable can be added to the condition for CPG execution if and only if the
condition for the guideline recommendation already has at least one decision variable.
CPGt = {DV1, ..., DVn; ...}
CPGt+1 = {DV1, ..., DVn+1; ...}
For example, the guideline recommendation for providing ART in special situations for
older children from age three years and older that have active TB, had an additional
decision variable ‘weight’ introduced in the 2014 version of the CPG as shown below:
2011 version
IF Active TB = [present] AND
On ART = [No] AND
Age >= [3 years & < 15 years] AND
HIV test result = [Positive]
THEN
Prescribe AZT/3TC + EFV AND
Initiate ART within 14 days
2014 version
IF Active TB = [present] AND
On ART = [No] AND
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HIV test result = [positive] AND
Age >= [3 years] AND
Weight < [35 kg]
THEN
Prescribe regimen 4P/4A AND
Initiate ART within 14 days
4.3.3.2 Change of a decision variable value
A value of a decision variable can be changed in a condition for CPG execution when
a guideline recommendation has a set of decision variables for a condition under which
the guideline is to execute when the condition is true.
CPGt = {C1{DV1,DVV1=a}, ..., Cn{DVn,DVVn}; ...}
CPGt+1 = C1{{DV1,DVV1=b}, ..., Cn{DVn,DVVn}; ...}
where a 6= b
Equally, the guideline recommendation for determining ART eligibility in children aged
12 months and above, had the value of the decision variable Age changed as follows: For
this generalised specification, I use the following notation. Let the following denotations
hold for CPG structural elements: clinical practice guideline be CPG, guideline recom-
mendation be GR, condition be C, decision variable be DV, value for a decision variable
be DVV, recommended action be RA, action verb be AV, and a verb complement for an
action verb be AVC. Then the state before the change is indicated with a subscript time
“t” and the changed CPG one chronon later, “t+1” (which for the examined CPGs is 3
years). 2011 version
IF Age = [12 to 24 months] AND
HIV test result = [positive]
THEN
Patient is eligible for ART
2014 version
IF Age = [12 to 60 months] AND
HIV test result = [positive]
THEN
Patient is eligible for ART
4.3.3.3 Removal of a decision variable from a guideline condition
A decision variable can be removed from the condition for CPG execution if and only if
the set of decision variables under which the guideline is to execute when the condition
is true, has at least two variables.
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CPGt = {DV1 ...DVn; ...}
CPGt+1 = {DV1 ...DVn−1; ...}
For instance, the guideline recommendation for suspecting ART failure due to a new
WHO clinical stage condition, had the CD4 count decision variable removed from the
2011 version of the CPG as follows:
2008 version
IF On ART = [Yes] AND
Duration of ART = [12 months or more] AND
Adhering to therapy = [Yes] AND
New WHO stage 4 = [Present] AND
CD4 count = [< 200 cells/mm3]
THEN
Patient has suspected ART drug failure
2011 version
IF On ART = [Yes] AND
Duration of ART = [12 months or more] AND
New WHO stage 3 or 4 = [Present] AND
THEN
Patient has suspected ART drug failure
4.3.3.4 Change of a decision variable
A decision variable can be replaced with another decision variable within a condition
for CPG execution if and only if the condition under which the guideline is to execute
exists.
CPGt = {{DV1=a} ...DVn; ...}
CPGt+1 = {{DV1=b} ...DVn; ...}
where a 6= b
For example, the guideline recommendation for determining dosage of CPT in infants
aged five months or younger, had the Age decision variable changed to weight in the
inclusion criteria of the guideline recommendation for the 2011 version of the CPG as
follows:
2008 version
IF Age = [6 weeks to 5 months] AND
Eligible for CPT = [Yes]
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THEN
CPT dosage is 120mg once a day
2011 version
IF Weight = [< 6kg] AND
Eligible for CPT = [Yes]
THEN
CPT dosage is 120mg once a day
4.3.3.5 Addition of a recommended action
A recommended action can be added to a set of recommended actions within a guideline
recommendation for CPG execution if and only if a guideline recommendation has got
at least one recommended action.
CPGt = {RA1 ...RAn; ...}
CPGt+1 = {RA1 ...RAn+1; ...}
Equally, the guideline recommendation for managing a patient presenting with renal
failure, had an additional recommended action added to the 2011 version as follows:
2008 version
IF On ART = [No] AND
Renal failure = [Present] AND
HIV test result = [Positive]
THEN
Refer to district or central hospital AND
Do not exclude from treatment
2011 version
IF On ART = [No] AND
Renal failure = [Present] AND
Age category = [Adult] AND
HIV test result = [Positive]
THEN
Refer to district or central hospital AND
Prescribe Regimen 4 AND
Start ART within 7 days of diagnosis
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4.3.3.6 Removal of a recommended action
A recommended action can be removed from an action set for CPG execution if and
only if the guideline recommendation under which the CPG is to execute has more than
one recommended action.
CPGt = {RA1 ...RAn; ...}
CPGt+1 = {RA1 ...RAn−1; ...}
For example, the guideline recommendation for managing a patient presenting with
renal failure, had the recommended action for “automatically excluding patients from
treatment” removed from the 2011 version of the CPG as follows:
2008 version
IF On ART = [No] AND
Renal failure = [Present] AND
HIV test result = [Positive]
THEN
Refer to district or central hospital AND
Do not exclude from treatment
2011 version
IF On ART = [No] AND
Renal failure = [Present] AND
Age category = [Adult] AND
HIV test result = [Positive]
THEN
Refer to district or central hospital AND
Prescribe Regimen 4 to patient AND
Start ART within 7 days of diagnosis
4.3.3.7 Change of an action verb complement
A verb complement of an action verb within a recommended action for CPG execution,
can be replaced with another verb complement, if and only if at least one recommended
action in the guideline recommendation under which the CPG is to execute exists.
CPGt = {RA1{AV1,AVC1=a}, ..., RAn{AVn,AVCn}; ...}
CPGt+1 = {RA1{AV1,AVC1=b}, ..., RAn{AVn,AVCn}; ...}
where a 6= b
For instance, the guideline recommendation for managing a patient presenting with renal
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failure in adults, had the action verb complement for the ‘medication prescription’ action
changed in the 2014 version of the CPG as follows:
2011 version
IF On ART = [No] AND
Renal failure = [Present] AND
HIV test result = [Positive] AND
Age = [>= 15 years]
THEN
Refer to district or central hospital AND
Prescribe Regimen 4 AND
Start ART within 7 days of diagnosis
2014 version
IF On ART = [No] AND
Renal failure = [Present] AND
HIV test result = [Positive]
THEN
Refer to district or central hospital AND
Prescribe Regimen 0 AND
Start ART within 7 days of diagnosis
4.3.3.8 Change of a recommended action
A recommended action for CPG execution can be replaced with another recommended
action if and only if the guideline recommendation under which the CPG is to execute
has at least one recommended action.
CPGt = {{RA1=a} ...RAn; ...}
CPGt+1 = {{RA1=b} ...RAn; ...}
where a 6= b
For example, the guideline recommendation for managing a patient presenting with
acute hepatitis, had the recommended action changed in the 2011 version of the CPG
as follows:
2008 version
IF On ART = [No] AND
Jaundice = [Present] AND
HIV test result = [Positive]
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THEN
Do not prescribe Regimen 1
2011 version
IF On ART = [No] AND
Jaundice = [Present] AND
HIV test result = [Positive]
THEN
Refer to district/central hospital
4.3.3.9 Addition of a guideline recommendation
A candidate guideline recommendation can be added to a CPG if and only if the CPG
has at least one existing candidate guideline recommendation.
CPGt = {GR1 ...GRn; ...}
CPGt+1 = {GR1 ...GRn+1; ...}
For example, the candidate guideline recommendation for determining ART eligibility
in infants presenting with Cryptococcal meningitis was added to the 2011 version of the
CPG for determining ART eligibility.
4.3.3.10 Removal of a guideline recommendation
A candidate guideline recommendation can be removed from a CPG if and only if the
CPG has two or more candidate guideline recommendations.
CPGt = {GR1 ...GRn; ...}
CPGt+1 = {GR1 ...GRn−1; ...}
For instance, the candidate guideline recommendation for determining ART eligibility
in infants associated with recent HIV related maternal death was removed from the 2011
version of the CPG for determining ART eligibility.
4.3.4 CPG change occurrences
Given the aforementioned type of changes, we analysed their incidence for the HIV CPGs
of Malawi. A summary of the frequencies of CPG changes is presented in Table 4.3.
Of the 30 candidate guideline recommendations that were carried over from the 2008 to
the 2011 version of the CPGs, 27 were modified with 41 incidents of guideline recom-
mendation changes. Similarly, 12 candidate guideline recommendations were modified
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with 17 incidents of guideline recommendation changes from the 82 candidate guideline
recommendations that were carried over from the 2011 to the 2014 version of the CPGs.
The frequencies of the changes that were identified between 2008 and 2011 version of
the CPGs were higher than those frequencies identified between the 2011 and the 2014
version of the CPGs. Three types of changes, addition of a a recommended action,
removal of a recommended action and change of recommended action, that occurred
between the 2008 and 2011 version of the CPGs were not identified in the changes that
occurred between the 2011 and the 2014 version of the CPGs.
Table 4.3: Frequency of changes in the Malawi clinical management of HIV CPGs.
Category Type of change
2008/2011 2011/2014
# % of total # % of total
Decision
Addition of a decision
variable to a guideline con-
dition
3 1.8 2 5.6
Change of a decision vari-
able value
13 7.6 4 11.1
Removal of a decision vari-
able from a guideline con-
dition
2 3.8 2 1.2
Change of a decision vari-
able
12 7.0 5 13.9
Action
Addition of a recom-
mended action
2 1.2 0 0.0
Removal of a recom-
mended action
2 1.2 0 0.0
Change of an action verb
complement
5 2.9 4 11.1
Change of a recommended
action
2 1.2 0 0.0
Recommendation
Addition of a recommen-
dation
55 32.2 16 44.4
Removal of a recommen-
dation
75 43.9 3 8.3
4.3.5 Analysis of existing CIG models
Having identified the characteristics of CPG changes, we further analysed existing CIG
models with respect to the changes. CIG models were identified from existing literature
accessible through Google Scholar, PubMed and Open Clinical portal. GLIF, Arden
Syntax, SAGE, EON, PROforma and Asbru [11] were analysed with regards to CPG
changes. Project websites, where accessible, were accessed to analyse any tutorials
and demonstrations that were found. Any knowledge modelling tools that were freely
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available were also downloaded and analysed. We analysed Arden Syntax Checker for
Windows, AsbruView, Tallis, SAGE workbench and GLIF Ontology in Prote´ge´.
The results of the analysis are now presented. Table 4.4 summarises CPG structural
components that are explicitly defined in existing CIG models and are directly accessible
within existing knowledge modelling tools. An alignment of our terms and representation
primitives from the existing CIG models are presented in table 4.5. From these results,
we can see that fine-grained CPG structural components that are affected by the changes
characterised in the previous section, are not explicitly defined as modelling elements in
existing CIG models. The fine-grained components in existing CIG models are implicitly
defined as part of other structural components, specified either as free text or using a
formal expression language such as GELLO [96]. As a result, all the changes that were
presented in the previous section and affect fine-grained CPG structural components
cannot be represented using concepts from existing CIG models.
Table 4.4: CPG structural components explicitly defined in CIG models.
Structural
Component
Arden
Syntax
GLIF SAGE EON PROforma Asbru
Condition (C) Yes Yes Yes Yes Yes Yes
Decision variable (DV) No No No No No No
Decision variable value
(DVV)
No No No No No No
Recommended action
(RA)
Yes Yes Yes Yes Yes Yes
Action verb (AV) No No No No No No
Action verb comple-
ment (AVC)
No No No No No No
Table 4.5: Representation primitives in existing CIG models.
Structural
Component
Arden
Syntax
GLIF SAGE EON PROforma Asbru
Condition (C) Logic
slot
Decision
step
Decision Decision Decision Plan
Recommended
action (RA)
Action
slot
Action
spec
Action Action/
Activity
Action/
Inquiry
Condition
4.4 Discussion
Evidence-based CPGs, available to task-shifted health workers at the point-of-care through
CDSSs, are a necessity towards improving the delivery of care. Due to the evolving na-
ture of clinical practice, CIGs in CDSSs need to be updated on a continuous basis to
provide recommendations based on up-to-date evidence-based CPGs. Characteristics of
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CPG changes need to be specified precisely if CPG change operations are to be mod-
elled accurately to ensure adequate clinical knowledge evolution support in CIGs. The
complexity of CIG models, a demanding and time-consuming formalisation process, de-
mands automating parts of the modelling process and modelling adaptations to decrease
the required implementation effort for CIGs [61].
Fundamental change operations of a CIG are defined from the addition, removing and
changing of basic structural components of a CPG. The 10 types of CPG changes identi-
fied within three categories cover changes that affect both coarse-grained and fine-grained
structural components of a CPG. The coarseness of the basic structural components in
existing CIG models can not sufficiently allow for specification of precise semantics for
CPG change operations. This limits the ability to explore the properties and limita-
tions of existing CIG models with respect to handling the 10 types of CPG changes.
Extensions to include the fine-grained structural components in a CIG would provide
a sufficient foundation for modelling change operations that can be used to provide
adequate knowledge evolution support in an implementation.
The categorisation of changes can also apply to other developing countries with similar
characteristics, such as those in the sub-Saharan Africa. In addition, the categorisation
of changes can also apply to other clinical domains that deploy or task-shifted health
workers such as clinical management of diabetes.
There was a significant difference between the updates introduced in the 2011 and the
2014 version of the CPGs with regards to the number of new guideline recommendations
that were introduced in each update. This might have been due to the fact that Malawi
introduced new recommendations into the 2011 Malawi CPGs for providing HIV services
based on the 2010 World Health Organisation (WHO) recommendations for managing
HIV-positive pregnant and breastfeeding women [275].
Having identified the characteristics of types of CPG changes and their incidences, pre-
cise semantics for modelling and handling CPG changes can be formally specified. The
CPG changes and their related semantics would give one a basis for modifying and
extending existing CIG models and related modelling platforms with capabilities for
handling CPG updates.
4.5 Chapter summary
I have described an evidence-based characterisation of the types of CPG changes and
their incidences. For each type of change, I have specified precisely each structural
component that exhibits a change and a description of how that particular change occurs
to facilitate its application. The characterisation of the types of changes serve as a
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foundation for devising formal semantics that can support the handling of CPG updates
in a CIG model suitable for regions that have adopted task-shifting. A CIG conceptual
model that is aware of the elements that are affected by CPG changes can serve as a
template for providing tooling that can support evolving CIGs in a model-driven clinical
information system.
In the next chapter, I conceptualise an evolving CIG and propose a layered architecture
for modelling these evolving CIGs. I further evaluate the novel CIG modelling architec-
ture for its adequacy in modelling an evolving CIG and its ability to enable smart-editing
features for the CIG elements that are affected CPG changes.
Chapter 5
Modelling evolving
computer-interpretable guidelines
5.1 Introduction
This chapter introduces the concepts of evolving CIG and evolving CPG formalization.
I start by discussing how a novel CIG modelling architecture was developed following a
model-driven approach. I further discuss how I evaluated this novel architecture for its
adequacy in supporting the authoring and maintenance of CIGs.
5.2 Evolving clinical practice guideline formalization
An electronic medical record system that uses CPGs should allow changes to be applied
to its CIGs systematically when changes to CPGs occur. In order to provide automated
or semi-automated support to the CIG modeller when applying these changes, an evolv-
ing CIG conceptual model is required. The specification of the evolving CIG conceptual
model should contain explicit and invariant definitions of all the elements that are af-
fected by CPG changes. Recall the types of CPG changes summarised in Table 5.1. A
language model and a concrete syntax can then be mapped from this evolving CIG con-
ceptual model, enabling the automated creation of tools that can support the authoring
and maintenance of CIGs through smart-editing features.
An individual CPG has one or more guideline recommendations. Each of the guideline
recommendations has one or more conditions, which must be satisfied in order for a
particular recommended action to be executed. Each condition has a decision variable
that is tested to determine whether it is appropriate to execute one or more related
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Table 5.1: Types of CPG changes [2]
.
Category Type of change
Updating decisions
Adding a decision variable
Changing a value of a decision variable
Removing a decision variable
Changing a decision variable
Updating actions
Adding a recommended action
Removing a recommended action
Changing an action verb complement
Changing a recommended action
Updating guideline recommendations
Adding a guideline recommendation
Removing a guideline recommendation
recommended actions. The actual value of a decision variable that is tested whether
a particular set of recommended actions is appropriate or not, is referred to as a vari-
able value. Different variable values can be stored in different units of measure. Each
recommended action within the guideline has an action verb that determines the type
of action to be taken, and an action verb complement that completes the sense of the
action verb by referring to a direct or indirect object. When a new version of a CPG is
introduced, any of these concepts can be affected.
Let me illustrate this with an example, so as to clarify the context in which evolving
CIGs are used. I use the CPG for determining ART eligibility in children and adults
aged five years and above from the Malawi guidelines for the clinical management of
HIV of 2011 and 2014. Extracts of the CPG from the guideline documents of 2011 and
2014 are presented in Fig. 5.1. The elements that make up the CPG are highlighted
and the change has been explicitly pointed out in the figure: when a new version of the
CPG was introduced in 2014, a change of type ‘changing a type of a decision variable’
had occurred.
5.3 Materials and methods
In order to evaluate the feasibility of creating a modelling architecture that can support
evolving CPG formalization, I started by defining a four-layer CIG modelling architec-
ture that is based on a model-driven engineering approach. Thereafter, I defined a formal
evolving CIG conceptual model that explicitly specifies the elements that are affected
when CPG changes occur. I later systematically map the evolving CIG conceptual model
into a comprehensive language model that includes denotational semantics and a formal
abstract syntax. I mapped the formal language model into a sufficient concrete syntax
specification for a model-based DSL that is tailored towards the modelling of evolving
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Figure 5.1: CPG for determining antiretroviral therapy (ART) eligibility in 2011 and
2014 of Malawi HIV CPGs, with each fine-grained element colour coded (see legend on
the right of the figure as insert)
CIGs, that I have named FCIG. Finally, I carried out a scenario-based and an empirical
evaluation of FCIG using CPGs from Malawi.
5.3.1 Research questions
Recall the second research question RQ2 in Section 3.1:
Can a model-driven engineering approach adequately support the modelling of an evolving
CIG?
In this study, I split the evaluation in two dimensions to address research question RQ2.
The first dimension focused on CPG representation adequacy. The second dimension
focused on the capacity to support the CIG modeller when applying a specific change.
As a result, I formulated two subquestions to guide the evaluations for each of the two
dimensions as follows:
RQ2-S1: Can FCIG be used to model an evolving CIG adequately?
RQ2-S2: Can FCIG directly support the application of fine-grained CPG changes?
I investigated the representational accuracy and adequacy of FCIG including FCIG ’s
ability to provide smart-editing support for the CPG elements that are affected by a
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change. I obtained CPG documents from Malawi and encoded guideline recommen-
dations from the CPG documents using FCIG. To answer sub-question RQ2-S1, I
measured the number of guideline recommendations that were encoded using FCIG suc-
cessfully. To answer RQ2-S2, I measured the number of language concepts that were
directly supported by smart-editing features when a language concept was affected by a
CPG change.
5.3.2 Research approach
I used a quantitative approach to conduct the two studies for this evaluation. The first,
was to assess the adequacy in encoding an evolving CIG using FCIG. The second, was
to assess FCIG ’s ability to support, and awareness of, evolving CIG concepts that are
affected when a change occurs. I collected quantitative data regarding the number of
guidelines and associated guideline recommendations that were able to satisfy each of
the two requirements.
5.3.3 Study design
I obtained a convenient sample of CPG documents from the Malawi Ministry of Health.
The CPG documents were the ones that the officials from the Central Monitoring and
Evaluation Division (CMED) of the Malawi Ministry of Health had provided. From the
convenient sample of CPG documents, I selected the Malawi integrated guidelines for
the clinical management of HIV and the guideline for community integrated manage-
ment of child illnesses (IMCI) because they are comprehensively documented and are
operationalised within the national EMR systems in Malawi. I further used the stratified
random sampling technique to select representative samples of guideline recommenda-
tions from the integrated guidelines. Stratified random sampling allows a researcher to
obtain a sample that best represents an entire population under study by ensuring the
presence of key subgroups within a population [231, 233]. I used the Malawi medical
concept dictionary to obtain a controlled set of medical vocabulary.
5.3.3.1 Evaluation study one: Assessing FCIG’s CPG representation ade-
quacy
In this study, I set out to answer research subquestion RQ2-S1. Noting that the structure
of guideline recommendations are usually similar within a particular guideline, I strati-
fied the guideline recommendations within the integrated guidelines by guideline. From
each guideline, I selected a weighted random sample of guideline recommendations for
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inclusion. I derived the randomised sample through a digital randomisation application
called Random UX1. Thereafter, I encoded the selected guidelines using FCIG.
5.3.3.2 Evaluation study two: Assessing FCIG’s ability to support CPG
changes
In this study, I set out to answer research subquestion RQ2-S2. Noting that the opera-
tions required to apply a particular type of change are similar, I stratified the guideline
recommendations from the Malawi HIV guidelines by type of CPG change. For each
type of CPG change, I selected a weighted random sample of guideline recommenda-
tions from the 2008 version of the guidelines. I derived the randomised sample through
a digital randomisation application called Random UX1. I later encoded each selected
guideline recommendation using FCIG. For each encoded guideline recommendation, I
applied its associated change that was required to update it to its 2011 version.
5.3.4 Criteria to address the research question RQ2
In this section, I describe the criteria that I used to address the second research question
RQ2 through subquestions RQ2-S1 and RQ2-S2.
5.3.4.1 Criteria to address research subquestion RQ2-S1
In order to address research question RQ2-S1, I recorded the total number of guideline
recommendations in the guideline strata and attempted to model the guideline recom-
mendations using FCIG. Recall, from the discussions in Chapter 4, that the conceptual
models of existing CIG modelling languages do not have explicit concepts for specifying
fine-grained CPG representation primitives such as action verb and verb complement.
Hence, adequate representation of a recommendation in a CPG was regarded as an in-
stance whereby FCIG modelling primitives were used to specify all guideline recommen-
dation concepts, including fine-grained constructs. I recorded the number of guideline
recommendations from the guideline strata that were adequately encoded using FCIG
in order to measure task completion rate.
I formulated the following hypothesis to guide my analyses:
H0: FCIG can not be used to complete CPG encoding tasks.
H1: FCIG can be used to complete CPG encoding tasks adequately.
1https://play.google.com/store/apps/details?id=ru.uxapps.random&hl=en
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5.3.4.2 Criteria to address research subquestion RQ2-S2
In order to address research question RQ2-S2, I encoded the 2008 versions of the
guideline recommendations from the CPG change type strata using FCIG. I recorded
the total number of required CPG changes in the CPG change type strata. Thereafter,
I attempted to apply the individual changes to the encoded guidelines. I took note
whether the evolving CIG semantic elements that were affected by each change were
directly supported by smart-editing features. I tracked the number of individual CPG
change occurrences whose affected elements were directly supported with smart-editing
features. This allowed me to measure task completion rate.
I formulated the following hypothesis to guide my analyses:
H0: FCIG can not provide smart-editing support for CPG maintenance tasks.
H1: FCIG can provide smart-editing support for CPG maintenance tasks.
5.4 A four-layer architecture for modelling evolving CIGs
Model-driven engineering can be based on a four-layer modelling architecture [276–278],
which has been extended to cater for its interaction with Semantic Web technologies,
notably the logic-based ontologies specified in the OWL languages and automated rea-
soning over the MDE’s metamodels (OWL’s so-called TBox) and models (OWL’s so-
called ABox) [277]. Staab et al.’s extension [277] was refined for to suit CIG change
management, which is presented in Fig. 5.2.
Figure 5.2: Four-layer CIG modelling architecture
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Layers M0 and M1 are concerned with the definitions of specific CIG models and layers
M2 and M3 of the CIG modelling architecture are mainly concerned with CIG modelling
language definition. More precisely, layer M0 is the lowest level of CIG abstraction,
which comprises CIGs in real world clinical decision support systems. Layer M1 is an
abstraction of CIGs at layer M0. At this layer, domain-specific CIG models are specified
such that the CIGs at layer M0 conform to their CIG models at layer M1. Layer M2
is an abstraction of the CIG models at layer M1 such that the CIG models at layer M1
conform to the CIG metamodel at layer M2. Layer M3, in turn, is an abstraction of
layer M2 such that the CIG metamodel at layer M2 conforms to the metametamodel at
layer M3. This layer can be handled by the usual metametamodel languages (OWL’s
metamodel or Ecore in praxis).
5.5 Evolving computer-interpretable guideline conceptual
model
I present a conceptual model of an evolving CIG in a formal (logic-based) specification.
The evolving CIG conceptual model is mapped into an evolving CIG metamodel at layer
M2 of the CIG modelling architecture of Fig. 5.2. The resultant UML Class Diagram
of the evolving CIG conceptual model showing an informal overview is presented in
Fig. 5.3.
5.5.1 Conceptual model development: the process
The development of the metamodel was informed by both existing CIG modelling pro-
posals and by obtaining modelling guidelines from foundational ontologies.
First, the metamodel builds on existing CIG modelling formalisms and refines it through
explicitly specifying the fine-grained CPG components affected by CPG changes. GEM,
GLIF, Asbru, PROforma, SAGE and Arden syntax were evaluated to identify guideline
modelling primitives. The CIG metamodel was iteratively constructed by analysing the
characteristics of each type of CPG change and subsequently including all elements that
are affected by that particular change to the CIG metamodel. Decisions and actions
were found to be the guideline representation primitives in existing guideline modelling
languages, concurring with [2], and lacking vocabulary for elements such as decision
variable values that can change (recall Fig. 5.1: a value changing from ≤ 350 to ≤ 500).
Thus, such entities were incorporated into the CIG metamodel.
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Figure 5.3: UML class diagram of an evolving CIG
Second, with as aim to foster wide interoperability between CIG formalization systems,
the CIG metamodel was extended by availing the knowledge from the Systematized
Nomenclature of Medicine – Clinical Terms (SNOMED CT), which is an ontology that
is one of the most comprehensive clinical terminology systems [279] and relatively widely
used for electronic health records. In particular, the concept Decision Variable now refers
to the same concept as Clinical Finding in SNOMED CT and the CIG metamodel was
further extended by the concept Unit in SNOMED CT.
Third, noting that also SNOMED CT has been analysed with respect to the DOLCE
foundational ontology [280], I considered foundational ontologies for further quality im-
provements regarding the guideline modelling primitives. As a full linking to any of the
foundational ontologies would introduce many new terms that are irrelevant for a prac-
tical domain-specific modelling language, I decided to only borrow ideas from it. This
resulted in an extension of the metamodel with the concept Relator from the General
Formal Ontology (GFO), which is a foundational ontology for integrating objects and
processes [281].
Chapter 5. Modelling evolving computer-interpretable guidelines 67
5.5.2 Precise specification of the evolving CIG conceptual model
This section specifies a precise semantics for the fine-grained CIG conceptual model pre-
sented in Section 5.5.1. The semantics presented in this section were expressed in OWL
using the Prote´ge´ [282] ontology development environment. I use Berardi et al’s [283]
encoding principles to map the informal CIG metamodel to a precise specification. Due
to OWL’s rather verbose syntax, and OWL 2 Description Logics (DL) being essentially a
serialisation of the ALCQ DL language, I present the CIG metamodel’s main axioms in
DL notation to demonstrate its feasibility, with the usual semantics as defined in [284].
In the DL notation, ≡ means ‘equivalent’, u ‘and’, ∃ ‘at least one’, = n ‘only n, where
n is an integer’, and ∀ ‘for all’. All classes are disjoint (axioms not included). The full
specification in OWL is presented in Appendix C. The DL statements use the class and
association names specified in Fig. 5.3. Each axiom in the formalisation listed below is
illustrated with examples from the Malawi HIV guidelines.
Guideline ≡(∃hasRecommendation.Recommendationu
∀hasRecommendation.Recommendation)u
(∃hasCondition.Condition u ∀hasCondition.Condition)u
(∃hasAction.Action u ∀hasAction.Action) (5.1)
Recommendation ≡(∃referencesCondition.Conditionu
∀referencesCondition.Condition)u
(∃referencesAction.Action u ∀referencesAction.Action) (5.2)
Condition ≡(= 1 hasDecisionVariable.DecisionVariableu
∀hasDecisionVariable.DecisionVariable)u
(= 1 hasRelator.Relator u ∀hasRelator.Relator)u
(= 1 hasVariableValue.VariableValueu
∀hasVariableValue.VariableValue) (5.3)
ConditionWithUnit ≡Condition u (= 1 hasUnit.Unit) (5.4)
Action ≡(= 1 hasActionVerb.ActionVerb u ∀hasActionVerb.ActionVerb)u
(= 1 hasActionVerbComplement.ActionVerbComplementu
∀hasActionVerbComplement.ActionVerbComplement) (5.5)
First, a clinical practice guideline denoted by Guideline is defined in Eq. 5.1, i.e., a Guide-
line has at least one guideline recommendation denoted by Recommendation, and only
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guideline recommendations. Guideline has as instance, e.g., “Definition of ART eligibil-
ity” in the “2014 Malawi Integrated Guidelines for Providing HIV Services”. An example
of a Recommendation is one for managing an “Infant under 12 months: Confirmed HIV
infection (DNA–PCR needed)”. A Recommendation consist of at least one condition,
denoted by Condition and at least one recommended action, denoted by Action to be
executed on a patient when the all the conditions in the Guideline are satisfied (Eq. 5.2).
For instance, “HIV test result is positive” is a Condition and “Prescribe regimen 4” is an
example of an Action. Delving into conditions, there are: decision variables, denoted by
DecisionVariable; relators, denoted by Relator; and decision variable values, denoted by
VariableValue, satisfying the constraints as in Eq. 5.3. For instance, take the Condition
“HIV test result is positive”, which has as DecisionVariable “HIV test result”, Relator
“is”, and a VariableValue “positive”. One can also have a unit, denoted by Unit, associ-
ated with conditions that have units denoted by ConditionWithUnit, as in Eq. 5.4; e.g., in
the Condition “Age more than five months”, “months” is a Unit. Finally, a recommended
action, denoted by Action, can be defined as in Eq. 5.5, availing of an action verb denoted
by ActionVerb and an action verb complement, denoted by ActionVerbComplement. For
instance, “Prescribe regimen 4” is an Action, in which the ActionVerb is “Prescribe” and
the ActionVerbComplement is then “regimen 4”.
5.6 The evolving CIG language model
In order to create a precise specification of a sufficient abstract grammar that can
model an evolving CIG, I created a formal language model as is with common practice
[153, 181, 186–188] using concepts, relationships and constraints from the previously
specified evolving CIG conceptual model. The sections that follow detail the denota-
tional semantics, abstract syntax and evaluation semantics of the evolving CIG modelling
grammar.
5.6.1 Denotational semantics for the evolving CIG modelling language
I started by defining semantic functions that map each of the axioms of the evolving CIG
conceptual model in Eqs 5.1–5.5 into meanings that constructors of an abstract grammar
should denote. I adopted Reynold’s [186] semantic equation theories and applied them to
specify denotational semantics that suit our evolving CIG modelling case. The semantic
equations were required so that the set of symbols or expressions that are required by
each constructor in the evolving CIG modelling language grammar could be identified.
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When a semantic equation rule is displayed for a linguistic construction, the kind of
equation as well as the type of construction is going to be indicated. For instance, DR
SEM EQ abbreviates direct semantic equation. Italic letters are used for metavariables
and a sans serif font is used for object variables. Metavariables, in the metalanguage,
indicate what type of entity they range over through the common mathematical conven-
tion. For instance, e ranges over expressions; v and w range over object variables; k, m
and n over integers; η over environments; and p will range over phrases of several types.
If D∞ is a domain that contains more than one element, the value of an expression
depends on the values of its free variables. The meaning of an expression is a continuous
function from D
〈var〉
∞ to D∞:
J−K ∈ 〈exp〉 → (D〈var〉∞ → D∞) (5.6)
All members of D
〈var〉
∞ are environments. The function φ or ψ is used to convert a value
into a function, or vice versa, where necessary. The expression
〈x′0, ..., x′n−1〉 for [0 : x′0|...|n− 1 : x′n−1], (5.7)
denotes the function with domain 0 to n − 1, called an n-tuple, that maps each i into
x′i. [186]
I started by defining the canonical forms that correspond to each semantic element of the
evolving CIG conceptual model. I define Eq. 5.8 for DecisionVariable, Eq. 5.9 for Relator,
Eq. 5.10 for VariableValue, Eq. 5.11 for Unit, Eq. 5.12 for ActionVerb and Eq. 5.13 for
ActionVerbComplement. These semantic elements can be constructed by their respec-
tive functions over a variable whose domain is an infinite set of variables of unspecified
representations. Thereafter, I defined Eq. 5.14 for Condition as a function over three ex-
pressions that depict DecisionVariable, Relator and VariableValue elements; and Eq. 5.15
for ConditionWithUnit as a function over four expressions that depict DecisionVariable,
Relator, VariableValue and Unit elements. Furthermore, I defined Eq. 5.17 for Recommen-
dation as a function over two sets of n-tuple of expressions where one set is for Condition
and the other set is for Action elements. I finally defined Eq. 5.18 for Guideline as function
over three sets of n-tuple of expressions that depict the first set for Condition elements,
the second set for Action elements, and the third set for Recommendation elements.
Table 5.2 shows the mapping between the axioms of the conceptual model in Eqs 5.1–
5.5 to their corresponding denotational semantics in equations 5.8–5.18. The semantic
functions are defined by their associated semantic equations as follows:
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Table 5.2: Conceptual model to semantic equation mapping
.
Concept name Conceptual Model Eq. Semantic Eq.
Guideline Eq. 5.1 Eq. 5.18
Recommendation Eq. 5.2 Eq. 5.17
Condition Eq. 5.3 Eq. 5.14
ConditionWithUnit Eq. 5.4 Eq. 5.15
Action Eq. 5.5 Eq. 5.16
DR SEM EQ: DecisionVariable
JvKη = ηv, (5.8)
DR SEM EQ: Relator
JvKη = ηv, (5.9)
DR SEM EQ: VariableValue
JvKη = ηv, (5.10)
DR SEM EQ: Unit
JvKη = ηv, (5.11)
DR SEM EQ: ActionVerb
JvKη = ηv, (5.12)
DR SEM EQ: ActionVerbComplement
JvKη = ηv, (5.13)
DR SEM EQ: Condition
Je0e1e2Kη = φ(Je0Kη)(Je1Kη)(Je2Kη), (5.14)
DR SEM EQ: ConditionWithUnit
Je0e1e2e3Kη = φ(Je0Kη)(Je1Kη)(Je2Kη)(Je3Kη), (5.15)
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DR SEM EQ: Action
Je0e1Kη = φ(Je0Kη)(Je1Kη), (5.16)
DR SEM EQ: Recommendation
J〈e0, ..., em−1〉〈e′0, ..., e′n−1〉Kη = φ(Jφ(Je0Kη)...(Jem−1Kη)Kη)(Jφ(Je′0Kη)...(Je′n−1Kη)Kη)
where m,n > 0,
(5.17)
DR SEM EQ: Guideline
J〈e0, ..., ek−1〉〈e′0, ..., e′m−1〉〈e′′0, ..., e′′n−1〉Kη = φ(Jφ(Je0Kη)...(Jek−1Kη)Kη)
(Jφ(Je′0Kη)...(Je′m−1Kη)Kη)(Jφ(Je′′0Kη)...(Je′′n−1Kη)Kη)
where k,m, n > 0. (5.18)
5.6.2 Abstract syntax of the CIG metamodel
The abstract syntax of the CIG modelling language was realised by mapping each of
the semantic equations presented in the previous section into constructors of an abstract
grammar. Table 5.3 shows the mapping of the semantic equations to their corresponding
constructors in the abstract grammar of the CIG DSL. I used Reynold’s [186] abstract
grammar specification theories to map the previously specified semantic equations into
a sufficient abstract grammar for the evolving CIG modelling language.
Table 5.3: Semantic equations to abstract grammar mapping
.
Concept name Semantic Eq. Abstract grammar Eq.
DecisionVariable Eq. 5.8 Eq. 5.19
Relator Eq. 5.9 Eq. 5.20
VariableValue Eq. 5.10 Eq. 5.21
Unit Eq. 5.11 Eq. 5.22
Condition Eq. 5.14 Eq. 5.23
ConditionWithUnit Eq. 5.15 Eq. 5.24
ActionVerb Eq. 5.12 Eq. 5.25
ActionVerbComplement Eq. 5.13 Eq. 5.26
Action Eq. 5.16 Eq. 5.27
Recommendation Eq. 5.17 Eq. 5.28
Guideline Eq. 5.18 Eq. 5.29
The phrases of a formal language are abstract entities such that specifying the semantics
of the language can be achieved by defining semantic functions whose domains are sets
of abstract phrases. Although phrases may be conceptually abstract, there is a need
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for their notation. L ::= ρ0|...|ρk−1 abbreviates a set {L ::= ρ0, ..., L ::= ρk−1} of
productions with the same left side. Each unabbreviated production has the form L ::=
s0R0...Rn−1sn, where n ≥ 0, L and the Ri are nonterminals, and the si are strings of
terminal symbols. Certain predefined nonterminals such as 〈var〉 do not occur on the
left side of productions. 〈var〉 is a predefined nonterminal denoting a countably infinite
set of variables with unspecified representations. Productions with the same left side
always have distinct patterns of terminal symbols such that if L ::= s0R0...Rn−1sn and
L ::= s′0R′0...R′n′−1s
′
n′ , are distinct productions with the same left side, then either n 6= n′
or, for some i ∈ 0 to n, si 6= s′i. For each nonterminal of the grammar, there must be a
set of abstract phrases, called a carrier. There must be a function called a constructor
for each production of the abstract grammar, such that, a production of the form L ::=
s0R0...Rn−1sn gives rise to a constructor c ∈ R0 × ... × Rn−1 → L. The operator →
is right associative and has a lower precedence than ×. The carriers and constructors
must satisfy the following: i) each of the constructors should be injective, ii) different
constructors into the same carrier must have disjoint ranges, iii) each member of every
carrier not predefined must be constructible using a finite number of applications of the
constructors. [186]
Let the carriers of the productions for the abstract grammar of our CIG modelling
language be among the following nonterminals: 〈var〉, 〈Unit〉, 〈Relator〉, 〈VariableValue〉,
〈DecisionVariable〉, 〈Condition〉, 〈ActionVerb〉, 〈ActionVerbComplement〉, 〈Action〉,
〈Recommendation〉, and 〈Guideline〉.
The constructors for the abstract grammar, depicted as c〈element〉 where 〈element〉 is
a semantic element of a CIG mapped from the semantic equations presented in Sec-
tion 5.5.2, be as follows:
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cDecisionV ariable ∈〈var〉 → 〈DecisionVariable〉 (5.19)
cRelator ∈〈var〉 → 〈Relator〉 (5.20)
cV ariableV alue ∈〈var〉 → 〈VariableValue〉 (5.21)
cUnit ∈〈var〉 → 〈Unit〉 (5.22)
cCondition ∈〈DecisionVariable〉 × 〈Relator〉 × 〈VariableValue〉
→ 〈Condition〉 (5.23)
cConditionWithUnit ∈〈DecisionVariable〉 × 〈Relator〉 × 〈VariableValue〉×
〈Unit〉 → 〈Condition〉 (5.24)
cActionV erb ∈〈var〉 → 〈ActionVerb〉 (5.25)
cActionV erbComplement ∈〈var〉 → 〈ActionVerbComplement〉 (5.26)
cAction ∈〈ActionVerb〉 × 〈ActionVerbComplement〉
→ 〈Action〉 (5.27)
cRecommendation ∈{〈Condition〉0, ..., 〈Condition〉m−1}
×{〈Action〉0, ..., 〈Action〉n−1}
→ 〈Recommendation〉
where m,n > 0 (5.28)
cGuideline ∈{〈Recommendation〉0, ..., 〈Recommendation〉k−1}
×{〈Condition〉0, ..., 〈Condition〉m−1}
×{〈Action〉0, ..., 〈Action〉n−1}
→ 〈Guideline〉
where k,m, n > 0 (5.29)
I start by mapping Eq. 5.8 to Eq. 5.19 for DecisionVariable, Eq. 5.8 to Eq. 5.20 for Rela-
tor, Eq. 5.8 to Eq. 5.21 for VariableValue, Eq. 5.8 to Eq. 5.22 for Unit, Eq. 5.8 to Eq. 5.25
for ActionVerb and Eq. 5.8 to Eq. 5.26 for ActionVerbComplement such that each of the
resulting constructors create its respective CIG semantic element from a variable whose
domain is an infinite set of variables of unspecified sequence. I further map Eq. 5.14 to
Eq. 5.23 that constructs Condition as a function of DecisionVariable, Relator and Variabl-
eValue. Eq. 5.15 to Eq. 5.24 to define a constructor that constructs ConditionWithUnit
as a function of DecisionVariable, Relator, VariableValue and Unit. Thereafter, I mapped
Eq. 5.16 to Eq. 5.27 to define a constructor that constructs Action as a function of Ac-
tionVerb and ActionVerbComplement. I further map Eq. 5.17 to Eq. 5.28 that construct
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Recommendation as function of a Condition tuple and an Action tuple. I finally map
Eq. 5.18 to Eq. 5.29 to define a constructor for Guideline as a function of Condition,
Action and Recommendation tuples.
5.6.3 Evaluation semantics
Evaluation semantics, which are also known as natural semantics, can describe the be-
haviour of software languages such as DSLs and programming languages [153, 186, 285].
In order to define evaluation semantics of the evolving CIG modelling language gram-
mar, I create a specification using evaluation contexts as is with common practice
[187, 285, 286]. Let T be a semantic element of an evolving CIG, and a list of the
semantic elements be List(T )(e.g. List(Recommendation) referring to a list of Recom-
mendation elements). I define three evaluation contexts that are of interest to CIG
evaluation.
I define the first evaluation context Ec for evaluating a Condition as a function on a
patient record P and a Condition so that the function returns a boolean true or false
depending on whether the condition is valid on the patient or not. Let bool be a boolean
TRUE or FALSE. The evaluation context for evaluating a particular Condition is
defined as:
Ec ∈ P× Condition → bool
I define the second CIG evaluation context Eg as a function on a patient record P and
a particular Guideline so that the function returns a list of applicable Action elements
from the Guideline. The evaluation context for evaluating a Guideline is defined as:
Eg ∈ P× Guideline → List(Action)
The evolving CIG evaluation context Eg allows an actor within a clinical decision support
system to evaluate an entire Guideline with a particular patient record and obtain a list
of applicable Action elements.
I define the third evolving CIG evaluation context Er as a function of a patient record
P and a particular Recommendation so that the function returns a list of applicable
Action elements from the Recommendation. The evaluation context for evaluating a
Recomendation is defined as:
Er ∈ P× Recommendation → List(Action)
The CIG evaluation context Er allows an actor within a clinical decision support system
to evaluate a particular Recommendation with a particular patient record and obtain a
list of applicable Action elements.
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5.7 A concrete syntax and tool implementation for mod-
elling evolving CIGs
In this section, I use a context-free grammar to define terminal and production rules
of the evolving CIG modelling language grammar. I use Xtext grammar language,
an Extended Backus-Naur Form-like notation, designed for the description of concrete
syntaxes for textual languages. Xtext grammar language is extended by object-oriented
concepts and features that are used for the automatic generation of metamodels, parsers
and related editors [287]. A context-free grammar was adopted because of the following:
i) is an established method that allows a precise syntactic specification of a software
language; ii) supports the introduction of new and the maintenance of existing features
as a software language evolves; iii) and supports the automatic construction of parsers
and language editors [153, 181, 288]. I use Bettini’s [207] methods to map the abstract
grammar of the CIG modelling language that is presented in Section 5.6.2 into a concrete
syntax that I call FCIG. I used Bettini’s methods because they provide quick and easy
methods, that are based on best practices, for mapping formal constructs of a software
language, into a working implementation using the Xtext framework [207].
Xtext can infer Ecore models from a grammar. A token is an atomic symbol that
consists of one or more characters that is matched by a particular terminal rule or
keyword. Terminal rules in the grammar language, also referred to as lexer rules or
token rules, return string (type ecore::Estring) by default although it is possible to
return any type that is an instance of ecore::EDataType. There are various kinds of
token rule expressions. Each token rule expression can have one of the four cardinalities
as follows: i) exactly one, which is the default, no operator; ii) one or none, operator ?;
iii) zero or more, operator *; iv) one or more, operator +. Keywords are terminal rule
literals that can contain arbitrary characters and can be of any length. Character ranges
can be declared using the ‘..’ operator. The wildcard operator ‘.’ can be used to allow
any character in particular position of a character sequence. The until operator ‘–〉’
allows one to state that everything should be consumed until a particular token occurs.
The negated operator ‘!’ can be used to invert any tokens that immediately succeed it.
The grammar language allows rules to refer to other rules by writing the name of the
rule to be called. Rule calls in terminal rules can only be make calls to other terminal
rules. The ‘ |’ operator allows one to state multiple different alternatives. [287]
When a parser reads a sequence of terminals and walks through a parser rule, a parse
tree that consists of non-terminal and terminal tokens is produced. Parser rules are
also called production rules. The character ranges, wildcard, until token and negation
operators are only available for terminal rules. Furthermore, the rest of the concepts
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and syntactical constructs available for terminal rules are also available for production
rules. In parser rules, assignments are used to assign parsed information to a feature
of the object that is in current scope. There are three different types of assignment
operators: i) The ‘=’ operator, for straight forward assignment ii) The ‘+=’ operator,
which adds the value on the right to a multi-valued feature iii) The ‘?=’ operator,
which sets a feature of type ecore::EBoolean to true if the right hand side was consumed
independently from the concrete value of the right hand side. The Xtext grammar
language allows one to declare crosslinks in the grammar by placing a type between
square brackets. [287]
Guideline: st+=(Condition | Action)*
st+=(Recommendation)+; (5.30)
Recommendation: ’Recommendation’ name=ID ’:’
’Conditions’
conditions+=[Condition](’,’ conditions+=[Condition])*
’Actions’
actions+=[Action](’,’ actions+=[Action])*; (5.31)
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Condition: ’Condition’ name=ID ’:’
decisionVariable=DecisionVariable
relator=Relator
variableValue=VariableValue
(unit=Unit)?; (5.32)
Action: ’Action’ name=ID ’:’
actionVerb=ActionVerb
actionVerbComplement=ActionVerbComplement; (5.33)
DecisionVariable: value = STRING |
value = ID; (5.34)
Relator: value= ’is’ | value= ’=’ |
value = ’〉’ | value = ’〉 =’ |
value = ’〈’ | value = ’〈=’; (5.35)
VariableValue: value = NUMBER | value = STRING |
value = ’true’ | value = ’false’ |
value = ID; (5.36)
Unit: value = STRING | value = ID; (5.37)
ActionVerb: value = ID | value = STRING; (5.38)
ActionVerbComplement: value = ID | value = STRING; (5.39)
terminal ID: ’ˆ’?(’a’..’z’|’A’..’Z’|’ ’)
(’a’..’z’|’A’..’Z’|’ ’|’0’..’9’)*; (5.40)
terminal STRING: ’”’ ( ’\\’ . /* ’b’|’t’|’n’|’f ’|’r’|’u’|’”’|”’”|’\\’ */ | !(’
\\’|’”’) )* ’”’ |
”’” ( ’\\’ . /* ’b’|’t’|’n’|’f ’|’r’|’u’|’”’|”’”|’\\’ */ | !(’
\\’|”’”) )* ”’”; (5.41)
terminal ML COMMENT: ’/*’ –〉 ’*/’; (5.42)
terminal SL COMMENT: ’//’ !(’\n’|’\r’)* (’\r’? ’\n’)?; (5.43)
terminal WS: (’ ’|’\t’|’\r’|’\n’)+; (5.44)
terminal NUMBER returns ecore::EString:
(’-’)?(’0’..’9’)* (’.’ (’0’..’9’)+)?; (5.45)
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I mapped the concrete syntax grammar of the CIG modelling language from the ab-
stract syntax grammar specified in Section 5.6.2. I further use the Xtext framework
with the Eclipse Modelling Framework (EMF) [199] to implement the concrete syntax
grammar and build appropriate language support tools for the CIG modelling language.
The terminal and production rules of a concrete syntax grammar, that I named FCIG,
are presented in Eqs. 5.30–5.45. I reused some of the terminal rules from the default
set of terminal rules of the Xtext framework. I specifically reused the terminal rules
for identifiers, strings, single line comments, multiple line comments and white spaces
specified in Eqs. 5.40–5.44. To complete the specification of terminal rules for the gram-
mar, I defined a new terminal rule for both positive and negative decimal numbers in
Eq. 5.45. I mapped the rest of the production rules in the concrete syntax grammar
specification from their corresponding constructors in the abstract grammar presented in
Section 5.6.2. Table 5.4 shows the mapping between the abstract grammar and concrete
syntax specification.
Table 5.4: Abstract grammar to concrete syntax mapping
.
Constructor Abstract grammar Eq. Concrete syntax Eq.
Guideline Eq. 5.29 Eq. 5.30
Recommendation Eq. 5.28 Eq. 5.31
Condition, ConditionWithUnit Eqs. 5.23-5.24 Eq. 5.32
DecisionVariable Eq. 5.19 Eq. 5.34
Relator Eq. 5.28 Eq. 5.31
VariableValue Eq. 5.21 Eq. 5.36
Unit Eq. 5.22 Eq. 5.37
Action Eq. 5.27 Eq. 5.33
ActionVerb Eq. 5.25 Eq. 5.38
ActionVerbComplement Eq. 5.26 Eq. 5.39
To start with, Eq. 5.29 is mapped to Eq. 5.30 which defines Guideline as the root ele-
ment of the AST for the CIG modelling DSL. Eq. 5.30 further declares that Guideline
is a collection of Condition, Action and Recommendation elements. Eq. 5.28 is mapped
to Eq. 5.31 defining a Recommendation as an element that references one or more of
existing Condition and Action elements. Eqs. 5.23-5.24 are mapped to Eq. 5.32 defining
that a Condition element is made up of DecisionVariable, Relator, VariableValue and op-
tional Unit elements. Eq. 5.32 further declares that the Condition construct begins with
the ’Condition’ keyword that is followed by the name of the condition succeeded by
semicolon and a space separated list of DecisionVariable, Relator, VariableValue and Unit
elements. Eq. 5.27 is mapped to Eq. 5.33 declaring that an Action element is made up
of ActionVerb and ActionVerbComplement elements. Eq. 5.33 further declares that the
Action construct begins with the ’Action’ keyword followed by the name of the Action
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Figure 5.4: An EMF metamodel generated from the concrete syntax implementation
in Xtext
succeeded by a semicolon and a space separated pair of ActionVerb and VerbComple-
ment elements. Each of the constructors for the carriers in Eqs. 5.23-5.24 are mapped
to their concrete syntax productions as follows: i) Eq. 5.19 is mapped to Eq. 5.34 for
DecisionVariable, ii) Eq. 5.20 is mapped to Eq. 5.35 for Relator, iii) Eq. 5.21 is mapped to
Eq. 5.36 for VariableValue, iv) Eq. 5.22 is mapped to Eq. 5.37 for Unit. And each of the
constructors for the carriers in Eq. 5.27 are mapped to their concrete syntax productions
as follows: i) Eq. 5.25 is mapped to Eq. 5.38 for ActionVerb, ii) Eq. 5.26 is mapped to
Eq. 5.39 for ActionVerbComplement. The complete concrete syntax grammar in Xtext
grammar language is presented in Appendix B. Figure 5.4 shows a class diagram of the
EMF metamodel, at layer M2 of the CIG modelling architecture of Fig. 5.2, generated
from the concrete syntax grammar implementation with the Xtext framework. It can be
noted that the EMF metamodel of FCIG corresponds to the evolving CIG conceptual
model in that all the concepts that are specified in the evolving CIG conceptual model
can be traced by name apart from the concept ConditionWithUnit. But because a Con-
ditionWithUnit is also a Condition, it can be traced as a Condition with an optional Unit
element in the EMF metamodel.
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I built a lexer, parser, abstract syntax tree (AST) model, smart editor plugin that in-
cludes full language support with features such as code completion, syntax highlighting,
code folding, immediate feedback, incremental syntax checking by implementing the
concrete syntax grammar using the Xtext and EMF frameworks.
5.8 Code generation for guideline-based clinical decision
support
In this section, I describe the code generation approach for generating application-
specific code for layer M0 of the CIG modelling architecture. The generated code con-
forms to CIG models at Layer M1 of the CIG modelling architecture. We can navigate
the abstract syntax tree (AST) of a particular CIG model to generate code that is
compatible with a specific clinical decision support systems application architecture. I
use the following generalised specification to describe the fundamental components of a
sufficient code generator for CIG models in the four-layer CIG modelling architecture.
For a Guideline in the AST of an evolving CIG model:
1. Create an empty sourcecode file that corresponds to the Guideline.
2. Retrieve all Recommendations from the Guideline
3. For each retrieved Recommendation, generate a function that evaluates applica-
bility of the Recommendation and returns a collection of Actions in the target
programming language as follows:
(a) Create an empty collection of Actions
(b) For each Condition of the Recommendation, evaluate its DecisionVariable, Re-
lator, Value and optional Unit tuple whether it is true for the instance
(c) When all Conditions are true:
i. Retrieve all Actions from the Recommendation
ii. For each Action, append its ActionVerb, VerbComplement and Recommen-
dation triple to the collection of Actions
(d) Return the collection of Actions
4. Generate a function that evaluates all Recommendations from the Guideline and
returns a collection of all applicable Actions
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I demonstrated the feasibility of implementing such a code generator using the Xtext
framework. I started by creating a prototype implementation of a guideline-based EMR
system by extending the existing Malawi national ART system with a guideline recom-
mendation evaluator capable of evaluating an evolving CIG based on the specification
that were presented in Section 5.6.3. The sourcecode for the revised Malawi national
ART system is on a github repository2. I further extended the Eclipse IDE plugin de-
scribed in Section 5.7 with a code generator that generates evolving CIG libraries that
are compatible with the patient reminders and alerts component of the Malawi national
ART System.
5.9 Case Study
This section uses a case study to demonstrate the feasibility of managing a change using
the CIG modelling architecture. We revisit the problem shown in Figure 5.1 (Section 5.2)
and show that it now can be done in an semi-automated fashion with the DSL. In order
to change the Value of the ‘cd4 threshold ’ Condition, the modeller selects the ‘con-
firmed with mild hiv ’ Recommendation from the ‘determining ART eligibility ’ CIG
model outline. Once input control is directed to the Recommendation definition, the
‘cd4 threshold ’ Condition is identified and verified through its reference and hover in-
formation. The modeller then clicks on the clickable reference (by holding the “Ctrl”
button and clicking the link) to be taken to the ’cd4 threshold ’ Condition definition.
Once input control is directed to the Condition, the modeller can double click on the
Value element of the Condition in the CIG model outline so input control is directed to
the value specification for overwriting. Thereafter, the Value is overwritten with the de-
sired value, in this case 500. The CIG model can be saved once the modeller is satisfied
with the update.
Fig. 5.5 shows an annotated screenshot of the resulting CIG model in the new CIG mod-
elling environment. The Value element is clearly identifiable, accessible and manageable
as a semantic element in the CIG model using an IDE. This process can be repeated
for other changes up until the application of changes is completed. Once the changes
are applied and the model is error-free, the code-generator automatically generates an
updated CIG code library as specified in the code-generator. The generated code li-
brary was then bundled and compiled with the Malawi national ART system. Figure
5.6 shows the alerts and reminders window on a patient dashboard for an HIV positive
patient whose CD4 count is 400 before and after the change was applied to the generated
code library.
2https://github.com/yamiko/bart2 fcig
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Figure 5.5: An annotated screenshot of a CIG modelling environment that shows a
CIG model on the left and its model outline on the right
Figure 5.6: Patient alerts window before and after a CPG change
5.10 Empirical results
In this section, I present results from the two evaluation studies. Recall the evaluation
criteria used to address the second research question RQ2, through subquestions RQ2-
S1 and RQ2-S2, that was discussed in Section 5.3.4.
In order to address research question RQ2-S1, I recorded the number of guideline
recommendations from the guideline strata that were adequately encoded using FCIG,
in order to measure task completion rate. The hypothesis that guided my analyses for
answering research question RQ2-S1 were formulated as follows:
H0: FCIG can not be used to complete CPG encoding tasks.
Chapter 5. Modelling evolving computer-interpretable guidelines 83
H1: FCIG can be used to complete CPG encoding tasks adequately.
In order to address research question RQ2-S2, I recorded the total number of CPG
changes that were directly supported with smart-editing features, in order to measure
task completion rate. The hypothesis that guided my analyses for answering research
question RQ2-S2 were formulated as follows:
H0: FCIG can not provide smart-editing support for CPG maintenance tasks.
H1: FCIG can provide smart-editing support for CPG maintenance tasks.
5.10.1 Results from study one: Assessing FCIG’s CPG representation
adequacy
The stratified random sampling technique resulted in a selection of 46 guideline rec-
ommendations from a total of 124 guideline recommendations identified in the 2008
Malawi integrated guidelines for the clinical management of HIV and the 2008 Malawi
community IMCI guideline. Table 5.5 shows the guideline recommendations stratified
by guideline. A detailed list of the representative sample of guideline recommendations
is presented in Appendix D. All 46 guideline recommendations were adequately encoded
using FCIG and the Malawi medical concept dictionary. The results allow us to reject
the null hypothesis, H0, on CPG representation adequacy. Furthermore, the results
allow for the alternative hypothesis H1: FCIG can be used to complete CPG encoding
tasks adequately, to be accepted. Hence, we can say that FCIG has adequate capacity to
encode CPGs. The encoded guidelines are available at the following online repository3.
5.10.2 Results from study two: Assessing FCIG’s ability to support
CPG changes
The stratified random sampling technique resulted in a selection of 44 CPG change
incidents from a total of 171 change incidents identified between the 2008 and 2011
versions of the Malawi integrated guidelines for the clinical management of HIV. Table
5.6 shows the CPG change incidents stratified by CPG change type. A detailed list of
the representative sample of guideline changes stratified by CPG change type is pre-
sented in Appendix E. All 44 CPG changes were successfully applied to their respective
guideline recommendations of 2008. All the CIG semantic elements that were affected
by the changes had corresponding FCIG language constructs with full smart-editing
3https://github.com/yamiko/chapter 5 study one
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Table 5.5: Guideline recommendations stratified by guideline
.
Guideline
document
Guideline
Number of
recommen-
dations
Weighted
strata
Malawi HIV 2008
Determining priority for
CD4-lymphocyte count testing
7 3
Determining ART eligibility 20 7
Managing suspected ART drug
failure
4 2
Implementing standardised ART
reviews
3 1
Managing first-line drug reactions 6 2
Managing first-line regimen in
children
3 1
Prescribing CPT 20 7
Adult doses of ART 17 6
Providing ART in special situations 13 5
Managing ART patients who
develop TB
5 2
Managing Kaposi’s Sarcoma 2 1
Managing drug toxicity 4 2
Managing symptoms during clinic
visit
1 1
Malawi
Community
IMCI 2008
Community IMCI 19 6
Total 124 46
support. These results allow us to reject the null hypothesis H0 and accept the alter-
native hypothesis H1: FCIG can provide smart-editing support for CPG maintenance
tasks. Therefore, we can say that FCIG enables smart-editing support for CPG update
tasks. The FCIG encoded guidelines both before and after the changes were applied are
available at the following online repository 4.
5.11 Discussion
The novel CIG modelling environment as an Eclipse plugin is the first of its kind to
include all fine-grained components of changing CPGs. The details behind this CIG
modelling environment, i.e., the rigorously defined evolving CIG conceptual model, de-
notational semantics, abstract syntax and concrete syntax within a CIG modelling archi-
tecture, are conveniently hidden for both types of prospective end users: CIG modellers
4https://github.com/yamiko/chapter 5 study two
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Table 5.6: CPG changes stratified by type of CPG change
.
Type of CPG change
Change
occurrences
Weighted
strata
Addition of a decision variable 3 1
Change of a decision variable value 13 3
Removal of a decision variable 2 1
Change of a decision variable 12 3
Addition of a recommended action 2 1
Removal of a recommended action 2 1
Change of an action verb
complement
5 2
Change of a recommended action 2 1
Addition of a recommendation 55 13
Removal of a recommendation 75 18
Total 171 44
and EMR system implementers. The CIG modelling framework enables a CIG mod-
eller to change only the fraction of an evolving CIG that has to be changed meanwhile
enforcing the language implementations’ conformity to the evolving CIG conceptual
model, rather than having to rewrite most of the CPG and possibly introducing errors
in the process. The CIG modelling framework further provides smart-editing features
to support the CIG modeller in carrying out CPG change operations. The EMR sys-
tem implementers now can spend less time on CIG maintenance and the tools that rely
on it, for automated and semi-automated support for managing CPG changes can be
provided.
Although FCIG has been created as a plugin for the Eclipse IDE, the Xtext language
development framework is behind it. Practically, this means that one also can use the
here presented concrete syntax to create other plugins that are targeted for other IDEs
or web browser-based editors. This can avail smart-editing features that can support
the modelling of evolving CIGs.
Observe that the CIG modelling language is comprised of language constructs that are
based on existing concepts in the clinical domain and other CIG models, and thus are
appropriate for modelling CIGs. The evolving CIG language model naturally fits within
rule-based CIG DSLs that are well aligned with the modelling of public health CPGs
which are a focus of this thesis.
The new evolving CIG conceptual model also naturally fits into the “if–then...” or
trigger-action programming model. The trigger-action programming model is a work-
able solution that has been used in other domains such as smart homes because of its
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conceptual simplicity [289]. The new CPG metamodel with its explicit definition of fine-
grained CPG elements may spurn the development of optional complex trigger-action
constructs within CIG models. These complex trigger-action constructs might be ex-
plored for application by experienced users of the new CIG modelling language, which
is an aspect of future work.
The use case demonstrated that hitherto manual operations can be carried out in the CIG
modelling environment. While a single example may seem limited, it was a CPG from a
common ‘stock’: many countries, including Malawi, adopt CPGs that are published by
international organisations such as the World Health Organisation (WHO) and deploy
these CPGs for routine clinical practice; e.g. countries in Latin America [290], Asia, and
other countries in Africa [291]. Thus, it can be equally well used elsewhere.
Xtext generates ANother Tool for Language Recognition (ANTLR) [292] parsers for
parsing context-free grammars [207]. ANTLR supports LL(∗) class of grammars that
are based on left-to-right scanning and leftmost derivation algorithms [153]. Noting that
LL parsers do not support left-recursion and are bounded by time and memory [153],
the concrete syntax specification ensured that none of the language constructs for the
new CIG modelling language were left-recursive. Furthermore, the lexing and parsing
of the CIG models in the implementation of the IDE were found to be sufficient and
efficient when editing CIG models.
5.12 Chapter summary
In this chapter, I started by describing a novel CIG modelling architecture whose foun-
dations are centred on a formal evolving CIG conceptual model. I specified formal
semantics of a language model that conforms with the evolving CIG conceptual model.
Thereafter, I systematically mapped the DSL model into a CIG modelling language
FCIG. I later evaluated FCIG within the novel CIG modelling architecture through
scenario-based validation and an empirical study. FCIG and its modelling architecture
were found to be adequate for modelling evolving CIGs. Furthermore, the evolving CIG
modelling architecture was found to enable smart-editing features that can support CPG
change operations. I further, demonstrated the feasibility of integrating the novel CIG
modelling architecture with an EMR system for clinical decision support. In the next
chapter, I describe the study that I carried out to evaluate the usability of the language
constructs that make up the evolving CIG modelling language FCIG.
Chapter 6
FCIG grammar evaluation of
perceived usability
6.1 Introduction
Computer-interpretable guideline (CIG) modelling languages form the interface between
CIG modellers and the CIGs they require to be executed in computer-based clinical
decision support systems. CPGs change frequently as the science and technology behind
clinical practice improves. The CPG changes demand alterations in related CIGs as
highlighted in a contextual inquiry that was carried out as part of this work in Section
2.4 of Chapter 2. These evolving CIGs require a CIG modelling language that can
support computational management of such changes. Like other software languages,
CIG modelling languages have rarely received usability or human factors evaluation
which may have led to the deployment of inadequate languages [217].
In Chapter 5, I evaluated the grammar of a novel and compact CIG modelling language
FCIG for its CPG representational adequacy and its support for enabling computational
management of CPG changes as characterised in Chapter 4. In this chapter, I contin-
ued to evaluate FCIG by evaluating the usability of its language constructs. I began
by assessing the perception of novice and experienced CIG modellers towards FCIG ’s
usability. I further highlighted key language characteristics and related evaluation tools
that were perceived to contribute to FCIG ’s usability.
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6.2 Materials and methods
The aim of this study was to evaluate whether FCIG’s grammar is suitable and accept-
able from a modeller’s standpoint when modelling an evolving CIG. I evaluated user
perceptions on the usability of FCIG’s language constructs.
6.2.1 Research questions
Recall the second research question RQ2 in Section 3.1:
Can a model-driven engineering approach adequately support the modelling of an evolving
CIG?
In this study, I continued to address the second research question RQ2 from a CIG
modeller’s viewpoint. Recall, from the discussions in Chapter 2, that incompatible ab-
stractions between language users and language designers can pose challenges to usability
of modelling languages [213]. In addition, perceived usability is an important high-level
construct of usability [231, 232]. In order to focus on this perspective, I set the following
research subquestion:
RQ2-S3: Are the language constructs of FCIG perceived as usable?
6.2.2 Research design
I adopted a mixed methods approach for this evaluation. A mixed methods approach
combines quantitative and qualitative techniques, methods, approaches, concepts or
language into a single study [19]. A mixed methods approach can provide strengths
from one method that can make up for the weaknesses in another method, thereby
developing rich insights into phenomena of interest that can not be fully understood
using a single method [293]. I separated the usability evaluation into two smaller studies,
one with novice CIG modellers and the other with experienced CIG modellers as study
participants. I collected quantitative through a standardised usability questionnaire that
used Likert scales. I further collected qualitative data regarding grammar usability in
order to understand the perception of CIG modellers when exposed to the language
constructs that are provided in FCIG ’s grammar.
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6.2.3 Study setup
Study participants were presented with FCIG ’s language constructs for evaluation. I
gave all the study participants a short paper-based orientation of FCIG ’s syntax. For
each study participant, I started by explaining the purpose of the CIG modelling lan-
guage. Thereafter, I gave a scripted description of the three main language constructs
of FCIG. A copy of the paper-based orientation is available in Appendix F. Finally, the
study participants evaluated the three main constructs of the grammar by responding
to a usability questionnaire.
6.2.4 Study participants
Voluntary participation in the study was open to potential participants. Two categories
of participants were recruited for the study through convenience sampling. The first
category was that of novice CIG modellers with basic knowledge in computing but no
experience in clinical decision support system design and deployment. I recruited the
first category of study participants from the computer science postgraduate research
laboratory at the University of Cape Town. The second category was that of individuals
with prior experience in clinical decision support system design and deployment. I
recruited the second category of study participants from my network of clinical decision
support system designers and implementers. I planned to recruit at least five study
participants in both categories of study participants.
6.2.5 Data collection methods
I used online questionnaires for data collection. In the questionnaires, I used the system
usability scale (SUS) [248] that uses a five-point Likert scale as a standardised question-
naire to collect data about study participants’ perceptions on the usability of FCIG’s
grammar. Figure 6.1 shows one of the questions from the questionnaire on such a Likert
Figure 6.1: Sample question using a five-point Likert scale
scale. I chose SUS as a standardised questionnaire because SUS is a simple and widely
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used ten-item scale that gives a global view of subjective assessments of usability [248].
As discussed in Section 2.2.2 of Chapter 2, the SUS as a standardised usability question-
naire underwent considerable psychometric evaluations which showed some evidence of
its validity, reliability and sensitivity [231]. In addition, the SUS does not require a user
licence [231, 232]. I further included two additional open-ended questions to the online
questionnaire in order to collect qualitative data that can give deeper insights where
possible. Table 6.1 shows questions from number one to ten that were used for the SUS
survey in addition to questions eleven and twelve for the qualitative survey.
Table 6.1: Questions for the survey
Question
Number
Text
1 I think that I would like to use this grammar frequently
2 I found the grammar unnecessarily complex
3 I thought the grammar was easy to use
4 I think that I would need the support of a technical person to be able
to use this grammar
5 I found the various functions in this language were well integrated
6 I thought there was too much inconsistency in this grammar
7 I would imagine that most people would learn to use this grammar
very quickly
8 I found the grammar very cumbersome to use
9 I felt very confident using the grammar
10 I needed to learn a lot of things before I could get going with this
grammar
11 Which keywords or concepts/functionality did you find useful whilst
evaluating the grammar for FCIG?
12 Are there any features or keywords that are missing or need to be
improved in the grammar?
6.2.6 Study design
I adopted a survey study for the evaluation. Survey studies are procedures in which
investigators administer a survey to a sample or entire population to get a description
of the attitudes, opinions, behaviours or characteristics of the population [21].
6.2.7 Study protocol
For this study, each participant went through the following procedure:
1. The purpose of the evaluation was explained to the participant
2. The participant completed an informed consent form
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3. The participant was given a short paper-based orientation of the three main lan-
guage constructs that make up FCIG ’s grammar
4. The participant was given a link to complete a survey electronically
5. The participant completed the survey
After following the afore described procedure with all the participants, I carried out
analyses and evaluations using the collected data.
6.2.8 Criteria to address the research subquestion RQ2-S3
In order to address research subquestion RQ2-S3, I calculated SUS scores from the
conducted surveys on a continuous scale that measures modellers’ perceptions on lan-
guage usability. Since FCIG ’s language constructs are based on terminology that is
commonly used in the clinical knowledge engineering domain, I expected CIG modellers
to perceive its usability with a more positive attitude. In order to guide my analyses I
set two alternative hypotheses.
I formulated the following hypothesis on the levels of SUS scores:
H0: CIG modellers do not perceive the language constructs of FCIG as usable.
H1: CIG modellers perceive the language constructs of FCIG as usable.
As the SUS surveys were conducted with two categories of CIG modellers, I further
formulated the following hypothesis on the SUS score differences:
H0: There is no difference in SUS scores between the ratings from experienced CIG
modellers and those from novice CIG modellers.
H1: The SUS scores from experienced CIG modellers are higher than the SUS scores
from novice modellers.
I used the Shapiro-Wilk test to test the samples of SUS scores from both experienced and
novice CIG modellers for normality. In addition, the Shapiro-Wilk test helped in deter-
mining a relevant statistical test that helped in determining the statistical significance
of observed differences between experienced and novice CIG modellers.
6.3 Results
In this section, I present the results from the studies that were carried out to evaluate
FCIG for its usability.
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6.3.1 Participants
There were six experienced CIG modellers and thirteen novice CIG modellers that par-
ticipated in this study. Of the six experienced CIG modellers, one was recruited from
South Africa whilst the rest were recruited from Malawi. The experienced modellers
were university graduates with a computing background. In addition, all the experi-
enced modellers worked for organisations that develop clinical decision support systems
in low- and middle-income countries. All the novice CIG modellers were recruited from
the Computer Science department at the University of Cape Town. Of the 13 CIG mod-
ellers, seven were students that were studying towards a doctoral degree whilst the rest
were studying towards a master’s degree. The sections that follow present the results
from the analysis that was carried out on the data that was collected through the SUS
and qualitative surveys completed by the CIG modellers.
6.3.2 Results from the SUS surveys
The sections that follow describe the results from the analysis of data that was col-
lected from the usability study questionnaires. The raw data from the questionnaires is
available in Appendix K.
6.3.2.1 SUS score levels
I began by testing the first null and first alternative hypotheses. Individual SUS scores
were calculated from the surveys that were carried out with both experienced and novice
CIG modellers. Table 6.4 shows the aggregate responses from the SUS survey with
experienced CIG modellers. The sample of experienced CIG modellers had a mean of
89.17, a median of 91.25 and a mode of 90 for its SUS scores.
From the SUS scores that were calculated from the survey that was carried out with the
novice CIG modellers, a mean of 79.23, a median of 80 and a mode of 80 were derived.
Table 6.5 shows the aggregate scores on how novice CIG modellers rated FCIG’s gram-
mar on the SUS questionnaire. Using the calculated SUS scores from both experienced
and novice modellers, I created density plots that are presented in Figure 6.2 so I could
visualise the results. Further to that, I also created a box plot for the resulting SUS
scores that is presented in Figure 6.3. I created the density plots and box plot to carry
out some exploratory analyses on the data that was collected through the questionnaire.
The exploratory analyses revealed that the samples of SUS scores from both experienced
and novice modellers might not have come from normally distributed populations. The
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Table 6.2: Statistics for SUS scores on FCIG language constructs
CIG modeller level
SUS score
Mean Median Mode
Experienced 89.17 91.25 90
Novice 79.23 80 80
analyses further revealed that the sample of SUS scores from experienced CIG modellers
were higher than those that were computed from novice CIG modellers.
Figure 6.2: Density plots of SUS scores on language constructs usability
I continued to carry out in-depth analyses of the collected data to test the hypotheses
that were set out for this study. To start with, recall the first null hypothesis, H0:
CIG modellers do not perceive the language constructs of FCIG as usable. Table 6.2
presents the statistics that were calculated from the samples of SUS scores on FCIG
language constructs’ usability. The mean and median values of the SUS scores from
experienced and novice CIG modellers were both higher than 75. The results indicate
that the first null hypothesis can be rejected. This means that there is evidence that
CIG modellers perceived the language constructs of FCIG as usable. Therefore, we can
say that both novice and experienced CIG modellers perceived FCIG as a usable CIG
modelling language.
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Figure 6.3: Box plots of SUS scores on language constructs usability
Table 6.3: Shapiro-Wilk test results on SUS scores of language constructs usability
CIG modeller category W p-value
Experienced 0.74 0.014
Novice 0.90 0.14
6.3.2.2 SUS score levels between experienced and novice CIG modellers
Thereafter, I continued to test the second null and second alternative hypotheses. I
began by using the Shapiro-Wilk test to test the samples of computed SUS scores from
the study for normality. Table 6.3 shows the details of the Shapiro-Wilk test results for
all two samples which comprised of experienced and novice CIG modellers. The Shapiro-
Wilk test result for the sample of SUS scores from experienced CIG modellers had a p-
value that was small (p < 0.05). Hence, the results showed that the SUS scores from the
sample of experienced CIG modellers were not from a normally distributed population.
Due to the fact that the SUS scores did not come from a normally distributed population,
I used a Wilcoxon Rank Sum test to test for statistical significance of the differences
measured from the two conditions of the experiment.
Recall the second null hypothesis, H0: There is no difference in SUS scores between
the ratings from experienced CIG modellers and those from novice CIG modellers. The
medians of SUS scores from experienced CIG modellers and novice CIG modellers were
89.17 and 79.23, respectively. A Wilcoxon Rank Sum test was carried out to evaluate
the differences in CIG modellers. The test showed that there was no significant effect of
CIG modellers (The mean ranks of experienced CIG modellers and novice CIG modellers
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were 13.67 and 8.31, respectively; U = 0.90, Z = 1.95, p = 0.05, r = 0.45). Due to the
fact that the effect of CIG modellers on SUS scoring was not significant, the second null
hypothesis can not be rejected. This means that there is no significant difference in SUS
scores between the ratings from experienced CIG modellers and those from novice CIG
modellers.
Table 6.4: Responses from the SUS survey with experienced CIG modellers
Question Score
1 2 3 4 5
1 - Would use the grammar
frequently
0 – 0% 0 – 0% 2 – 33.3% 2 – 33.3% 2 – 33.3%
2 - Grammar was unnecessar-
ily complex
6 – 100% 0 – 0% 0 – 0% 0 – 0% 0 – 0%
3 - Grammar was easy to use 0 – 0% 0 – 0% 1 – 16.7% 3 – 50% 2 – 33.3%
4 - Need support of a technical
person
4 – 66.7% 2 – 33.3% 0 – 0% 0 – 0% 0 – 0%
5 - Functions were well inte-
grated
0 – 0% 0 – 0% 0 – 16.7% 4 – 66.7% 1 – 16.7%
6 - Too much inconsistency 6 – 100% 0 – 0% 0 – 0% 0 – 0% 0 – 0%
7 - Most people would learn
quickly
0 – 0% 0 – 0% 1 – 16.7% 0 – 0% 5 – 83.3%
8 - Grammar very cumber-
some to use
6 – 100% 0 – 0% 0 – 0% 0 – 0% 0 – 0%
9 - Confident using the gram-
mar
0 – 0% 0 – 0% 0 – 0% 3 – 50% 3 – 50%
10 - Needed to learn a lot of
things
5 – 83.3% 0 – 0% 1 – 16.7% 0 – 0% 0 – 0%
6.4 Discussion
Although SUS is a subjective assessment of usability, it can be considered as a valid
and reliable indicator of usability [249]. It is argued that the SUS has undergone some
considerable amount of psychometric testing to evaluate its validity, reliability and sen-
sitivity [231, 250]. Furthermore, other studies have shown that results from the SUS can
reliably converge at samples that are as low as eight [231, 294]. Some researchers have
argued that the word ‘cumbersome’ in statement number eight of the SUS question-
naire can cause confusion when posed to non-native English speaking participants in a
multinational setting [250, 295]. Since this study was carried out in sub-Saharan Africa
which is a predominantly non-native English speaking region, the validity of the results
in the SUS survey was not negatively affected as the participants in the study were
all proficient in the English language. Five experienced CIG modellers were university
graduates who had completed their formal education from institutions whose medium of
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Table 6.5: Responses from the SUS survey with novice CIG modellers
Question Score
1 2 3 4 5
1 - Would use the grammar
frequently
0 – 0% 0 – 0% 4 – 30.8% 6 – 46.2% 3 – 23.1%
2 - Grammar was unnecessar-
ily complex
8 – 61.5% 4 – 30.8% 1 – 7.7% 0 – 0% 0 – 0%
3 - Grammar was easy to use 0 – 0% 0 – 0% 3 – 23.1% 3 – 23.1% 7 – 53.8%
4 - Need support of a technical
person
6 – 46.2% 3 – 23.1% 1 – 7.7% 2 – 15.4% 1 – 7.7%
5 - Functions were well inte-
grated
0 – 0% 0 – 0% 1 – 7.7% 8 – 61.5% 4 – 30.8%
6 - Too much inconsistency 9 – 69.2% 4 – 30.8% 0 – 0% 0 – 0% 0 – 0%
7 - Most people would learn
quickly
0 – 0% 3 – 23.1% 2 – 15.4% 4 – 30.8% 4 – 30.8%
8 - Grammar very cumber-
some to use
9 – 69.2% 3 – 23.1% 1 – 7.7% 0 – 0% 0 – 0%
9 - Confident using the gram-
mar
1 – 7.7% 1 – 7.7% 4 – 30.8% 3 – 23.1% 4 – 30.8%
10 - Needed to learn a lot of
things
4 – 30.8% 8 – 61.5% 1 – 7.7% 0 – 0% 0 – 0%
instruction was English. The sixth CIG modeller was a native English speaker. Further-
more, all novice CIG modellers were university students who had received their prior
education in English.
The results in Section 6.3.1 show that both novice and experienced CIG modellers rated
the grammar of FCIG modelling language highly on the system usability scale. Hence
it can be said that the participants in this study perceived the grammar of FCIG to be
usable. Such a grammar evaluation can provide invaluable insights that can assist a soft-
ware language designer to improve a software language of interest. Hence contributing
to the likelihood of the software language to be adopted in practice.
From the ten dimensions of usability assessment on the SUS scale, the majority of both
the novice and expert CIG modellers indicated that FCIG ’s grammar was easy to use,
had well integrated structural elements, did not have too much inconsistency in addition
to not being very cumbersome to use. The reason for FCIG being perceived as a language
with an easy-to-use and consistent grammar might stem from the fact that the language
has a small and clear vocabulary consisting of just three main language constructs.
Simplicity, clarity and consistency are widely accepted to be essential qualities of good
modelling languages [180, 296, 297]. This can be further evidenced by the comments
that the participants gave in their qualitative feedback after the survey. The following
comments are selected from the feedback that was given by the novice CIG modellers:
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1. Participant p5 commented, “The three constructs explain the model well. Specifi-
cally Condition as it can load data that’s vital to making an informed recommen-
dation”.
2. Participant p10 commented, “It was quite idiomatic and the syntax flows”.
Most experienced CIG modellers had similar positive perceptions across the same four
usability assessment dimensions indicated positively by novice CIG modellers. In ad-
dition to the four dimensions, most experienced CIG modellers also indicated that the
grammar of the experimental language was not unnecessarily complex. Most of the
experienced CIG modellers may have that perception on the grammar because of their
prior familiarity with the process of modelling clinical knowledge which is typically car-
ried out using a general purpose programming language. Furthermore, the experienced
modellers can have such a positive perception because the semantics and vocabulary of
the new CIG modelling language are based on existing concepts that are widely used in
the clinical domain. Domain-appropriateness of a language, that entails that a software
language be powerful enough to capture major domain concepts and be able to match
the mental model of the domain, is very important for software language adoption [227].
This can also be evidenced from the comments that experienced CIG modellers gave in
their feedback after the experiment as follows:
1. Participant p1 commented, “Condition, action, recommendation. These really
cover the basics one would need to use in this kind of setup”.
2. Participant p5 commented, “The syntax, CAR for Conditions, Actions and Rec-
ommendations were easy to follow”.
Although the mean SUS scores for both novice and expert CIG modellers were differ-
ent, the statistical test results in Section 6.3.1 show that the perception of experienced
CIG modellers on the usability of the grammar of FCIG was not significantly different
to that of novice CIG modellers. This is an expected result because the grammar of
FCIG uses a small set of language concepts that have a direct mapping to the clinical
guideline formalization concepts. By employing a small set of language concepts with
adequate expressive power, both novice and experienced modellers are likely to find the
grammar as usable. Incompatible domain abstractions in a DSL grammar can introduce
limitations that can negatively impact a DSl’s usability [158, 213, 298].
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6.5 Chapter summary
In this chapter, I evaluated the usability of FCIG ’s grammar which is a novel, simple and
compact syntax for modelling evolving CIGs. I achieved this by assessing the perceptions
of CIG modellers on the usability of FCIG ’s grammar. Novice CIG modellers were
recruited from the University of Cape Town in South Africa where as experienced CIG
modellers were recruited from EMR system implementing organisations in Malawi and
South Africa. FCIG was found to have a pragmatic grammar for modelling CIGs.
Both novice and experienced CIG modellers perceived FCIG’s grammar as a usable and
practical grammar for modelling evolving computer-interpretable guidelines. In the next
chapter, I describe how I evaluated FCIG for its efficacy in modelling evolving CIGs by
comparing it with the HL7 certified standard Arden Syntax.
Chapter 7
Experimental evaluation of FCIG
7.1 Introduction
As CPGs evolve over time, their corresponding computer-interpretable guidelines (CIGs)
in clinical decision support systems are required to be kept up-to-date so that clinical
advice is based on correct guideline recommendations. A CIG modelling architecture
that explicitly models the CIG elements that are affected by clinical practice guide-
line (CPG) changes has the potential to improve the maintenance of CIGs by enabling
effective and efficient computational support, not available in current CIG modelling en-
vironments, for encoding and maintaining CIGs. In order to enable such computational
support, a CIG modelling language, FCIG, has been developed for use in a four-layer
model-driven architecture. An experimental CIG modelling environment for FCIG has
been implemented in Eclipse.
Recall the discussion on Arden Syntax in Chapter 2. Arden Syntax was established
in 1989 and subsequently developed as a Health Level Seven (HL7) certified standard
for modelling computer-interpretable guidelines [73, 79]. HL7 is a not-for-profit, Amer-
ican National Standards Institute (ANSI)-accredited standards developing organisation
dedicated to providing a comprehensive framework and related standards for the ex-
change, integration, sharing, and retrieval of electronic health information that supports
clinical practice and the management, delivery and evaluation of health services [73].
Practical and technical limitations have forced researchers developing guideline mod-
elling formalisms and execution software to confine the use of their technology to their
home institutions [80]. Arden Syntax represents procedural clinical knowledge in MLMs.
Each MLM contains sufficient knowledge to make a single decision that invokes a specific
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action [78]. Arden syntax has been used for clinical decision support by generating clin-
ical alerts, diagnostic interpretations, management messages and screening for research
studies [81].
Arden4Eclipse is an editor for writing Arden Syntax Medical Logic Modules (MLMs) in
the Eclipse IDE. It integrates Arden2ByteCode, an open source Arden Syntax compiler,
so that Arden Syntax code can be easily written as well as executed. Arden2ByteCode
runs on Java Virtual Machines (JVM) and translates Arden Syntax directly to Java
bytecode (JBC) executable on JVMs [299]. It also serves as runtime environment for
execution of the compiled bytecode. For straightforward use there is an Arden Syntax
Editor plugin for the Eclipse IDE which integrates Arden2ByteCode so Arden Syntax
code can be written and executed. Unlike FCIG, Arden Syntax has a formal syntax but
no formal semantics [300].
Significant effort is required to maintain guideline-based clinical decision support sys-
tems so that their recommendations are based on up-to-date CPGs. Adoption of a CIG
modelling language that uses CPG structural elements that are affected by changes as
representation primitives has the potential to provide computational-support for mod-
elling evolving CIGs. This work introduced FCIG, in Chapter 5, as such a language that
has an explicit specification of elements that are affected by CPG changes in its formal
language model.
This chapter presents the methods and related results of an experimental evaluation
study that I carried out to compare the novel CIG modelling language FCIG with the
HL7 standard Arden Syntax.
7.2 Research methods
This section describes the methods that were adopted in this evaluation study.
7.2.1 Research question
Recall the third research question RQ3 in Section 3.1:
RQ3: What is the effect of modelling an evolving CIG using FCIG in comparison with
the HL7 standard for modelling CIGs?
In this study, I investigated the effect of modelling CIGs using FCIG, a novel language
that has fine-grained CPG representation primitives that are affected by CPG changes. I
carried out this investigation by comparing FCIG with Arden Syntax, the HL7 standard
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for modelling CIGs. At one-point, a group of novice CIG modellers carried out a set of
CIG modelling tasks using FCIG. At another point, the same group of CIG modellers
carried out the same set of CIG modelling tasks using Arden Syntax. The CIG modelling
tasks were counter-balanced in order to reduce order effects. I collected and analysed
data from the two groups of activities to measure differences in the following: time spent
on the CIG modelling tasks; success rate, number of errors and error rate; efficiency on
task; lines of code; and usability perception.
7.2.2 Research design and approach
A mixed methods research design was used. Recall the advantages of a mixed methods
research design discussed in Chapter 6. A mixed methods approach combines quantita-
tive and qualitative techniques or methods into a single study [19]. A mixed methods
research design can allow a researcher to develop rich insights into various phenomena
of interest that can not be fully understood using only a qualitative or quantitative
method [293]. In this part of the study, I conducted an experiment with novice CIG
modellers. The novice CIG modellers carried out the same set of CIG modelling tasks
using both FCIG and Arden Syntax. Quantitative data regarding the time taken to
complete CIG modelling tasks, the number of tasks completed, the number of errors on
completed tasks, lines of code and subjective usability ratings was collected and anal-
ysed. In addition, I collected and analysed qualitative data in order to gain a deeper
understanding of the CIG modelling experience and other subjective factors that may
have affected the perception of modellers when using FCIG.
7.2.3 Study setup
Two CIG modelling environments were set up. One modelling environment used the
fine-grained CIG modelling language, FCIG. The other modelling environment used the
existing HL7 standard guideline modelling language, Arden Syntax for MLMs. Arden
Syntax was chosen because it is a CIG modelling language that is currently being main-
tained as an international standard. Furthermore, both languages had the same base
of model editing support features as both languages were implemented using the same
software language implementation framework, Xtext. Standard smart-editing features,
made available through the Xtext software language implementation framework, were
available for use in the Eclipse integrated development environment(IDE). The standard
smart-editing features that are enabled by Xtext and are provided by the Eclipse IDE
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out-of-the-box include: syntax highlighting, error checking, auto-completion, content-
assist, formatting, quick-fixes and outline view [207]. Both modelling environments
were setup on the same computer with the following specification:
• Computer type: Dell Proline desktop computer with mouse and keyboard
• Monitor: Samsung 20 inch high-definition multimedia interface (HDMI) colour
monitor
• Memory: 3.8 gigabytes (GB)
• Processor: Intel Core i3-2100 with 3.1 gigahertz (GHz) processing speed
• Operating system: Ubuntu 64-bit 16.04 long-term support (LTS)
• Disk capacity: 156 GB
• Web browser: Mozilla Firefox for Ubuntu 52.0.1
• Integrated Development Environment (IDE): Eclipse Neon.
7.2.4 Study participants
This section describes the characteristics of the participants that took place in the ex-
periments.
Participation in this experiment was open to individuals with basic software engineering
skills similar to that required for entry level positions in clinical decision support systems
development roles. Such entry level positions in countries like Malawi are usually carried
out by fresh graduates with a diploma or a degree in computing with basic software engi-
neering knowledge that includes experience with computer programming using multiple
software languages and IDEs. To that regard, computer science students in third year of
study and above from the University of Cape Town participated in the study as novice
modellers. By third year of university education, the participants will have acquired the
basic software engineering skills required for entry level clinical decision support systems
design and development roles in countries like Malawi. Participants were given a small
monetary incentive of ZAR50.00 in appreciation of their time. Figure 7.1 shows one
of the study participants carrying out computer-interpretable guideline modelling tasks
during the experiment.
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Figure 7.1: A study participant taking part in the experiment
7.2.5 Experiment design
There were two experimental conditions for the experiment. The first, Condition A,
was where participants carried out tasks using the HL7 standard, Arden Syntax. The
second, Condition B, was where participants carried out tasks using FCIG.
In the experiment, a repeated measures experimental design was used. A within-subjects
or repeated measures design uses the same subjects with every condition of the research,
by manipulating the explanatory variable on the same subjects [301, 302]. As such, each
participant was exposed to both experimental conditions, Condition A and Condition B.
This technique attempted to reduce the effects of natural variation between participants
upon the results.
Practice effects may occur in an experiment, causing participants to become better at
a task over time. In addition, fatigue effects may also occur causing participants to
become worse at a task through boredom and fatigue [302]. In order to reduce the
order effects that may have occurred during an experiment, counterbalancing using a
crossover design was used in the design of the experiments. Counterbalancing is a
technique whereby each of the two groups performs all tasks but in reverse order to
each other to offset practice or fatigue effects [302]. The research study participants
were randomly assigned to one of two groups. The first group, Group one, subjected
participants to experimental Condition A followed by experimental Condition B. The
second group, Group two, subjected participants to experimental Condition B followed
by experimental Condition A. Table 7.1 shows the groups and the sequence in which the
participants were subjected to both experimental conditions.
A pretest-posttest design was used in the study. A pretest-posttest experiment design
ensures that the research design is a true experimental design so that the degree of
change occurring because of particular research conditions can be measured. Figure 7.2
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Table 7.1: Counterbalancing in the experiments
Category First Condition Second Condition
Group one Condition A Condition B
Group two Condition B Condition A
shows how the pretest-posttest design with counterbalancing technique was used in the
research design.
Figure 7.2: Pretest-posttest design
The pre-test for the experiment was that only those participants that had at least had
basic computer programming skills and had no prior CIG modelling experience were
eligible to enrol into the study. The post-test was the performance comparison between
the experimental Condition A and experimental Condition B collective measurements
in terms of success rate, time taken to complete the tasks, error rate, lines of code, and
usability perception ratings measured during the CIG modelling tasks.
7.2.5.1 Guideline modelling tasks
The guideline modelling tasks simulated guideline encoding and maintenance activities
that are typically undertaken when a CIG modeller creates new or revises existing CIGs.
The tasks were validated and verified by two experienced CIG modellers from Malawi.
Each participant was asked to encode three guideline recommendations from the CPG for
managing ART in special situations extracted from the 2011 Malawi HIV management
guidelines. Only three guideline recommendations were selected for the first task to
reduce fatigue effects in the experiment. Thereafter, participants were asked to update
a previously coded CPG for managing ART in special situations from the 2011 Malawi
HIV management guidelines to its 2014 version. The conveniently selected CPG was
the one that included all of the ten types of CPG changes [2] to simulate adequate CPG
version update activities. The tasks were as follows:
1. Encode three new guideline recommendations from the 2011 CPG for managing
ART in special situations
2. Update the complete 2011 CPG for managing ART in special situations to its 2014
version
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Task one was made up of three subtasks and task two was made up of 10 subtasks. The
details of the subtasks for the two tasks are available in Appendix G.
7.2.5.2 Research protocol
Each participant went through the experiment independently of other study participants.
All participants used the same computer at different times in a secluded room in order
to reduce design contamination for the experiments and to enhance my ability to carry
out effective observations. Each participant followed the following procedure:
1. The purpose of the experiment was explained to the participant
2. The participant completed an informed consent form. Refer to Section H.1 in
Appendix H for more details
3. The procedure of the experiment was explained to the participant. Refer to Section
H.2 in Appendix H for more a script that was read to each participant
4. The participant was randomly assigned to either experimental Group one or Group
two where language A was Arden Syntax and FCIG respectively
• The experiment administrator assigned a sealed and unmarked envelope con-
taining written instructions for the experiment. The instructions were pre-
viously randomly set for either Group one or Group two through a digital
randomisation application called Random UX1.
• There were two sets of instructions for the experiment. The first set of instruc-
tions was for participants in Group one2 and the second set of instructions
was for participants in Group two3
5. The participant was allocated a preset computer
6. The participant followed appropriate instructions for Group one or Group two
depending on the group allocated to them
7. The participant undertook self-paced basic training for language A using an ap-
propriate tutorial for Group one4 or Group two5 accordingly
1https://play.google.com/store/apps/details?id=ru.uxapps.random&hl=en
2https://github.com/yamiko/CIG-Modelling-Languages/wiki
3https://github.com/yamiko/cig modelling languages/wiki
4https://github.com/yamiko/CIG-Modelling-Languages/wiki/Language-A
5https://github.com/yamiko/cig modelling languages/wiki/Language-A
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8. The participant was issued with an appropriate set of instructions for the CIG
modelling tasks on a printout depending on the sequence of the experimental
conditions. Refer to Section H.3 and Section H.4 in Appendix H for Group one
and Group two instructions respectively
9. The participant was observed whilst carrying out tasks for the experiment
10. The participant carried out the tasks using a guideline modelling language accord-
ing to the group one was allocated to in step three
11. The participant was asked to fill an online post-test questionnaire. Refer to Section
H.5 in Appendix H for a list of questions asked in the post-test questionnaire
12. The participant was given a five minute break
13. The participant undertook self-paced basic training for language B using an ap-
propriate tutorial for Group one6 or Group two7 accordingly
14. The participant carried out the same set of guideline modelling tasks as those
issued in step six using the CIG modelling language allocated in step 11. Refer
to Section H.3 and Section H.4 in Appendix H for Group one and Group two
instructions respectively
15. The participant was asked to fill an online post-test questionnaire after completing
tasks with the second experimental condition. Refer to Section H.5 in Appendix
H for more details on the set of questions asked in the post-test questionnaire
16. The participant was interviewed to get a qualitative description of the CIG mod-
elling language that the participant preferred
17. The participant signed in the participant log and received ZAR50.00 to compensate
for their time.
7.2.6 Data collection methods
I used the following data collection methods in the study:
• Low level computer logs from the Fluorite plugin [303] of the Eclipse IDE were
used to collect data on guideline modellers’ interaction with the guideline modelling
environments.
6https://github.com/yamiko/CIG-Modelling-Languages/wiki/Language-B
7https://github.com/yamiko/cig modelling languages/wiki/Language-B
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• Questionnaires were used. Where possible, online questionnaires were deployed
for data collection. In addition, the SUS that uses a Likert scale was used as
a standardised questionnaire to collect data about participants’ perceptions on a
particular CIG modelling language.
• Observations were used to record details as modellers were carrying out the CIG
modelling tasks. I observed from close enough a distance to see what was happen-
ing but not so close as to interfere with the CIG modelling tasks.
7.2.7 Criteria to address the research question RQ2
In order to address research question RQ2, I compared collective performance measure-
ments from FCIG modellers and Arden Syntax modellers. Each participant attempted
to use the benchmark and HL7 standard guideline modelling language, Arden Syntax,
as experimental Condition A. And at another point each of the participants used the
new fine-grained CIG modelling language, FCIG, as experimental Condition B. Hence
the independent variable was the particular CIG modelling language used during the
experiment. Participants were randomly divided into two groups, Group one and Group
two, as categorised in Section 7.2.5. As each participant was subjected to perform the
same set of tasks using both CIG modelling languages, data was collected to measure:
task time, success rate, error rate and efficiency. Success rate, task time and errors are
fundamental metrics that can be applied to scientific or user research [231]. In order to
measure and evaluate these various dimensions separately, sub-questions are devised for
each of the dimensions as discussed in the following sub-sections.
7.2.7.1 Task time
In order to measure and evaluate task time, I asked the following sub-question:
SRQ1: What is the effect of using FCIG, in comparison with Arden Syntax, on task
time?
Task time, which is defined as how long a user spends on an activity, can be reported
as an average of time spent on tasks per participant [231]. Task time is a fundamental
evaluation metric that can assist in determining the quality of user experience [233]. Task
time can be related to efficiency and effectiveness of an artefact which are fundamental
goals of usability [231, 233, 304]. Task time was measured as the duration between
the time a participant started and ended a guideline modelling task. However, some
guideline modelling tasks might have been attempted but not completed whilst others
could have been completed. Task time can be measured in the following ways: 1) Task
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completion time: time of participants who complete the task successfully, 2) Time until
failure: time on task until participant gives up on uncompleted tasks and 3) Total
time on task: the total duration of time users spend on a task for both completed and
uncompleted tasks [231]. In order to address sub-question SRQ1, data regarding time
on task between the FCIG modellers and Arden Syntax modellers was compared. In
order to guide the comparison, three alternative hypotheses were derived in line with
the different ways that time can be measured.
I formulated the following hypothesis for time taken on completed tasks:
H0: There is no difference in the mean time taken on completed tasks between FCIG
modellers and Arden Syntax modellers.
H1: The mean time taken on completed tasks by FCIG modellers is less than the mean
time on completed tasks by Arden Syntax modellers.
In addition, I formulated the following hypothesis for time taken on uncompleted tasks:
H0: There is no difference in the mean time taken on uncompleted tasks between FCIG
modellers and Arden Syntax modellers.
H1: The mean time taken on uncompleted tasks by FCIG modellers is less than the
mean time on uncompleted tasks by Arden Syntax modellers.
At the same time, I also formulated the following hypothesis for total time taken on
tasks, that included time taken on both completed and uncompleted tasks:
H0: There is no difference in the total time taken on tasks between FCIG modellers
and Arden Syntax modellers.
H1: The total time taken on tasks by FCIG modellers is less than the total time taken
on tasks by Arden Syntax modellers.
Noting that the nature of specific subtasks can influence the total time a CIG modeller
spends on a particular task, I formulated the following hypothesis for time taken on
subtasks:
H0: There is no significant difference in the time taken on subtasks between FCIG
modellers and Arden Syntax modellers.
H1: The time taken on subtasks by FCIG modellers is less than the time taken on
subtasks by Arden Syntax modellers.
I used the Shapiro-Wilk test to test for normality and to determine a relevant statistical
test to test for statistical significance.
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7.2.7.2 Success rate
In order to measure and evaluate success rate, I posed the following sub-question:
SRQ2: What is the effect of using FCIG, in comparison with Arden Syntax, on success
rate?
Success rates also called completion rates, typically collected as a binary measure of task
success or task failure, are the most fundamental of usability metrics [231]. Success rate
is also a key evaluation metric of usability that can assist in determining the quality of
user experience [231, 233]. In order to address the sub-question, data on success rates
was compared between FCIG modellers and Arden Syntax modellers. Some guideline
modelling tasks might have been completed by the participants whilst other tasks might
not have been completed. Each task was marked with a binary measure to indicated
whether the task was completed or not.
The following hypothesis was used on success rates:
H0: There is no difference in success rates between FCIG modellers and Arden Syntax
modellers.
H1: The success rate of Arden Syntax modellers is more than the success rate of FCIG
modellers.
I used a Chi-squared test to test for statistical significance of the differences in success
rates between FCIG modellers and Arden Syntax modellers.
7.2.7.3 Number of errors and error rates
In order to measure and evaluate the number of errors and the error rate, I devised the
following sub-questions:
SRQ3A: What is the effect of using FCIG, in comparison with Arden Syntax, on error
rate?
SRQ3B: What is the effect of using FCIG, in comparison with Arden Syntax, on the
number of errors made?
An error, typically analysed as a binary measure, is any unintended action, slip, mistake,
or omission a user makes while attempting a task [231].Number of errors on task is also
a key evaluation metric of usability that can assist in determining the quality of user
experience [231, 233]. In this experiment, I considered all syntax and logical errors that
were evident in the source code that was saved after each CIG modelling task. I loaded
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the source code files for each task and for each participant in the Eclipse Integrated
Development Environment (IDE) and counted the number of syntax errors that were
reported by the IDE. I further manually validated all conditions and actions for each
guideline in each source code file for the presence of semantic errors. In order to address
sub-question SRQ3A, binary measures on errors between FCIG modellers and Arden
Syntax modellers were compared. The following hypothesis was used on error rates:
H0: There is no difference in the error rate between FCIG modellers and Arden Syntax
modellers.
H1: The error rate of the FCIG modellers is less than the error rate made by Arden
Syntax modellers.
Since I collected data on the occurrence of errors as binary measures and that I adopted
a repeated measures design for the experiments, I used the McNemar’s Chi-squared test
with continuity correction to test for statistical significance of any differences between
experimental Condition A and experimental Condition B error rates.
In order to address sub-question SRQ3B, the number of errors between FCIG modellers
and Arden Syntax modellers were compared. The following hypothesis was used on
number of errors on tasks:
H0: There is no difference in the number of errors between FCIG modellers and Arden
Syntax modellers.
H1: The number of errors made in FCIG modellers is less than the number of errors
made in Arden Syntax modellers.
On the number of errors on subtasks, I used the following hypothesis:
H0: There is no difference in the number of errors made on subtasks between FCIG
modellers and Arden Syntax modellers.
H1: The number of errors made on subtasks between experimental Condition A is
significantly higher than the number of errors on subtasks in FCIG modellers.
I used the Shapiro-Wilk test to test for normality and to determine a relevant statistical
test to test for statistical significance of any differences on number of errors between
FCIG modellers and Arden Syntax modellers.
7.2.7.4 Efficiency
In order to measure and evaluate efficiency, I asked the following sub-question:
Chapter 7. Experimental evaluation of FCIG 111
SRQ4: What is the effect of using FCIG on efficiency?
Efficiency, indicated as task completion time, is the relation between the accuracy and
completeness with which users achieve certain goals and the resources expended in
achieving them [305]. Measures of efficiency relate the level of effectiveness achieved
to the expenditure of resources as a ratio between task success rate and task time [306].
The formula for calculating efficiency is presented below:
task success rate
total task time
(7.1)
Efficiency is a fundamental goal of usability of an artefact [231, 233]. In order to address
this sub-question, task success rate to task time ratios between the FCIG modellers
and Arden Syntax modellers were compared. The following hypothesis was used on
efficiency:
H0: There is no difference in the task success rate to task time ratio between FCIG
modellers and Arden Syntax modellers.
H1: The task success rate to task time ratio of the FCIG modellers is more than the
task success rate to task time ratio of the Arden Syntax modellers.
I used the Shapiro-Wilk test to test for normality of the samples and its results deter-
mined a relevant statistical test that was used to test for statistical significance.
7.2.7.5 Lines of code
In order to measure and evaluate the differences in lines of code (LOC) and effective
lines of code (ELOC), I asked the following sub-questions:
SRQ5A: What is the effect of using FCIG on LOC?
SRQ5B: What is the effect of using FCIG on ELOC?
LOC is a software size metric that that represent the number of lines of source code
where as ELOC captures the number of source code lines that exclude comments and
blank lines [307]. In order to address these sub-questions, LOC and ELOC measures
between the FCIG modellers and Arden Syntax modellers were compared. In order to
address sub-research question SRQ5A, the following hypothesis was used on LOC:
H0: There is no difference in LOC between FCIG modellers and Arden Syntax modellers.
H1: The LOC in FCIG modellers are less than the LOC of the Arden Syntax modellers.
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In order to address sub-research question SRQ5A, the following hypothesis was used
on ELOC:
H0: There is no difference in ELOC between FCIG modellers and Arden Syntax mod-
ellers.
H1: The ELOC in FCIG modellers are less than the ELOC of the Arden Syntax mod-
ellers.
I used the Shapiro-Wilk test to test for normality of the samples and its results deter-
mined a relevant statistical test that was used to test for statistical significance.
7.2.7.6 SUS scores
In order to measure and evaluate usability perception from SUS ratings scales, I asked
the following sub-question:
SRQ6: What is the effect of using FCIG on SUS scores?
To reiterate, the system usability scale (SUS) uses a five-point likert scale as a stan-
dardised questionnaire to collect data about participants’ perceptions on usability [248].
The SUS has undergone some considerable amount of psychometric evaluation that can
attest to its validity, reliability and sensitivity [231, 250]. In addition, other studies have
shown that results from the SUS can reliably converge at relatively lower samples than
other standardised usability questionnaires by converging at samples that are as low as
eight [231, 294].
In this study, SUS scores were calculated from the questionnaires that were filled by each
participant on FCIG modellers and Arden Syntax modellers. In order to address the
sub-question on SUS scores, the SUS scores that were calculated from FCIG modellers
and Arden Syntax modellers were compared. The following hypothesis was used on the
calculated SUS scores:
H0: There is no difference in SUS scores between FCIG modellers and Arden Syntax
modellers.
H1: The SUS scores from FCIG modellers are higher than the SUS scores from the
Arden Syntax modellers.
I used the Shapiro-Wilk test to test for normality and its results determined a relevant
statistical test that was used to test for statistical significance.
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7.2.7.7 Qualitative data and user perceptions
I collected qualitative data through questionnaires. I carried out a thematic analysis
on the collected qualitative data in order to systematically identify relevant patterns.
Thematic analysis is a common form of qualitative analysis that records information that
is linked by a common idea allowing the researcher to categorise the information into a
framework of thematic ideas about it [308]. In this study, I followed the widely used six-
step approach to thematic analysis [309]. I started by familiarising myself with the data.
Thereafter, I coded interesting features of the data. Using the coded features, I searched
for relevant themes by comparing the coded features and grouping all information that
was found as related under one theme. Thereafter, I reviewed the themes to ensure that
each set of coded data and its related datasets correlated with their respective themes.
I further refined the themes by assigning appropriate names and clear definitions of
the themes. Lastly, I wrote-up an analytical narrative of the results in relation to the
research question and existing literature. The steps in a thematic analysis process do
not follow a linear pattern but rather a recursive one [309]. Figure 7.3 illustrates the
approach to thematic analysis that I adopted for this study.
Figure 7.3: Thematic analysis approach
7.2.8 Other experimental design validity considerations
The CIG modelling tasks for the experiments were designed in such a way that takes
account of experimental mortality and maturation. By having a few tasks that are
of reasonable length for both experimental conditions, the likelihood of participants
dropping off the experiment before completion was reduced. In addition, the likelihood
of participants becoming significantly better at tasks or significantly developing fatigue
through excessive repetition of tasks was reduced.
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Table 7.2: General purpose programming languages known by novice CIG modellers
Programming language Number of participants
C 3
C++ 24
C# 2
Java 25
Python 25
All experiment procedures and instructions were written down before the experiments
began so that all study participants are exposed to uniform instrumentation. In addition,
all study participants used the same computer at different times. The experimental
conditions were not disclosed to study participants to further reduce chances of design
contamination.
All study participants were compensated equally for their time in taking part in the
experiments. This was aimed at ensuring that there was no compensatory rivalry among
study participants or that performance in a specific task was motivated by the amount
of compensation.
7.3 Discussion of results
In the subsections that follow, I present and discuss the results from the experiment
that I carried out with novice CIG modellers. To repeat, I carried out this experiment
to objectively compare FCIG against the HL7 standard, Arden Syntax. The raw data
from these experiments is in Appendix L.
7.3.1 Participants
There were 26 students from the University of Cape Town that participated in the
study. Nineteen of the students were in their fourth year of study; whilst three of the
students were undertaking their master’s degree studies; and the other four students
were undertaking their doctoral degree studies. All the participants had not worked
with medical computing systems prior to the study. In addition, all the participants
were studying computer science and had working knowledge of at least two general
purpose programming languages. Table 7.2 shows the programming language proficiency
amongst the participants as reported during the experiments.
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7.3.2 Task time
Firstly, recall the hypothesis for task time on completed tasks:
H0: There is no difference in the mean time taken on completed tasks between FCIG
modellers and Arden Syntax modellers. I formulated this as the first null hypothesis.
H1: The mean time taken on completed tasks by FCIG modellers is less than the mean
time on completed tasks by Arden Syntax modellers. I formulated this as the first
alternative hypothesis.
Secondly, recall the hypothesis for time taken on uncompleted tasks:
H0: There is no difference in the mean time taken on uncompleted tasks between FCIG
modellers and Arden Syntax modellers. I formulated this as the second null hypothesis.
H1: The mean time taken on uncompleted tasks by FCIG modellers is less than the
mean time on completed tasks by Arden Syntax modellers. I formulated this as the
second alternative hypothesis.
Thirdly, recall the hypothesis for total time taken on tasks:
H0: There is no difference in the total time taken on tasks between FCIG modellers
and Arden Syntax modellers. I formulated this as the third null hypothesis.
H1: The total time taken on tasks by FCIG modellers is less than the total time taken on
tasks by Arden Syntax modellers. I formulated this as the third alternative hypothesis.
Lastly, recall the hypothesis for time taken on subtasks:
H0: There is no difference in the time taken on subtasks between FCIG modellers and
Arden Syntax modellers. I formulated this as the fourth null hypothesis.
H1: The time taken on subtasks by FCIG modellers is less than the time taken on sub-
tasks by Arden Syntax modellers. I formulated this as the fourth alternative hypothesis.
7.3.2.1 Time taken on completed tasks
I started by carrying out some exploratory analysis of the data on mean time taken on
completed tasks from the experiment. I created box plots showing the time taken on
completed tasks. Thereafter, I checked and validated all odd data points. Figure 7.4
shows the box plots for both task one and two that show the distribution of mean time
taken on completed tasks. As part of the exploratory analysis, I created density plots
so I could visualise the data. Figure 7.5 shows the density plots for mean time taken
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Table 7.3: Shapiro-Wilk test results on mean time taken on completed tasks
Language Task W p-value
Arden Syntax
Task one 0.89 0.001
Task two 0.82 <0.001
FCIG
Task one 0.93 0.089
Task two 0.55 <0.001
task one and task two when completed with both modelling languages Arden Syntax
and FCIG. The initial analysis showed that the samples of mean time taken on tasks
might not have come from normally distributed populations.
Figure 7.4: Box plots showing mean time taken on completed tasks in the experiment
I continued to test the samples for normality by using the Shapiro-Wilk test on the sam-
ples of mean task times recorded in the experiment. The Shapiro-Wilk test results had
p-values of less than 0.05 (p < 0.05) for the estimates from FCIG modellers and Arden
Syntax modellers. Table 7.3 shows the details of the Shapiro-Wilk test results. This
meant that the samples of mean task times of completed tasks were not from normally
distributed populations. Due to the mean task times of completed tasks not coming
from normally distributed populations, and the fact that I chose a repeated measures
design for the experiment, I used a Wilcoxon Signed-Rank test to test for statistical
significance of the differences measured in the different conditions in the experiment.
Since the tests were conducted on both task one and two, the Bonferonni correction was
used to account for multiple hypothesis testing.
Recall the first null hypothesis, H0: There is no difference in the mean time taken on
completed tasks between FCIG modellers and Arden Syntax modellers. The medians
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Figure 7.5: Density plots showing time taken on completed tasks in the experiment
of mean time taken on task one for FCIG and Arden Syntax were 368.8 and 483 re-
spectively. A Wilcoxon Signed-rank test showed that there was a significant effect of
mean time taken on task one (W = 44, Z = 3.34, p < 0.001 with Bonferonni correction,
r = 0.46). The medians of mean time taken on task two for FCIG and Arden Syntax
were 92.3 and 121.7 respectively. A Wilcoxon Signed-rank test showed that there was
a significant effect of mean time taken on task two (W = 74, Z = 2.58, p = 0.017 with
Bonferonni correction, r = 0.36). The statistical test results provide enough evidence
such that the first null hypothesis could be rejected. This meant that the first alterna-
tive hypothesis could be accepted. The results suggest that a particular kind of CIG
modelling language does have an effect on the average time it takes to complete a task.
Specifically, the results suggest that tasks are carried out in less time using FCIG in
comparison with Arden Syntax.
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7.3.2.2 Time taken on uncompleted tasks
Recall the second null hypothesis, H0: There is no difference in the mean time taken on
uncompleted tasks between FCIG modellers and Arden Syntax modellers. I proceeded
with the analysis by evaluating the second null hypothesis. All tasks that were requested
during the experiment were completed by all participants. Therefore, the second null
hypothesis could not be rejected. The results suggest that there was not enough evidence
that pointed to the fact that a particular CIG modelling language has an effect on the
ability of a modeller to complete a task.
7.3.2.3 Total time taken on tasks
I carried out some exploratory data analysis on total task times for both task one and
task two that were recorded during the experiment. I created box plots showing the total
time taken on tasks. I subsequently checked and validated all odd data points. Figure
7.8 depicts the box plots that show the distribution of total time taken on task one and
two. I further created density plots in order to visualise the distribution of the samples
that were collected during the experiment. Figure 7.7 shows the density plots for total
time spent on task one and task two when completed with both modelling languages
Arden Syntax and FCIG. The exploratory analysis showed that the samples might not
have come from a normally distributed population.
Figure 7.6: Box plots showing total time taken on tasks in the experiment
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Figure 7.7: Density plots showing total time taken on tasks in the experiment
I proceeded to test the samples of total time taken on task for normality using the
Shapiro-Wilk test. The Shapiro-Wilk test resulted in p-values that were less than 0.05
(p < 0.05) for the estimates from FCIG modellers and Arden Syntax modellers. Table
7.4 shows the details of the Shapiro-Wilk test results. For this reason, the samples of
total task times for both task one and task two carried out using both Arden Syntax
and FCIG did not come from normally distributed populations. Due to the total task
times not coming from normally distributed populations, and the fact that I chose a
repeated measures design for the experiment, I used a Wilcoxon Signed-Rank test to
test for differences and statistical significance of the measures that were recorded for the
different conditions in the experiment. I also used the Bonferronni correction to account
for multiple hypothesis testing.
Recall the third null hypothesis, H0: There is no difference in the total time taken on
tasks between FCIG modellers and Arden Syntax modellers. The medians of total time
taken on task one for FCIG and Arden Syntax were 1106.5 and 1449 respectively. A
Wilcoxon Signed-rank test showed that there was a significant effect of total time taken
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Table 7.4: Shapiro-Wilk test results on total time taken on tasks
Language Task W p-value
Arden Syntax
Task one 0.89 0.008
Task two 0.82 <0.001
FCIG
Task one 0.93 0.089
Task two 0.55 <0.001
on task one (W = 44, Z = 3.34, p < 0.001 with Bonferonni correction, r = 0.46). The
medians of total time taken on task two for FCIG and Arden Syntax were 923 and 1216.5
respectively. A Wilcoxon Signed-rank test showed that there was also a significant effect
of total time taken on task two (W = 74, Z = 2.58, p = 0.017 with Bonferonni correction,
r = 0.36). The statistical results provided enough evidence such that the third null
hypothesis could be rejected. This meant that the third alternative hypothesis could be
accepted. The results suggest that a particular kind of CIG modelling language does
have an effect on the overall time a modeller spends on a task. Specifically, the results
suggest that tasks are carried out in less time using FCIG in comparison with Arden
Syntax.
7.3.2.4 Time taken on subtasks
Since there were statistically significant differences in the total times taken for each of
the tasks in the experiment, I continued to analyse the observed differences in each of
the subtasks within each task. I started by carrying out some exploratory data analysis
on individual subtask times for each task. I created box plots showing the time taken on
individual subtasks and subsequently checked and validated all odd data points. Figure
7.8 and Figure 7.9 contain the box plots, that show the distribution of time taken, for the
subtasks in task one and two respectively. In addition, I created density plots to visually
inspect the distribution of the samples in this analysis. Figure 7.10 shows density plots
for task one when completed with both modelling languages Arden Syntax and FCIG.
Figures 7.11 and 7.12 further depict the density plots for task two when completed with
the CIG modelling languages Arden Syntax and FCIG respectively. The exploratory
analysis showed that most of the samples might not have come from normally distributed
populations.
Thereafter, I continued with to test for normality using the Shapiro-Wilk test to test on
task times recorded for each subtask in the experiment. The Shapiro-Wilk test results
indicated that 84.61% of p-values were below 0.05 (p < 0.05). For this reason, the results
show that the majority of subtask times in both task one and task two carried out using
both Arden Syntax and FCIG did not come from normally distributed populations.
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Figure 7.8: Box plots showing time taken on each of the subtasks for task one in the
experiment
Table 7.5 shows the details of the Shapiro-Wilk test results. Due to the majority of task
times not coming from normally distributed populations, and the fact that I chose a
repeated measures design for the experiment, I used the Wilcoxon Signed-rank test to
test for statistical significance of the differences measured between subtask times for the
two conditions of the experiment.
Recall the fourth null hypothesis, H0: There is no difference in the time taken on
subtasks between FCIG modellers and Arden Syntax modellers. The medians of the
time taken on each of the subtasks are presented in Table 7.6. The Wilcoxon Signed-
rank test results varied. To start with, the statistical test results showed that there was
a significant effect of time taken on subtask for subtask one of task one and subtasks
four, five, six, seven, and eight of task two. Table 7.7 details the test results on subtask
times. The statistical test results provided enough evidence such that the fourth null
hypothesis could be rejected on specific subtasks. A closer inspection of these subtasks
revealed that these were the tasks that required identification and reuse of fine-grained
clinical practice guideline components such as Variable Values. As a result, the fourth
alternative hypothesis could be accepted on such kind of tasks. The results suggest
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Figure 7.9: Box plots showing time taken on each of the subtasks for task two in the
experiment
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Figure 7.10: Density plots showing time taken on subtasks in task one during the
experiment
Table 7.5: Shapiro-Wilk test results of time taken on subtasks
Task Subtask
Arden Syntax FCIG
W p-value W p-value
One One 0.87 0.005 0.94 0.16
Two 0.94 0.13 0.93 0.07
Three 0.96 0.5 0.89 0.01
Two One 0.96 0.45 0.94 0.19
Two 0.35 <0.001 0.9 0.02
Three 0.85 0.001 0.29 <0.001
Four 0.93 0.048 0.89 0.009
Five 0.43 <0.001 0.83 0.001
Six 0.89 0.012 0.9 0.016
Seven 0.96 0.41 0.64 <0.001
Eight 0.43 <0.001 0.93 0.079
Nine 0.93 0.094 0.96 0.34
Ten 0.92 0.036 0.37 <0.001
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Figure 7.11: Density plots showing time taken on subtasks in task two with Arden
Syntax in the experiment
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Figure 7.12: Density plots showing time taken on subtasks in task two with FCIG in
the experiment
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Table 7.6: Medians of subtask times
Task Subtask
Medians
FCIG
Arden
Syntax
One
One 569 904
two 314.5 294.5
Three 214 234.5
Two
One 205.5 187
Two 168.5 148
Three 54 96
Four 68 164.5
Five 58 120.5
Six 52.5 113
Seven 57 95
Eight 25.5 43.5
Nine 125 94.5
Ten 15 27.5
Table 7.7: Statistical test results on subtask times with Bonferonni correction
Task Subtask W Z p-value r
One
One 23.5 3.86 <0.001 0.54
Two 231.5 1.4 0.48 0.2
Three 110.5 1.65 0.3 0.23
Two
One 232.5 1.45 1 0.2
Two 213.5 0.97 1 0.13
Three 93 2.1 0.35 0.29
Four 21 3.92 <0.001 0.54
Five 25 3.82 <0.001 0.53
Six 6 4.31 <0.001 0.6
Seven 51 3.16 0.009 0.44
Eight 62.5 2.87 0.03 0.4
Nine 271.5 2.44 0.132 0.34
Ten 112 1.61 1 0.22
that a particular kind of CIG modelling language does have an effect on success rate
of particular types of CIG modelling functions. Specifically, the results suggest that
tasks that require manipulation of fine-grained clinical practice guideline components
are carried out more accurately using FCIG in comparison with Arden Syntax. On
the other hand, the statistical test results did not provide enough evidence to reject
the fourth null hypothesis on subtasks two and three of task one; and subtasks one,
two, three, nine and ten of task two. These were the subtasks that required creation of
composite clinical practice guideline elements such as Conditions. A closer inspection of
these subtasks revealed that these subtasks were the ones that allowed participants to
copy and paste clinical guideline patterns from the tutorials that were provided during
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the experiment. Therefore, there was not enough evidence to reject the fourth null
hypothesis on subtasks that required the creation of composite elements.
7.3.3 Success rate
Recall the hypothesis for success rate:
H0: There is no difference in success rates between FCIG modellers and Arden Syntax
modellers. This was the null hypothesis.
H1: The success rate of Arden Syntax modellers is more than the success rate of FCIG
modellers. This was the alternative hypothesis.
I began to evaluate the hypothesis for success rate. All tasks were recorded as completed
during the experiment on FCIG modellers and Arden Syntax modellers. Therefore, there
was not enough evidence to warrant that the null hypothesis be rejected. We can not
reject that there is no difference between the success rate of tasks completed with FCIG
and those tasks completed with Arden Syntax. Although all participants completed all
tasks for both experimental conditions, more participants completed their tasks in less
time using FCIG.
7.3.4 Number of errors and error rates
Firstly, recall the hypothesis for error rates:
H0: There is no difference in the error rate between FCIG modellers and Arden Syntax
modellers. This was the first null hypothesis.
H1: The error rate of the FCIG modellers is less than the error rate made by Arden
Syntax modellers. This was the first alternative hypothesis.
Secondly, recall the hypothesis for number of errors on tasks:
H0: There is no difference in the number of errors made on tasks between FCIG mod-
ellers and Arden Syntax modellers. This was the second null hypothesis.
H1: The number of errors made on tasks in FCIG modellers is less than the number of
errors made in Arden Syntax modellers. This was the second alternative hypothesis.
Thirdly, recall the hypothesis for number of errors on subtasks:
H0: There is no difference in the number of errors made on subtasks between FCIG
modellers and Arden Syntax modellers. This was the third null hypothesis.
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H1: The number of errors made on subtasks between experimental Condition A is
significantly higher than the number of errors on subtasks in FCIG modellers. This was
the third alternative hypothesis.
I began by comparing error rates between FCIG modellers and Arden Syntax modellers.
I used the McNemar’s Chi-squared test with continuity correction to test for statistically
significant differences in error rates between taswhether theks carried out with FCIG
and those that were carried out with Arden Syntax. Furthermore, I applied the Bon-
feronni correction to account for multiple testing of the hypothesis. The McNemar’s
Chi-squared test with continuity correction revealed that the error rate on task one did
not significantly differ by CIG modelling language (X2(1, N = 26) = 4.27, p = 0.078,
φ = 0.35, the odds ratio is 0.83). On the other hand, the McNemar’s Chi-squared test
with continuity correction revealed that the error rate on task two significantly differed
by CIG modelling language (X2(1, N = 26) = 8.1, p = 0.009, φ = 0.4, the odds ratio
is ∞). There was significant evidence that the first null hypothesis could be rejected
on error rates of task two. A closer inspection of both task one and task two revealed
that the error rate was significantly less when participants modelled fine-grained clinical
practice guideline components using FCIG during the experiment. This allowed the
first alternative hypothesis to be accepted on tasks that required some manipulation
of fine-grained computer-interpretable guideline components. The results suggest that
there is effect of CIG modelling languages on error rate. Specifically, the results sug-
gest that CIG modellers encounter a smaller error rate when using FCIG in comparison
with Arden Syntax on tasks that require updates to fine-grained computer-interpretable
guideline components.
I continued with the analysis in order to test the second hypothesis. I began by carrying
out some exploratory analysis of the data on number of errors from the two tasks of the
experiment. I created box plots showing the number of errors on tasks and subsequently
checked and validated all odd data points. Figure 7.13 shows the box plots for both
task one and two that show the distribution of total number of errors on tasks. I further
created a set of density plots that allowed me to visualise the data on number of errors.
Figure 7.14 shows density plots for total number of errors on task one and task two
when completed with Arden Syntax and FCIG. The initial analysis showed that the
samples of number of errors on ttasks might not have come from normally distributed
populations.
I used the Shapiro-Wilk test to test the samples for normality. The Shapiro-Wilk test
results had p-values that were below 0.05 (p < 0.05) on the samples for the experimental
condition tests. Table 7.8 shows the details of the Shapiro-Wilk test results. The
results showed that the samples of total number of errors on tasks for both task one
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Figure 7.13: Box plots showing total number of errors on task in the experiment
Figure 7.14: Density plots showing total number of errors on tasks in the experiment
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Table 7.8: Shapiro-Wilk test results on total number of errors on tasks
Language Task W p-value
Arden Syntax
Task one 0.84 <0.001
Task two 0.85 0.002
FCIG
Task one 0.66 <0.001
Task two 0.67 <0.001
and task two completed using both Arden Syntax and FCIG did not originate from
normally distributed populations. Due to the fact that the number of errors on tasks did
not come from normally distributed populations, and the fact that I chose a repeated
measures design for the experiment, I used a Wilcoxon Signed-rank test to test for
statistical significance of the differences measured between the different conditions in the
experiment. In addition, I also used the Bonferonni correction to account for multiple
hypothesis testing.
Recall second null hypothesis on number of errors, H0: There is no difference in the
number of errors made on tasks between FCIG modellers and Arden Syntax modellers.
The medians of number of errors made on task one for FCIG and Arden Syntax were
0 and 1 respectively. A Wilcoxon Signed-rank test showed that there was no significant
effect of number of errors on task one (W = 42, Z = 1.96, p = 0.11 with Bonferonni
correction, r = 0.27). The medians of number of errors on task two for FCIG and
Arden Syntax were 0 and 2 respectively. A Wilcoxon Signed-rank test showed that
there was a significant effect of number of errors on task two (W = 18, Z = 3.47,
p < 0.001 with Bonferonni correction, r = 0.48). The statistical test results did not
provide enough evidence such that the second null hypothesis could not be rejected
on task one. Therefore, we can say that there was not enough evidence to reject the
second null hypothesis on task one. On the other hand, the statistical test results
provide enough evidence such that the first null hypothesis can be rejected on task
two. This means that the first alternative hypothesis can be accepted on task two.
Recall that task two of the experiment comprised of computer-interpretable guideline
maintenance tasks, which included maintenance of fine-grained computer-interpretable
guideline elements. The results suggest that a particular kind of CIG modelling language
does have an effect on the number of errors that are encountered on tasks that require
manipulation of fine-grained computer-interpretable guideline components. Specifically,
the results suggest that tasks that require updates to fine-grained computer-interpretable
guideline components are completed with less errors using FCIG in comparison with
Arden Syntax.
Since there was enough evidence that there were differences in the total number of errors
made during the tasks between the two different conditions for the experiment, I carried
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out some further exploratory data analysis on the number of errors made on individual
subtasks. I created box plots showing the number of errors on individual subtasks.
Thereafter, I checked and validated all odd data points. Figure 7.15 and Figure 7.16
depict the box plots that show the distribution of number of errors on subtasks for
task one and two respectively. I further continued with the exploratory analysis by
creating density plots. Figure 7.17 shows density plots for task one when completed with
both modelling languages Arden Syntax and FCIG. Figure 7.18 and Figure 7.19 further
show the density plots for task two when completed with the CIG modelling languages
Arden Syntax and FCIG respectively. The visual analysis of the data indicated that
the samples of number of errors on subtasks might not have originated from normal
distributed populations.
Figure 7.15: Box plots showing number of errors on each of the subtasks for task one
in the experiment
I continued to test the samples of numbers of errors on subtasks for normality. I carried
out the Shapiro-Wilk test on the number of errors that were recorded for each subtask
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Figure 7.16: Box plots showing number of errors on each of the subtasks for task two
in the experiment
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Figure 7.17: Density plots showing number of errors on substasks in task one during
the experiment
in the experiment. The Shapiro-Wilk test results had p-values that were above 0.05
(p > 0.05). Table 7.9 shows the details of the Shapiro-Wilk test results. For this reason,
the results show that the samples for both task one and task two carried out using
both Arden Syntax and FCIG were not from normally distributed populations. Due
to the fact that the none of the paired samples originated from normally distributed
populations, I used a Wilcoxon Signed-Rank test to test for statistically significant
differences in the measurements of number of errors on subtasks. I further used the
Bonferonni correction to account for multiple hypothesis testing.
Recall the third null hypothesis, H0: There is no difference in the number of errors
made on subtasks between FCIG modellers and Arden Syntax modellers. The medians
of the time taken on each of the subtasks are presented in Table 7.11. The Wilcoxon
Signed-rank test results showed that there was no significant effect of CIG modelling
languages on number of errors on subtasks. Table 7.10 details the test results on subtask
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Figure 7.18: Density plots showing number of errors on subtasks in task two with
Arden Syntax in the experiment
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Figure 7.19: Density plots showing number of errors on subtasks in task two with
FCIG in the experiment
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Table 7.9: Shapiro-Wilk test results on number of errors on subtasks
Task Subtask
Arden Syntax FCIG
W p-value W p-value
One One 0.63 <0.001 0.52 0.0
Two 0.72 <0.001 0.52 0.0
Three 0.72 <0.001 0.48 <0.001
Two One 0.38 <0.001 0.3 <0.001
Two 0.68 <0.001 0.38 <0.001
Three 0.6 <0.001 0.2 <0.001
Four 0.6 <0.001 0.38 <0.001
Five 0.62 <0.001 0.44 <0.001
Six 0.6 <0.001 0.44 <0.001
Seven 0.66 <0.001 0.2 <0.001
Eight 0.38 <0.001 all values identical
Nine 0.58 <0.001 0.51 <0.001
Ten 0.3 <0.001 all values identical
Table 7.10: Statistical test results on subtask errors with Bonferonni correction
Task Subtask W Z p-value r
One
One 12 0.75 1 0.1
Two 11 2.13 0.17 0.3
Three 16.5 1.81 0.29 0.25
Two
One 6 0.45 1 0.06
Two 11 2.13 0.56 0.3
Three 4 2.13 0.63 0.3
Four 19.5 1.73 1 0.24
Five 11 1.9 1 0.26
Six 10 1.67 1 0.23
Seven 5 2.54 0.2 0.35
Eight 0 1.73 1 0.24
Nine 13.5 0.71 1 0.098
Ten 0 1.4 1 0.2
times. The statistical test results did not provide sufficient evidence that could warrant
the rejection of the third null hypothesis.
7.3.5 Efficiency
Recall the hypothesis for efficiency:
H0: There is no difference in the task success rate to task time ratio between FCIG
modellers and Arden Syntax modellers. This is the null hypothesis.
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Table 7.11: Medians of number of errors on subtask
Task Subtask
Medians
FCIG
Arden
Syntax
One
One 0 0
two 0 0.5
Three 0 0
Two
One 0 0
Two 0 0
Three 0 0
Four 0 0
Five 0 0
Six 0 0
Seven 0 0
Eight 0 0
Nine 0 0
Ten 0 0
H1: The task success rate to task time ratio of the FCIG modellers is more than the task
success rate to task time ratio of the Arden Syntax modellers. This is the alternative
hypothesis.
I started by carrying out some exploratory analysis of the data on efficiency from the
experiment. I created box plots showing the efficiency estimates calculated as success
rate to time on task ratios. I subsequently checked and validated all odd data points
indicated on the box plots. Figure 7.20 shows the box plots for both task one and two
that show the distribution of efficiency estimates on tasks. I continued with the visual
analysis by creating density plots. Figure 7.21 shows density plots for task one and task
two when completed with both modelling languages Arden Syntax and FCIG. The initial
analysis showed that the samples of efficiency estimates on tasks might have originated
from normally distributed populations.
I continued to test the samples of efficiency estimates for normality. I used the Shapiro-
Wilk test to test the estimates. The Shapiro-Wilk test results had p-value higher than
0.05 (p > 0.05). The test results meant that samples of efficiency estimates for both task
one and task two using both experimental conditions did not originate from normally
distributed populations. Table 7.12 shows the details of the Shapiro-Wilk test results.
Due to the fact that the efficiency estimates originated from normally distributed popu-
lations, and the fact that I chose a repeated measures design for the experiment, I used a
paired t-test to test for statistical significance of the differences measured in the different
conditions in the experiment. I further used the Bonferonni correction to account for
multiple hypothesis testing.
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Figure 7.20: Box plots showing efficiency estimates in the experiment
Figure 7.21: Density plots showing efficiency on tasks in the experiment
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Table 7.12: Shapiro-Wilk test results on efficiency on tasks
Language Task W p-value
Arden Syntax
Task one 0.98 0.78
Task two 0.94 0.15
FCIG
Task one 0.95 0.24
Task two 0.94 0.15
Recall the null hypothesis, H0: There is no difference in the task success rate to task time
ratio between FCIG modellers and Arden Syntax modellers. The paired t-test results
showed that there was a significant effect for CIG modelling languages on efficiency for
task one (t = 4.74, p < 0.001, Cohen’s d = 0.93) with FCIG outperforming Arden
Syntax. Furthermore, the paired t-test results also showed that there was a significant
effect for CIG modelling languages on efficiency for task two (t = 2.99, p = 0.006,
Cohen’s d = 0.59) with FCIG outperforming Arden Syntax. These results meant that
the null hypothesis could be rejected such that the alternative hypothesis was accepted.
The results suggest that a particular kind of CIG modelling language does have an effect
on efficiency. Specifically, the results suggest that tasks are carried out more efficiently
using FCIG in comparison with Arden Syntax.
7.3.6 Lines of code
Firstly, recall the hypothesis for lines of code (LOC):
H0: There is no difference in LOC between FCIG modellers and Arden Syntax modellers.
This was the first null hypothesis.
H1: The LOC in FCIG modellers are less than the LOC of the Arden Syntax modellers.
This was the first alternative hypothesis.
Secondly, recall the hypothesis for ELOC:
H0: There is no difference in ELOC between FCIG modellers and Arden Syntax mod-
ellers. This was the second null hypothesis.
H1: The ELOC in FCIG modellers are less than the ELOC of the Arden Syntax mod-
ellers. This was the second alternative hypothesis.
I started by carrying out some exploratory analysis of the data on LOC from the experi-
ment. I created box plots showing the LOC from each task. I subsequently checked and
validated all odd data points indicated on the box plots. Figure 7.22 shows the box plots
for both task one and two that show the distribution of LOC from tasks. I continued
with the exploratory analysis of the samples by creating some density plots. Figure 7.23
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shows density plots for task one and task two when completed with both modelling lan-
guages Arden Syntax and FCIG. The initial analysis showed that the samples of LOC
for tasks might not have come from normally distributed populations.
Figure 7.22: Box plots showing LOC in the experiment
I continued to test the samples for normality by using the Shapiro-Wilk test on the
samples of lines of code measurements. The Shapiro-Wilk test results had p-values of
less than 0.05 (p < 0.05) for the estimates from FCIG modellers and Arden Syntax
modellers. Table 7.13 shows the details of the Shapiro-Wilk test results. The test
results showed that not all the LOC samples for both task one and task two were from
normally distributed populations. Due to the LOC measurements of tasks not coming
from normally distributed populations, and the fact that I chose a repeated measures
design for the experiment, I used the Wilcoxon Signed-Rank test to test for statistically
significant differences in the LOC measurements. I also used the Bonferonni correction
to account for multiple hypothesis testing.
Recall the first null hypothesis, H0: There is no difference in LOC between FCIG
modellers and Arden Syntax modellers. The medians of LOC on task one for FCIG and
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Figure 7.23: Density plots showing LOC on tasks in the experiment
Table 7.13: Shapiro-Wilk test results on LOC on tasks
Language Task W p-value
Arden Syntax
Task one 0.98 0.8
Task two 0.7 <0.001
FCIG
Task one 1 1
Task two 0.94 0.13
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Table 7.14: Shapiro-Wilk test results on ELOC on tasks
Language Task W p-value
Arden Syntax
Task one 0.91 0.028
Task two 0.75 <0.001
FCIG
Task one 0.76 <0.001
Task two 0.72 <0.001
Arden Syntax were 52.5 and 171.5 respectively. A Wilcoxon Signed-rank test showed
that there was a significant effect of CIG modelling language on LOC for task one (W =
0, Z = 4.46, p < 0.001 with Bonferonni correction, r = 0.62). The medians of LOC on
task two for FCIG and Arden Syntax were 156 and 551 respectively. A Wilcoxon Signed-
rank test also showed that there was a significant effect of CIG modelling language on
LOC for task two (W = 0, Z = 4.45, p < 0.001 with Bonferonni correction, r = 0.62).
The statistical test results provide enough evidence such that the first null hypothesis
can be rejected. This means that the first alternative hypothesis can be accepted. The
results suggest that a particular kind of CIG modelling language does have an effect on
LOC. Specifically, the results suggest that tasks are completed in less lines of code using
FCIG in comparison with Arden Syntax.
I continued to carry out some exploratory analysis of the data on effective lines of code
(ELOC). I started by creating box plots showing the distribution of ELOC from the
measurements of each task. Thereafter, I checked and validated all odd data points
indicated on the box plots. Figure 7.24 shows the box plots for both task one and two
that show the distribution of ELOC from tasks. I continued with the exploratory analysis
of the samples by creating some density plots. Figure 7.25 shows density plots for task
one and task two when completed using both modelling languages, Arden Syntax and
FCIG. The initial analysis showed that the samples of ELOC for tasks might not have
originated from normally distributed populations.
I continued to test the samples for normality by using the Shapiro-Wilk test on the
samples of effective lines of code measurements. The Shapiro-Wilk test results had p-
values of less than 0.05 (p < 0.05) for the estimates from FCIG modellers and Arden
Syntax modellers. Table 7.14 shows the details of the Shapiro-Wilk test results. The
test results showed that not all the ELOC samples for both task one and task two
originated from normally distributed populations. Due to the ELOC measurements of
tasks not coming from normally distributed populations, and the fact that I chose a
repeated measures design for the experiment, I used the Wilcoxon Signed-rank test to
test for statistically significant differences in the ELOC measurements. I also used the
Bonferonni correction to account for multiple hypothesis testing.
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Figure 7.24: Box plots showing ELOC in the experiment
Recall the second null hypothesis, H0: There is no difference in ELOC between FCIG
modellers and Arden Syntax modellers. The medians of ELOC from task one for FCIG
and Arden Syntax were 31 and 135.5 respectively. A Wilcoxon Signed-rank test showed
that there was a significant effect of CIG modelling language on ELOC for task one (W
= 0, Z = 4.46, p < 0.001 with Bonferonni correction, r = 0.62). The medians of ELOC
from task two for FCIG and Arden Syntax were 84 and 439.5 respectively. A Wilcoxon
Signed-rank test also showed that there was a significant effect of CIG modelling language
on ELOC for task two (W = 0, Z = 4.46, p < 0.001 with Bonferonni correction, r =
0.62). The statistical test results provided enough evidence such that the second null
hypothesis could be rejected. This means that the second alternative hypothesis could
be accepted. The results suggest that a particular kind of CIG modelling language does
have an effect on ELOC. Specifically, the results suggest that tasks are completed in less
effective lines of code using FCIG in comparison with Arden Syntax.
7.3.7 SUS scores
Recall the hypothesis for SUS scores:
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Figure 7.25: Density plots showing ELOC on tasks in the experiment
H0: There is no difference in SUS scores between FCIG modellers and Arden Syntax
modellers. This is the null hypothesis.
H1: The SUS scores from FCIG modellers are higher than the SUS scores from the
Arden Syntax modellers. This is the alternative hypothesis.
I started by carrying out some exploratory analysis of the data on SUS scores from the
experiment. I created box plots showing the SUS scores from each task. I subsequently
checked and validated all odd data points indicated on the box plots. Figure 7.26 shows
the box plots for that show the distribution of SUS scores for each CIG modelling
language. I continued with the exploratory analysis by creating density plots. Figure
7.27 shows the density plots for SUS scores for both Arden Syntax and FCIG. The
initial analysis showed that the samples of efficiency estimates on tasks might have not
originated from normally distributed populations.
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Figure 7.26: Box plots showing SUS scores in the experiment
Figure 7.27: Density plots showing SUS scores in the experiment
Chapter 7. Experimental evaluation of FCIG 146
Table 7.15: Shapiro-Wilk test results on SUS scores for the CIG modelling languages
Language W p-value
Arden Syntax 0.91 0.034
FCIG 0.83 <0.001
I continued to test the samples for normality using the Shapiro-Wilk test. The Shapiro-
Wilk test results had p-values that were less than 0.05 (p < 0.05). For this reason,
the results show that not the all SUS samples for both Arden Syntax and FCIG did
not originate from normally distributed populations. Table 7.15 shows the details of
the Shapiro-Wilk test results. Due to the SUS scores of tasks not coming from nor-
mally distributed populations, and the fact that I chose a repeated measures design for
the experiment, I used a Wilcoxon Signed-rank test to test for statistically significant
differences in SUS scores between FCIG and Arden Syntax.
The medians of SUS scores for FCIG and Arden Syntax were 83.75 and 77.5 respectively.
A Wilcoxon Signed-rank test showed that there was a significant effect of CIG modelling
languages on SUS score (W = 204, Z = 2.02, p = 0.042, r = 0.28). The statistical
test results provide enough evidence such that the null hypothesis could be rejected.
This meant that the alternative hypothesis could be accepted. The results suggest
that a particular kind of CIG modelling language does have an effect on SUS scores.
Specifically, the results suggest that CIG modellers perceive FCIG as a more usable
modelling language in comparison with Arden Syntax.
7.3.8 Qualitative analysis results
The thematic analysis allowed for a systematic comparison of FCIG against the HL7
standard, Arden Syntax, to be carried out. A number of interesting insights into how the
computer-interpretable guideline (CIG) modellers perceived the usability of both CIG
modelling languages when carrying out CIG modelling tasks were uncovered. The rest
of this section discusses the six themes that were derived from the thematic analysis.
The first theme was identified as ‘simplicity’. This theme was concerned with the sim-
plicity of the CIG modelling languages. A number of CIG modellers found FCIG to be
a simpler CIG modelling language in comparison with Arden Syntax. In particular, the
CIG modellers found FCIG as a simple, flexible and easy to understand syntax when
creating and maintaining CIG models. CIG modellers labelled FCIG as a “straight for-
ward”, “intuitive”, “pleasant enough”, “flexible” and an “easy to use and modify” CIG
modelling language. Simplicity is a key characteristic of a DSL that has to be considered
in order to realise a pragmatic domain-specific language (DSL) [1, 216, 230].
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The second theme focused on ‘re-usability’. This theme was centred around the re-
usability of semantic elements of a CIG. Some CIG modellers expressed that FCIG
allowed them to reuse Condition and Action constructs of a CIG where as Arden Syntax
did not. The CIG modellers indicated that they found the ability to reuse previously
constructed CIG elements in FCIG very helpful as that feature enabled them to complete
the CIG modelling and maintenance tasks faster. Software engineering concerns such as
re-usability are desirable characteristics that contribute to usable DSLs [182, 209].
The third theme was identified as ‘domain-appropriateness’. This theme was concerned
with the overall language features that enable the formalization of a clinical practice
guideline into a CIG. A number of CIG modellers indicated that FCIG felt more of a
natural-fit when modelling CIGs as compared to the times they used Arden Syntax. The
CIG modellers further indicated that all of FCIG ’s language constructs were quite useful
when modelling evolving CIGs. Domain-appropriateness of a DSL is a key characteristic
that can assist in making a particular DSL to be a tool of choice in a particular domain [1,
215].
The fourth theme was identified as ‘extensions’. This theme was concerned with the
possibility of adding GPL-like language constructs into the core DSL vocabulary of the
CIG modelling languages. A number of CIG modellers indicated that some language
features such as composite conditions, negation and range selection can be beneficial to
the CIG modelling process. Though other CIG modellers were of the opinion that FCIG
requires more language constructs, a number of CIG modellers found Arden Syntax to
be too verbose as it requires a lot of boilerplate code. Inclusion of GPL-like language
constructs as language modelling requirements for FCIG would have to be carefully eval-
uated and balanced so as to not affect language simplicity and compactness negatively.
Simplicity and compactness are key factors that should be considered in the design of a
DSL in order to increase the likelihood of DSL adoption [1, 230].
The fifth theme was named ‘adequacy’. This particular theme was concerned with the
adequacy of the languages in modelling evolving CIGs. Quite a number of CIG modellers
felt that FCIG was adequate for modelling evolving CIGs and that the language did not
need new features to support CIG modellers in modelling evolving CIGs. Semantic
correctness and completeness of models that are created using a particular DSL are key
to determining the DSL’s success [1, 310].
The sixth theme was identified as ‘smart-editing support’. This theme focused on avail-
ability of smart-editing features in the CIG modelling tools when modelling CIGs using
the two languages. The CIG modellers found that smart-editing support for features
such as auto-complete, suggestion and outline for both FCIG and Arden Syntax con-
tributed to simplifying the evolving CIG modelling process when using both languages.
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But some CIG modellers found the outline feature to be misleading when using Arden
Syntax. For instance, one participant had the following to say about Arden Syntax:
“I kept losing track of where to edit”. Modelling tools for a DSL are key to the DSL’s
acceptance in its modelling community [153, 221, 222].
On the whole, CIG modellers preferred FCIG when modelling CIGs. This was an
expected result noting that FCIG ’s language model is based on a CIG conceptualisation
that closely matches how clinical practice guidelines are presented in low- and middle-
income countries. Recall the discussion on clinical practice guidelines in Chapter 2.
Clinical practice guidelines for many conditions in low- and middle-income countries are
designed for use by different levels of health workers which include task-shifted health
workers with limited training and at times with limited access to diagnostic testing
tools [54]. In addition, these CPGs are often revised as new evidence emerge on how to
manage the various conditions targeted in the CPGs [57–59]. FCIG ’s language model
explicitly specifies simplified clinical practice guideline representation primitives that
also include the fine-grained components that are typically affected by CPG changes.
7.4 Chapter summary
An experiment was carried out to compare FCIG with the HL7 standard for modelling
CPGs, Arden Syntax. The experiment was conducted with a total of 26 participants
recruited from the University of Cape Town in South Africa. All the participants were
students that novice CIG modellers that had no prior experience with medical computing
systems. On the other hand, the novice CIG modellers were familiar with at least two
general-purpose computer programming languages. During the experiment, novice CIG
modellers were asked to complete CIG modelling tasks using both FCIG and Arden
Syntax using a repeated measures experiment design.
Results from this experiment provided enough evidence that novice CIG modellers per-
formed better at CIG encoding and maintenance tasks when using FCIG in comparison
with Arden Syntax. The performance measurements were assessed across the following
six dimensions: i) task time, ii) success rate, iii) errors on task, iv) efficiency, v) lines
of code, vi) usability perception.
When considering time on task, the results suggest that CIG modellers take less time on
modelling tasks when using FCIG in comparison with Arden Syntax. Further analysis
also suggest that CIG modellers spend less time handling fine-grained CIG components
when using FCIG in comparison with Arden Syntax. Such was not the case with success
rate as the results suggest that that there is no effect of CIG modelling languages on
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task completion rates between those tasks that are attempted with FCIG in comparison
with those that are attempted with Arden Syntax.
Two aspects with regards to errors on task were considered. The first set of results,
concerning error rate, suggest that there is effect of CIG modelling languages on error
rate. To be specific, CIG modelling tasks are completed with a lower error rate when
using FCIG in comparison with Arden Syntax. The second set of results, concerning
number of errors, suggest that participants completed tasks with fewer errors when using
FCIG in comparison with Arden Syntax on tasks that required updates to fine-grained
CIG components.
When considering efficiency, the results suggest that CIG modellers completed tasks
more efficiently when using FCIG as compared to Arden Syntax. Another related set
of measures were lines of code (LOC) and effective lines of code (ELOC), whose results
suggest that CIG modellers complete tasks with fewer lines of source code when using
FCIG as compared with Arden Syntax.
The last dimension that was measured was participant perception on CIG modelling
language usability. The results from this experiment provide enough evidence that the
CIG modellers perceived FCIG as more usable when compared with Arden Syntax.
The results of the thematic analysis that was carried out on the qualitative data uncov-
ered a number of interesting insights with regards to the perceptions the CIG modellers
had on the two CIG modelling languages. CIG modellers found FCIG to be a natural
fit with its simplicity and reusable language constructs when modelling evolving CIGs.
The chapter that follows provides a synthesis of how the empirical results address the
overall research questions that were posed for this work. The following chapter further
concludes this thesis.
Chapter 8
Conclusion
This work proposed a novel model-based DSL, FCIG, in a four-layer guideline modelling
architecture that can be used for modelling evolving CIGs in low- and middle countries.
In order to address this proposition, the following three research questions were set:
1. What are the CPG change requirements for modelling an evolving CIG?
2. Can a model-driven engineering approach adequately support the modelling of an
evolving CIG?
3. What is the effect of modelling an evolving CIG using FCIG in comparison with
the HL7 standard for modelling CIGs?
This chapter starts with a synthesis of how the empirical findings from this work ad-
dressed the research questions. Further to that, a discussion on the implications of the
study follows on. Finally, the limitations of the study and implications for future work
are discussed.
8.1 Synthesis of empirical results
This section synthesises empirical findings from this work in relation to their research
questions.
8.1.1 What are the CPG change requirements for modelling an evolv-
ing CIG?
The findings for this research question indicate that fine-grained semantic elements of
a CPG are affected when changes occur. The findings further revealed that there are
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10 types of CPG changes that occur, which are outlined in Table 8.1. In addition, the
findings showed that the CPG changes affected fine-grained semantic elements of a CPG
such as decision variables, variable values, action verbs and verb complements. Further-
more, the findings indicated that existing CIG modelling languages, that are mostly
experimental, lack explicit language construct specifications for the fine-grained CPG
components that are affected when the changes occur. Table 8.2 shows the representa-
tion primitives in existing CIG modelling languages.
Table 8.1: Summary of CPG changes categories.
Category
Semantic
element
Type of change
Decision
Decision variable
Addition of a decision variable to a
guideline condition
Variable value Change of a decision variable value
Decision variable
Removal of a decision variable from a
guideline condition
Decision variable Change of a decision variable
Action
Action Addition of a recommended action
Action Removal of a recommended action
Verb complement Change of an action verb complement
Action Change of a recommended action
Recommendation
Recommendation Addition of a recommendation
Recommendation Removal of a recommendation
Table 8.2: Representation primitives in existing CIG modelling languages.
Structural
Component
Arden
Syntax
GLIF SAGE EON PROforma Asbru
Condition Yes Yes Yes Yes Yes Yes
Decision variable No No No No No No
Variable value No No No No No No
Action Yes Yes Yes Yes Yes Yes
Action verb No No No No No No
Verb complement No No No No No No
8.1.2 Can a model-driven engineering approach adequately support
the modelling of an evolving CIG?
In order to investigate the answers to this research question, a four-layer architecture for
modelling evolving CIGs that included FCIG as its DSL was created. Further to that,
CPG documents were obtained from the Malawi Ministry of Health for experimentation.
The resulting findings that answered this research question are synthesised through
discussions of its related sub-questions that follow.
Chapter 8. Conclusion 152
Can FCIG be used to model an evolving CIG adequately?
A representative sample of the Malawi CPGs were formalized into CIGs using FCIG.
The findings from this work showed that FCIG can be used to model evolving CIGs
adequately.
Can FCIG directly support the application of fine-grained CPG changes?
A representative sample of CPG changes between successive sets of CPGs were applied to
existing FCIG encoded CIGs. The findings from this work showed that FCIG language
constructs were available for all concepts of an evolving CIG. Furthermore, the find-
ings showed that smart editing features for supporting all CPG change operations were
available in the language-aware code editor of the novel CIG modelling environment.
Are the language constructs of FCIG perceived as usable?
Novice and experienced CIG modellers were introduced to FCIG ’s language constructs.
Both novice and experienced CIG modellers perceived FCIG as highly usable.
8.1.3 What is the effect of modelling an evolving CIG using FCIG in
comparison with the HL7 standard for modelling CIGs?
FCIG was compared with the HL7 standard for modelling clinical guidelines Arden
Syntax. The findings that answered this research question are synthesised through the
discussion of its sub-questions that follow.
What is the effect of using FCIG, in comparison with Arden Syntax, on task time?
CIG modellers completed CIG encoding and maintenance tasks in less time when using
FCIG in comparison with the existing HL7 standard.
What is the effect of using FCIG, in comparison with Arden Syntax, on success rate?
There was no difference in success rate when the CIG modellers completed tasks using
FCIG as compared to when they used the HL7 standard. However, the CIG modellers
completed the CIG modelling tasks with fewer errors when they used FCIG.
What is the effect of using FCIG, in comparison with Arden Syntax, on error rate?
There was no difference in error rate when CIG modellers completed CIG modelling
tasks using FCIG in comparison with when they used Arden Syntax. In spite of this,
CIG modellers completed with fewer number of errors when using FCIG.
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What is the effect of using FCIG, in comparison with Arden Syntax, on the number of
errors made?
CIG modellers completed CIG modelling tasks with fewer errors when using FCIG as
in comparison to the existing HL7 standard.
What is the effect of using FCIG on efficiency?
CIG modellers completed CIG modelling tasks more efficiently when using FCIG in
comparison with the HL7 standard.
What is the effect of using FCIG on LOC?
CIG modellers completed CIG modelling tasks with fewer lines of code when using FCIG
in comparison with the HL7 standard.
What is the effect of using FCIG on ELOC?
CIG modellers completed CIG modelling tasks with fewer effective lines of code when
using FCIG in comparison with the HL7 standard.
What is the effect of using FCIG on SUS scores?
CIG modellers perceived FCIG as a more user-friendly CIG modelling language as com-
pared to the HL7 standard Arden Syntax.
8.2 Summary of contributions
This research explored the potential of managing CPG changes using a model-driven
engineering approach in a clinical setting. In conducting these studies, I have established
a base of knowledge for the development of evolving guideline-based clinical decision
support tools that can be used to improve the quality of clinical care in low- and middle-
income countries.
8.2.1 Evolving clinical practice guideline formalization
CPGs are formalized into CIGs to increase adoption and application of CPGs in computer-
supported clinical settings [49, 311]. But CPGs evolve over time as the science and
technology behind clinical practice improves, necessitating changes in their formalized
form as CIGs. This gives rise to the question: How should evolving CPGs be formalized
to facilitate their integration into Electronic Medical Record systems? Hence evolving
CPG formalization forming the underlying theoretical perspective for this work.
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There are a number of studies that have proposed various approaches to CPG formal-
ization [11]. Attempts have been made to address the complexities involved when sup-
porting evolving CPGs in CPG formalization systems. For example, Miller et al. [115]
focused on maintaining and revalidating child immunization CIGs when changes occur.
Whilst the other studies were concerned with supporting multiple versions of a CIG in
a single repository [11, 61, 118]. As such, little emphasis was placed on how to support
the CIG modeller to effect a change in a CIG when the change occurs, even more so, in
low- and middle-income countries. This work seeks to fill this gap.
8.2.2 Characterisation of CPG changes
In this research, a characterisation of CPG changes was proposed by looking at semantic
elements that are affected when changes occur. The characteristics of the CPG changes
were elicited through an inductive learning approach that used successive sets of CPG
documents obtained from the Malawi Ministry of Health. In addition, this work looked
at CPG representation primitives in current executable CIG modelling languages and
identified semantic elements that are typically affected by CPG changes but are not
currently supported by explicit CPG modelling primitives in current CIG modelling
languages.
8.2.3 Four-layer computer-interpretable guideline modelling architec-
ture
In this work, a novel layered-architecture for modelling evolving CIGs was designed
using a model-driven approach. The novel CIG modelling architecture is based on the
four-layer Model-Driven Architecture (MDA). Further to that, this novel CIG modelling
architecture was implemented and evaluated using open standards. Each layer of the
architecture focused on a different aspect of CIG modelling concerns.
8.2.4 A compact and usable CIG modelling language
This work introduced a fine-grained yet a compact CIG modelling language that was
named FCIG. Modelling CIGs using CIG modelling methods published in current liter-
ature can entail quite a significant effort [62]. Further to that, understanding the seman-
tics of some existing CIG modelling languages prove difficult to a CIG modeller, increas-
ing the likelihood of introducing errors during the CIG modelling process [62, 102, 312].
The novel CIG modelling language has formal semantics that are fully compatible with
the layered CIG modelling architecture. The feasibility of modelling CIGs using FCIG
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was evaluated using Ecore and the Eclipse Modelling Framework (EMF) where an Eclipse
IDE plugin was implemented with full language support and smart-editing features for
FCIG.
8.2.5 Contributions to Health Informatics and Development
This work contributes to Health Informatics research in low- and middle-income coun-
tries by enhancing the understanding of requirements for CPG formalization in such
settings. Furthermore, this work identifies a systematic approach to developing and
evaluating interoperable evolving-CIG formalization tools for clinical decision support
in low-resource settings.
8.3 Limitations of the study
There are a number of important limitations that need to be highlighted in this work.
Whilst the results in this work are grounded in significant research effort and some of
the evaluations were done using CIG modelling experts, the foundational aspects of this
work have not been evaluated in a production environment and over a significant period
of time. A necessary and critical step would be to evaluate the novel CIG modelling ar-
chitecture with CIG modellers in a production environment and over a significant length
of time to evaluate its impact in a real clinical practice setting. The second limitation
is that the characteristics of CPG changes may not be exhaustive. Hence, we may not
know further characteristics of CPG changes until the CIG modelling architecture has
been used successfully in practice and over a significant period of time. The third limi-
tation is that this work was confined to CPG formalization for electronic medical record
systems in Malawi. Though the CPGs that were used in this work have been adapted
from the World Health Organization (WHO) CPGs, which have also been adopted in
other low- and middle-income countries, the findings from this work cannot be gener-
alised to high-income countries. Going forward, the CIG modelling approach should be
evaluated in different settings to overcome this limitation.
8.4 Opportunities for future work
There are a number of potential areas that would be interesting to pursue in the future.
The subsections that follow discuss these areas.
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8.4.1 Deployment in a real-world clinical setting
The evolving CIG modelling architecture and its related CIG modelling language FCIG
has been evaluated through prototype experimentation. It would be ideal to evaluate
FCIG and the CIG modelling architecture from this work in a real-world clinical setting.
8.4.2 Co-designing with clinical personnel
This work can be extended to design and build more CIG modelling tools with clinical
personnel in addition to the CIG modellers who are clinical knowledge engineering ex-
perts. Such tools would be ideal as they would enable clinical experts to directly author
and verify CIGs using the proposed CIG modelling tools.
8.4.3 Using formal CIGs in guideline adherence interventions
The CIG modelling architecture presented in this work can be extended with CPG
adherence measurement algorithms. Such functionality can be used for measuring and
subsequent reporting of clinical performance to health managers.
8.4.4 Extension of FCIG
Though the results from this work show that FCIG is more effective than the HL7
standard Arden Syntax when modelling evolving CIGs, the language should be evaluated
in practice and possibly through a longitudinal study. And from the results of such an
evaluation, more advanced language constructs such as logical connectors or negation
operators can be added to FCIG to cater for advanced CIG modellers.
8.4.5 Evaluation with other upcoming CIG modelling standards
There are other upcoming standards for modelling CIGs such as the Guideline Definition
Language of the openEHR [313]. FCIG should be evaluated against any other upcoming
standards for modelling CIGs to ensure its relevancy in addition to incorporating any
relevant new features as the language evolves.
Chapter 8. Conclusion 157
8.4.6 Evaluating the approach in a longitudinal study
The evaluation in this work was mostly carried out in an experimental setting. It would
be ideal to evaluate the CIG modelling architecture in a longitudinal study to measure
its impact in practice.
8.5 Final remarks
This work has the potential to significantly impact the deployment of sustainable clinical
decision support systems that require up-to-date clinical practice guidelines. If the novel
approach and its related framework is adopted in practice, it could improve the tool base
that supports task-shifted health workers, thereby enabling patients to receive better
care in low- and middle-income countries which shoulder the majority of the global
disease burden.
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Purpose of the research
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consultation. 
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Please note that your participation is entirely voluntary. Should you decide to participate 
as a respondent, please know you are free to withdraw at any point without any penalty.
Procedures 
If you consent you will only have to allow that we observe your visit. 
Risks and Benefits
We do not anticipate any risks pertaining to your involvement in the study. There will be  
no  direct  benefits,  but  your  participation  will  assist  us  in  understanding  how   best 
information technology can be used during  a patient's visit at a health centre.
Confidentiality 
We will not store any names or details that can be used to identify you in our records.
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If you need clarification as to what we are doing or you have concerned on how we 
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Health   Sciences Research Council  (NHSRC) using the details below: 
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Kasankhidwe ndi ufulu wa ofunsidwa
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Ngati  mutalora kuti  mulowe nawo mu kafukufuku ameneyi,  mukulora kuti  tiwonelere 
pokhapo pamene mukuthandizidwa ndi a chipatala.
Chiopsezo ndi ubwino
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odwala pa chipatala.
Chinsisi 
Sitisunga  mayina  kapena  chilichonse  mu  kawundula  wathu  chimene  chingathe 
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m'mene tachezera, mukhoza kulumikizana ndi wa pampando wa bungwe loyang'anira 
kafukufuku  wa  za  umoyo  la  National  Health  Sciences  Research  Council  (NHSRC) 
motere: Dr C. Mwansambo, The Chairperson, NHSRC, P.O. Box 30377, Lilongwe 3, 
Malawi.
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mafunso  ndipo  mafunso  anga  onse  ayankhidwa.  Kutenga  mbali  kwanga  mu 
kafukufukuyi ndi kosakakamizidwa.
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A.6 Consent forms - healthworkers
INFORMATION AND CONSENT   (Health worker) 
Part I: Information and Consent Sheet 
Introduction 
I am a researcher from the University of Cape Town. I would like to investigate how best 
information  technology  can  be  applied  to  assist  heathcare  workers  during  patient 
consultation. I would like you to allow us to interview you and observe you during patient 
consultation sessions.
Purpose of the research
As stated above,  the purpose of  the work we are doing is to  understand how best 
information  technology  can  be  applied  to  assist  healthcare  workers  during  patient 
consultation. 
Participant selection and rights
You are being invited to consider allowing me to interview you and observe your patient 
consultations  at  the  health  centre.  Please  note  that  your  participation  is  entirely 
voluntary. Should you decide to participate as a respondent, please know you are free 
to withdraw at any point without any penalty.
Procedures 
If you consent you will only have to allow that we observe your visit. In addition we will  
conduct a semi-structured interview with you. 
Risks and Benefits
We do not anticipate any risks pertaining to your involvement in the study. There will be  
no  direct  benefits,  but  your  participation  will  assist  us  in  understanding  how   best 
information technology can be used during  a patient's visit at a health centre.
Confidentiality 
We will not store any names or details that can be used to identify you in our records.
Who to Contact for Clarification or Further Information
If you need clarification as to what we are doing or you have concerned on how we 
have interacted with  you,  we encourage you to  contact  the chairperson of  National  
Health   Sciences Research Council  (NHSRC) using the details below: 
Dr C. Mwansambo, The Chairperson, NHSRC, P.O. Box 30377, Lilongwe 3, Malawi.
Part II: Certificate of Consent 
I have been invited to participate in the technology assisted patient consultation study. I 
have read the foregoing information (The foregoing has been read to me). I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered. My participation in the study is entirely voluntary.
  ☐ I consent to participate in the study
  ☐ I do not consent
____________________ _________________________ ______________
Participant Name           Participant Signature   Date
____________________        _________________________          ______________
Interviewer                            Interviwer Signature                              Date
Chidziwitso ndi Chilolezo (Ogwira ntchito pa za umoyo)
Ndondomeko yoyamba: Chidziwitso 
Mawu otsogolera 
Ine ndi wophunzira ku sukulu ya ukachenjede ya University of Cape Town. Ndikufuna 
kuti  ndifufuze  njira  zabwino  zogwiritsa  ntchito  luso  la  makono  la  mauthenga  ndi 
kulumikizana  pothandizira  a  chipatala  pamene  akuthandiza  odwala.  Ndikufuka  kuti 
mundilore kuti ndikufunseni mafunso ndi kuwonelera pamene mukuthandiza odwala.
Zifukwa za kafukufuku
Monga tanenera, ntchito imene tikupangayi ithandiza kuti  tidziwe motsindika za njira 
zabwino  zogwiritsira  luso  la  makono  la  mauthenga ndi  kulumikizana pothandizira  a 
chipatala pamene akuthandiza odwala.
  
Kasankhidwe ndi ufulu wa ofunsidwa
Tikupempha  kuti  mutilore  kuti  ndikufunseni  mafunso  ndi  kuwonelera  mukuthandiza 
odwala  pa chipatalachi.  Dziwani  kuti  kuthandiza  kwanu ndi  kosakakamizidwa.  Ngati 
mutalora kuti mulowe nawo mu kafukufuku ameneyi, mudziwe kuti muli ndi ufulu otuluka 
nthawi ina iliyonse popanda chilango.
Ndondomeko 
Ngati  mutalora kuti  mulowe nawo mu kafukufuku ameneyi,  mukulora kuti  tiwonelere 
pokhapo  pamene  mukuthandiza  odwala.  Moonjezera,  tidzakufunsaniko  mafunso  pa 
nthawi ina imene tingagwirizane.
Chiopsezo ndi ubwino
Palibe  choopsa  chilichonse  chimene  chingadze  chifukwa  cha  kulowa  kwanu  mu 
kafukufuku  ameneyi.  Palibe  malipiro  mukalowa  kafukufuku  ameneyi,  koma  kulowa 
kwanu kutithandiza ife kuti tidziwe motsindika za njira zabwino zogwiritsa ntchito luso la 
makono la mauthenga ndi kulumikizana pothandizira a chipatala pamene akuthandiza 
odwala pa chipatala.
Chinsisi 
Sitisunga  mayina  kapena  chilichonse  mu  kawundula  wathu  chimene  chingathe 
kulondolera wina aliyense kwa kwa inu.
Amene mungathe kulumizana nawo pofuna kudziwa zambiri
Ngati mukufuna kudziwa zambiri za kafukufuku ameneyi kapena muli ndi nkhawa  ndi 
m'mene tachezera, mukhoza kulumikizana ndi wa pampando wa bungwe loyang'anira 
kafukufuku  wa  za  umoyo  la  National  Health  Sciences  Research  Council  (NHSRC) 
motere: Dr C. Mwansambo, The Chairperson, NHSRC, P.O. Box 30377, Lilongwe 3, 
Malawi.
Ndondomeko yachiwiri: Chilolezo 
Ndapemphedwa kuti ndilowe nawo kafukufuku wa luso la makono la mauthenga ndi  
kulumikizana  pa  chipatala.  Ndawelenga  uthenga  umene  walembedwa  kale 
(andiwelengera  uthenga  umene  walembedwa  kale).  Ndinali  ndi  mpata  wofunsa 
mafunso  ndipo  mafunso  anga  onse  ayankhidwa.  Kutenga  mbali  kwanga  mu 
kafukufukuyi ndi kosakakamizidwa.
  Ndikulora kuti ndilowe nawo mu kafukufuku ameneyi☐
  Sindikulora kuti ndilowe nawo mu kafukufuku ameneyi☐
____________________    _________________________            ______________
   Dzina la ofunsidwa Chidindo cha ofunsidwa          Tsiku
____________________        _________________________          ______________
        Ofunsa                                     Chidindo cha ofunsa                             Tsiku
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A.7 Consent forms - software developers
INFORMATION AND CONSENT (EHR developer/implementer)
Part I: Information and Consent Sheet 
Introduction 
I am a researcher from the University of Cape Town. I would like to investigate 
how best information technology can be applied to assist heathcare workers during 
patient consultation. I would like you to allow us to interview you.
Purpose of the research
As stated above, the purpose of the work I am doing is to understand how best 
information technology can be applied to assist healthcare workers during patient 
consultation. 
Participant selection and rights
You are being invited to consider allowing me to interview you. Please note that 
your  participation  is  entirely  voluntary.  Should  you  decide  to  participate  as  a 
respondent, please know you are free to withdraw at any point without any penalty.
Procedures 
If you consent you will only have to allow that we observe your visit. 
Risks and Benefits
We do not anticipate any risks pertaining to your involvement in the study. There 
will be no direct benefits, but your participation will assist us in understanding how 
best information technology can be used during  a patient's visit at a health centre.
Confidentiality 
We will not store any names or details that can be used to identify you in our 
records.
Who to Contact for Clarification or Further Information
If you need clarification as to what we are doing or you have concerned on how we 
have interacted with you, we encourage you to contact the chairperson of National 
Health   Sciences Research Council  (NHSRC) using the details below: 
Dr C. Mwansambo, The Chairperson, NHSRC, P.O. Box 30377, Lilongwe 3, Malawi.
Part II: Certificate of Consent 
I have been invited to participate in the technology assisted patient consultation 
study. I have read the foregoing information (The foregoing has been read to me). I 
have had the opportunity to ask questions about it and any questions I have asked 
have been answered. My participation in the study is entirely voluntary.
  ☐ I consent to participate in the study
  ☐ I do not consent
____________________ _________________________ ______________
Participant Name           Participant Signature   Date
____________________        _________________________          ______________
Interviewer                            Interviewer Signature                             Date
Appendix B
The concrete syntax using Xtext
grammar language
grammar org.xtext.dsl.CIG
hidden(WS, ML_COMMENT , SL_COMMENT)
import "http ://www.eclipse.org/emf /2002/ Ecore" as ecore
generate cig "http ://www.xtext.org/dsl/CIG"
Guideline:
statements +=( Condition | Action)*
statements +=( Recommendation)*
;
Recommendation:
’Recommendation ’ name=ID ’:’
’Conditions ’ conditions +=[ Condition ](’,’ conditions +=[ Condition ])*
’Actions ’ actions +=[ Action ](’,’ actions +=[ Action ])*
;
Condition:
’Condition ’ name = ID ’:’
decisionVariable=DecisionVariable relator=Relator variableValue=
↪→ VariableValue
(unit=Unit)?
;
DecisionVariable:
value = STRING |
value = ID
;
Relator :
value = ’is’ |
value = ’=’ |
value = ’>’ |
value = ’>=’ |
value = ’<’ |
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value = ’<=’
;
VariableValue:
value = NUMBER |
value = STRING |
value = ’true’ |
value = ’false’ |
value = ID
;
Unit:
value = STRING | value = ID
;
Action:
’Action ’ name = ID ’:’
actionVerb = ActionVerb actionVerbComplement = ActionVerbComplement
;
ActionVerb:
value = ID |
value = STRING
;
ActionVerbComplement:
value = ID |
value = STRING
;
/* Reusing common terminals from Xtext */
terminal ID : ’^’?(’a’..’z’|’A’..’Z’|’_’) (’a’..’z’|’A’..’Z’|’_’|’0’..’9’)*;
terminal STRING :
’"’ ( ’\\’ . /* ’b ’|’t ’|’n ’|’f ’|’r ’|’u ’|’"’|"’"|
’\\’ */ | !(’\\’|’"’) )* ’"’ |
"’" ( ’\\’ . /* ’b ’|’t ’|’n ’|’f ’|’r ’|’u ’|’"’|"’"|
’\\’ */ | !(’\\’|"’") )* "’"
;
terminal ML_COMMENT : ’/*’ -> ’*/’;
terminal SL_COMMENT : ’//’ !(’\n’|’\r’)* (’\r’? ’\n’)?;
terminal WS : (’ ’|’\t’|’\r’|’\n’)+;
/* Definition of a optionally signed number in the format -9999.999 */
terminal NUMBER returns ecore:: EString:
(’-’)?(’0’..’9’)* (’.’ (’0’..’9’)+)?;
Appendix C
OWL specification for the CIG
modelling language
<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org /2002/07/ owl#"
xml:base="http: //www.yamiko.org/ontologies/cpg_model"
xmlns:rdf="http: //www.w3.org /1999/02/22 -rdf -syntax -ns#"
xmlns:xml="http: //www.w3.org/XML /1998/ namespace"
xmlns:xsd="http: //www.w3.org /2001/ XMLSchema#"
xmlns:rdfs="http://www.w3.org /2000/01/rdf -schema#"
ontologyIRI="http://www.yamiko.org/ontologies/cpg_model">
<Prefix name="" IRI="http://www.w3.org /2002/07/ owl#"/>
<Prefix name="owl" IRI="http: //www.w3.org /2002/07/ owl#"/>
<Prefix name="rdf" IRI="http: //www.w3.org /1999/02/22 -rdf -syntax -ns#"/>
<Prefix name="xml" IRI="http: //www.w3.org/XML /1998/ namespace"/>
<Prefix name="xsd" IRI="http: //www.w3.org /2001/ XMLSchema#"/>
<Prefix name="rdfs" IRI="http://www.w3.org /2000/01/rdf -schema#"/>
<Declaration >
<Class IRI="#Unit"/>
</Declaration >
<Declaration >
<Class IRI="#VariableValue"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasVariableValue"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasAction"/>
</Declaration >
<Declaration >
<Class IRI="#Recommendation"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#referencesCondition"/>
</Declaration >
<Declaration >
<Class IRI="#Relator"/>
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</Declaration >
<Declaration >
<ObjectProperty IRI="#referencesAction"/>
</Declaration >
<Declaration >
<Class IRI="#DecisionVariable"/>
</Declaration >
<Declaration >
<Class IRI="#ActionVerb"/>
</Declaration >
<Declaration >
<Class IRI="#Guideline"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasRecommendation"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasUnit"/>
</Declaration >
<Declaration >
<Class IRI="#Condition"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasCondition"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasDecisionVariable"/>
</Declaration >
<Declaration >
<Class IRI="#ActionVerbComplement"/>
</Declaration >
<Declaration >
<Class IRI="#Action"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasRelator"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasActionVerb"/>
</Declaration >
<Declaration >
<Class IRI="#ConditionWithUnit"/>
</Declaration >
<Declaration >
<ObjectProperty IRI="#hasActionVerbComplement"/>
</Declaration >
<EquivalentClasses >
<Class IRI="#Action"/>
<ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasActionVerb"/>
<Class IRI="#ActionVerb"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
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<ObjectProperty IRI="#hasActionVerb"/>
<Class IRI="#ActionVerb"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasActionVerbComplement"/>
<Class IRI="#ActionVerbComplement"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasActionVerbComplement"/>
<Class IRI="#ActionVerbComplement"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
</ObjectIntersectionOf >
</EquivalentClasses >
<EquivalentClasses >
<Class IRI="#Condition"/>
<ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#DecisionVariable"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#DecisionVariable"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Relator"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Relator"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#VariableValue"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#VariableValue"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
</ObjectIntersectionOf >
</EquivalentClasses >
<EquivalentClasses >
<Class IRI="#ConditionWithUnit"/>
<ObjectIntersectionOf >
<ObjectIntersectionOf >
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<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#DecisionVariable"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#DecisionVariable"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Relator"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Relator"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasUnit"/>
<Class IRI="#Unit"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasUnit"/>
<Class IRI="#Unit"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#VariableValue"/>
</ObjectAllValuesFrom >
<ObjectExactCardinality cardinality="1">
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#VariableValue"/>
</ObjectExactCardinality >
</ObjectIntersectionOf >
</ObjectIntersectionOf >
</EquivalentClasses >
<EquivalentClasses >
<Class IRI="#Guideline"/>
<ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectSomeValuesFrom >
<ObjectProperty IRI="#hasAction"/>
<Class IRI="#Action"/>
</ObjectSomeValuesFrom >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasAction"/>
<Class IRI="#Action"/>
</ObjectAllValuesFrom >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
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<ObjectSomeValuesFrom >
<ObjectProperty IRI="#hasCondition"/>
<Class IRI="#Condition"/>
</ObjectSomeValuesFrom >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasCondition"/>
<Class IRI="#Condition"/>
</ObjectAllValuesFrom >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectSomeValuesFrom >
<ObjectProperty IRI="#hasRecommendation"/>
<Class IRI="#Recommendation"/>
</ObjectSomeValuesFrom >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#hasRecommendation"/>
<Class IRI="#Recommendation"/>
</ObjectAllValuesFrom >
</ObjectIntersectionOf >
</ObjectIntersectionOf >
</EquivalentClasses >
<EquivalentClasses >
<Class IRI="#Recommendation"/>
<ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectSomeValuesFrom >
<ObjectProperty IRI="#referencesAction"/>
<Class IRI="#Action"/>
</ObjectSomeValuesFrom >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#referencesAction"/>
<Class IRI="#Action"/>
</ObjectAllValuesFrom >
</ObjectIntersectionOf >
<ObjectIntersectionOf >
<ObjectSomeValuesFrom >
<ObjectProperty IRI="#referencesCondition"/>
<Class IRI="#Condition"/>
</ObjectSomeValuesFrom >
<ObjectAllValuesFrom >
<ObjectProperty IRI="#referencesCondition"/>
<Class IRI="#Condition"/>
</ObjectAllValuesFrom >
</ObjectIntersectionOf >
</ObjectIntersectionOf >
</EquivalentClasses >
<DisjointClasses >
<Class IRI="#Action"/>
<Class IRI="#ActionVerb"/>
<Class IRI="#ActionVerbComplement"/>
<Class IRI="#Condition"/>
<Class IRI="#DecisionVariable"/>
<Class IRI="#Guideline"/>
<Class IRI="#Recommendation"/>
<Class IRI="#Relator"/>
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<Class IRI="#Unit"/>
<Class IRI="#VariableValue"/>
</DisjointClasses >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasAction"/>
<Class IRI="#Guideline"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasActionVerb"/>
<Class IRI="#Action"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasActionVerbComplement"/>
<Class IRI="#Action"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasCondition"/>
<Class IRI="#Guideline"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#Condition"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasRecommendation"/>
<Class IRI="#Guideline"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Condition"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasUnit"/>
<Class IRI="#ConditionWithUnit"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#Condition"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#referencesAction"/>
<Class IRI="#Recommendation"/>
</ObjectPropertyDomain >
<ObjectPropertyDomain >
<ObjectProperty IRI="#referencesCondition"/>
<Class IRI="#Recommendation"/>
</ObjectPropertyDomain >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasAction"/>
<Class IRI="#Action"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasActionVerb"/>
<Class IRI="#ActionVerb"/>
</ObjectPropertyRange >
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<ObjectPropertyRange >
<ObjectProperty IRI="#hasActionVerbComplement"/>
<Class IRI="#ActionVerbComplement"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasCondition"/>
<Class IRI="#Condition"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasDecisionVariable"/>
<Class IRI="#DecisionVariable"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasRecommendation"/>
<Class IRI="#Recommendation"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasRelator"/>
<Class IRI="#Relator"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasUnit"/>
<Class IRI="#Unit"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#hasVariableValue"/>
<Class IRI="#VariableValue"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#referencesAction"/>
<Class IRI="#Action"/>
</ObjectPropertyRange >
<ObjectPropertyRange >
<ObjectProperty IRI="#referencesCondition"/>
<Class IRI="#Condition"/>
</ObjectPropertyRange >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#Action </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/ rdf -schema#Literal">This
↪→ class is adapted from the element Action of the Guideline Elements Model (
↪→ GEM) and the equivalents of the action representation primitive in existing
↪→ guideline modelling platforms such as Guideline Interchange Format (GLIF),
↪→ Arden Syntax and Shareable and Active Guideline Environments (SAGE). The
↪→ Action Element defines an appropriate activity to be carried out given the
↪→ specific circumstances.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#ActionVerb </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/ rdf -schema#Literal">Adapted
↪→ from the Element ActionVerb of the Guideline Elements Model (GEM). The
↪→ Action Element defines the word or phrase in a recommendation that
↪→ expresses action.</Literal >
</AnnotationAssertion >
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<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#ActionVerbComplement </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">Adapted
↪→ from the Element ActionVerb of the Guideline Elements Model (GEM). The
↪→ Action Element defines the word or phrase in a recommendation that
↪→ expresses action.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#Condition </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This
↪→ class is adapted from the equivalents of the condition representation
↪→ primitive in existing guideline modelling platforms such as Guideline
↪→ Interchange Format (GLIF), Arden Syntax and Shareable and Active Guideline
↪→ Environments (SAGE). It defines the specific circumstances that a
↪→ recommendation is applicable.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#ConditionWithUnit </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This
↪→ class defines a Condition that is qualified with a Unit.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#DecisionVariable </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This
↪→ class is adapted from the element DecisionVariable of the Guideline
↪→ Elements Model (GEM) and the equivalents of the decision representation
↪→ primitive in existing guideline modelling platforms such as Guideline
↪→ Interchange Format (GLIF), Arden Syntax and Shareable and Active Guideline
↪→ Environments (SAGE). The Decision Variable element defines a condition that
↪→ must be tested to indicate the appropriateness of a conditional
↪→ recommendation.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#Recommendation </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This
↪→ class is adapted from the element Recommendation of the Guideline Elements
↪→ Model (GEM). The Recommendation Element defines the statement of
↪→ appropriate practice and the conditions under which it is to be undertaken.
↪→ </Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#Relator </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">Adopted
↪→ from the class gfo:Relator of the foundational ontology General Formal
↪→ Ontology (GFO). It mediates how a VariableValue instance relates to a
↪→ particular decisionVariable instance.</Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
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<IRI>#Unit</IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This is
↪→ modelled from the class Unit of the Systematized Nomenclature of Medicine -
↪→ Clinical Terms (SNOMED -CT) that defines Unit as a Qualifier Value.</
↪→ Literal >
</AnnotationAssertion >
<AnnotationAssertion >
<AnnotationProperty abbreviatedIRI="rdfs:comment"/>
<IRI>#VariableValue </IRI>
<Literal datatypeIRI="http://www.w3.org /2000/01/rdf -schema#Literal">This
↪→ class is adapted from the element Value of the Guideline Elements Model (
↪→ GEM) and the equivalents of the Decision representation primitive in
↪→ existing guideline modelling platforms such as Guideline Interchange Format
↪→ (GLIF), Arden Syntax and Shareable and Active Guideline Environments (SAGE
↪→ ). The Value element defines a specified state of a decision variable.</
↪→ Literal >
</AnnotationAssertion >
</Ontology >
<!-- Generated by the OWL API (version 4.1.3.20151118 -2017) https: // github.com/
↪→ owlcs/owlapi -->
Appendix D
Representative sample of
guideline recommendations
Table D.1: Guideline recommendations stratified by guideline
Guideline Recommendation
Determining priority for CD4 count
testing
HIV-positive pregnant women
patients in WHO Stage 2
follow up every 6 months
Definition of ART eligibility
Adults - WHO Clinical Stage 2 with a total
lymphocyte count < 1200/mm3
Children over the age of 18 months –
Lymphocyte count below threshold ( 3 years to
< 5 yrs)
Children over the age of 18 months -
Lymphocyte count below threshold (¡ 3 yrs)
PSHD - oral candidiasis and severe pneumonia
Stopping ART and CPT at 18 months - If the
test is negative - On ART
Lymphocyte counts below threshold values for
starting ART (≥ 12 months under 18 months)
WHO Paediatric Clinical Stage 3 or 4 (≥ 12
months under 18 months)
Suspected ART drug failure
New WHO Clinical Stage 4 feature
CD4 count at pre-treatment values or less
Implementing standardised ART
reviews
Stable patients after 6 months
Managing first-line drug reactions
Managing lactic acidosis
Managing skin reactions
Managing first-line regimen in
children
Prescribing triomune-baby
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Guideline Recommendation
Prescribing CPT
Person with symptomatic HIV disease
Child born to an HIV-positive woman
Managing renal or hepatic toxicity in adults
Managing severe haematological toxicity in
adults
Managing severe cutaneous reactions in
children
Managing renal or hepatic toxicity in children
Dosing in younger children
Determining standard
adult doses of ART
drugs
Zidovudine
Lamivudine
Zalcitabine
Emtricitabine
Nelfinavir
Atazanavir
Providing ART in spe-
cial situations
Contraceptives and Neverapine
Contraceptives and Efavirenz
d4T/3TC/NVP not contraindicated in
pregnancy
Discontinuing NVP at the onset of labour
Child born to HIV positive mother on ART
Managing ART patients
who develop TB
Suspecting TB
Managing patients who develop TB when
patient is on ART
Managing Kaposi’s sarcoma Patient with mild to moderate disease
Managing drug toxicity
Diagnosing peripheral neuropathy
Diagnosing pancreatitis
Managing symptoms during clinic
visit
Managing new symptoms
Community IMCI
Managing child who can feed with convulsions
Managing palmar pallor
Managing swollen feet
Managing child who can feed with severe red
eyes
managing child who can feed with red eyes and
vision difficulties
Managing child who can feed with chest
indrawing
Appendix E
Representative sample of
guideline recommendation change
instances
Table E.1: Guideline recommendation changes stratified by type of CPG change
Change category Guideline Recommendation
Addition of a
decision variable
Managingsuspected ART
drug failure
Presenting with suspected ART
drug failure
Change of a decision
variable
Definition of ART
eligibility
Adults – CD4 count below
250/mm3
Definition of ART
eligibility
Children over the age of 18 months
- CD4 or TLC counts (<3 yrs)
Definition of ART
eligibility
Children over the age of 18 months
- WHO Paediatric Clinical Stage 4
or WHO Paediatric Clinical Stage 3
Removal of a
decision variable
Managing suspected ART
drug failure
Suspected ART failure – new
WHO stage 4
Change of a decision
variable
Prescribing CPT
Dosages of CPT – Children aged 6
weeks to 5 months
Prescribing CPT
Dosages of CPT – Children aged 5
– 14 years
Standard Adult Doses of
Antiretroviral Drugs
Lopinavir / ritonavir
Addition of a
recommended action
Providing ART in special
situations
ART in case of renal failure
Removal of a
recommended action
Providing ART in special
situations
ART in case of renal failure
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Change category Guideline Recommendation
Change of an action
verb complement
Determining standard
adult doses of ART drugs
Stavudine
Determining standard
adult doses of ART drugs
Abacavir
Change of a
recommended action
Managing suspected ART
drug failure
Presenting with suspected ART
drug failure
Addition of a recom-
mendation
ART side–effects –
stopping ART
Yellow eyes / hepatitis
ART side-effects –
stopping ART
Severe stomach pain and vomiting
ART side-effects –
stopping ART
Shortness of breath
ART side-effects –
stopping ART
Severe skin rash with blisters,
involving eyes, mouth or genitals
CD4 monitoring for ART
eligibility
CD4 monitoring of patients in HIV
Care Clinic followup Stopping CD4
monitoring
Definition of ART
eligibility
Presumed severe HIV disease
(PSHD) Cryptococcal meningitis
Monitoring of nutritional
status
BMI under 17 – Non–pregnant
adults 15 years and above
Monitoring of nutritional
status
MUAC less than 22cm
Provider initiated family
planning (PIFP)
Implementing routine PIFP in HIV
clinic - women
Provider initiated testing
and counselling (PITC)
Tested negative more than 3
months ago
Selecting regimen and
formulation for
continuation
Children on 1st line regimens when
their weight is over 25kg
Selecting regimen and
formulation for
continuation
If a woman became pregnant while
on an ART regimen that contains
EFV
Removal of a recom-
mendation
Managing first-line drug
reactions
Lactic acidosis/ Lipodystrophy
syndrome
Managing first-line drug
reactions
Adverse reactions to first line
regimen - child <3 yrs
Managing first-line drug
reactions
Child born to HIV positive mother
on ART
Managing first-line drug
reactions
Initial phase of,anti-TB treatment -
severely immuno-compromised
patients
Prescribing CPT All patients eligible for ART
Definition of ART
eligibility
PSHD - recent HIV-related
maternal death
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Change category Guideline Recommendation
Removal of a recom-
mendation
Definition of ART
eligibility
At 18 months - If the test is
positive - On ART
Definition of ART
eligibility
Children under the age of 18
months - CD4 or TLC counts
below threshold values for starting
ART (>= 12 months)
Definition of ART
eligibility
Children over the age of 18 months
- CD4 or TLC counts (5 years,to
<15 years)
Definition of ART
eligibility
Adults - WHO Clinical Stage 2
with a TLC <1200/mm3
Managing Kaposi ’s
sarcoma
In patients with mild to moderate
disease
Managing Kaposi ’s
sarcoma
For others (severe)
Determining priority for
CD4 count testing
Patients in WHO stage 2
Determining priority for
CD4 count testing
Whenever ART failure is suspected
Determining priority for
CD4 count testing
Base-line
Determining priority for
CD4 count testing
Follow-up every 12 months
Standard Adult Doses of
Antiretroviral Drugs
Emtricitabine
Managing symptoms
during clinic visit
new or worsening symptoms since
last visit
Appendix F
FCIG paper-based orientation
189
Appendix F. FCIG five minute paper-based orientation 190
Appendix G
Tasks for the CIG modelling
experiments
G.1 Task one
ENCODING SUB-TASKS: Guideline recommendations for providing ART in special
situations (2011)
1. For an HIV positive patient that is not on ART, is presenting with Anaemia and
is aged 15 years or more, flag patient as eligible for ART and prescribe Regimen
1A - d4T/3TC/NVP.
2. For an HIV positive patient that is not on ART, is presenting with Anaemia
(<8g/dl) and is aged 6 weeks up to 14 years, flag patient as eligible for ART and
prescribe Regimen 1P - d4T/3TC/NVP.
3. For an HIV positive patient that is not on ART, is presenting with Active TB and
is aged 15 years or more, flag patient as eligible for ART and prescribe Regimen
5A – TDF/3TC/EFV.
G.2 Task two
UPDATE SUB-TASKS: Guideline recommendations for providing ART in special situ-
ations (2014)
1. For an HIV positive patient that is not on ART, is presenting with Anaemia
(<8g/dl) and is aged 15 years or more whose weight is 35 kg or more, flag
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patient as eligible for ART and prescribe Regimen 1A - d4T/3TC/NVP 5A –
TDF/3TC/EFV.
2. For an HIV positive patient that is not on ART, is presenting with Anaemia
(<8g/dl) and is aged 6 weeks up to 14 years whose weight is less than 35 kg,
flag patient as eligible for ART and prescribe Regimen 1P - d4T/3TC/NVP 0P
– ABC/3TC+NVP.
3. For an HIV positive patient that is not on ART, is presenting with Active TB and
is aged 15 years or more whose weight is 35 kg or more, flag patient as eligible
for ART and prescribe Regimen 5A – TDF/3TC/EFV.
4. For an HIV positive patient that is not on ART, is presenting with Active TB,
whose weight is less than 35 kg and is aged 6 weeks to under 3 years, flag
patient as eligible for ART and prescribe Regimen 2P – AZT/3TC/NVP.
5. For an HIV positive patient that is not on ART, is presenting with Active TB,
whose weight is less than 35 kg and is aged from 3 years up to 14 years, flag
patient as eligible for ART and prescribe Regimen 4P – AZT/3TC+EFV.
6. For an HIV positive patient that is not on ART, is presenting with Jaundice and
is aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient as
eligible for ART, prescribe Regimen 4P – AZT/3TC+EFV and Refer to District
or Central Hospital (Secondary care).
7. For an HIV positive patient that is not on ART, is presenting with Jaundice and
is aged 15 years or more whose weight is 35 kg or more, flag patient as eligible
for ART, prescribe Regimen 3A – d4T/3TC+EFV 5A – TDF/3TC/EFV and
Refer to District or Central Hospital (Secondary care).
8. For an HIV positive patient that is not on ART and is pregnant and are in their
2nd trimester of pregnancy, flag patient as eligible for ART and prescribe Regimen
5A – TDF/3TC/EFV.
9. For an HIV positive patient that is not on ART, is presenting with renal failure
and is aged 6 weeks up to 14 years, flag patient as eligible for ART, prescribe
Regimen 2P – AZT/3TC/NVP 0 – ABC/3TC+NVP and Refer to District or
Central Hospital (Secondary care).
10. For an HIV positive patient that is not on ART, is presenting with renal failure and
is aged 15 years or more, flag patient as eligible for ART, prescribe Regimen 4A
– AZT/3TC + EFV and Refer to District or Central Hospital (Secondary care).
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Appendix H
Documentation for experiments
H.1 Consent form
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H.2 Experiment procedure explanation
We are comparing two CIG modelling languages, Language A and Language B. You
will be randomly given the modelling basics of one of the two languages via a self-paced
tutorial through a wiki. Thereafter, you will perform two CIG modelling tasks using
the language assigned to you. You will then evaluate the CIG modelling language that
you used. You will take a five minute break, after which, you will be given the basics
of the other modelling language via a wiki. Thereafter, you will perform the same two
CIG modelling tasks using the second language. You will then evaluate the second CIG
modelling language as well.
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H.3 Group one experiment instructions
H.3.1 Condition A instructions
Task 1 – Create Guideline Recommendations for Providing Antiretroviral
Therapy (ART) in Special Situations
 1. Open Eclipse IDE using the default workspace
 2. Switch to a new workspace named ‘/first_experiment_part_1/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/first_experiment_part_1/
 3. Create a new general project named ‘task_1’ by using the following menu ‘File > 
New > Project...’ and select project of type general as shown below:
4. Click finish to create the new project
 5. Create a new file named ‘ART_in_special_situations.mlm’ using the ‘File > New > 
File’ menu as shown below:
 6. Type in the file name and click finish as shown below:
1
 7. Click ‘Yes’ on the dialogue box similar to the one shown below:
 8. For each itemised encoding sub-task below ( i, ii, iii, ...) :
 8.1. Record your start time on the self reporting form in the corresponding field
 8.2. Encode the guideline recommendation accordingly using Language A. 
 8.3. Record the stop time at the end or when you are unable to complete the task
2
ENCODING SUB-TASKS: Guideline recommendations for providing ART in special 
situations (2011)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia and is 
aged 15 years or more, flag patient as eligible for ART and prescribe Regimen 1A - 
d4T/3TC/NVP.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years, flag patient as eligible for ART and prescribe 
Regimen 1P -  d4T/3TC/NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more, flag patient as eligible for ART and  prescribe Regimen 5A 
– TDF/3TC/EFV.
3
Task 2 – Update Guideline Recommendations for Providing ART in 
Special Situations
 1. Switch to a new workspace named ‘/first_experiment_part_2/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/first_experiment_part_2/
 2. Select the project named ‘task_3’ and double click ‘ART_in_special_situations.mlm’ 
in Package Explorer as shown below:
 3. For each itemised update sub-task below ( i, ii, iii, ...) :
 3.1. Record your start time on the self reporting form in the corresponding field
 3.2. Update the guideline recommendation accordingly using Language A. 
 3.3. Record the stop time at the end or when you are unable to complete the task
UPDATE SUB-TASKS: Guideline recommendations for providing ART in 
special situations (2014)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 15 years or more whose weight is 35 kg or more, flag patient as 
eligible for ART and prescribe Regimen 1A -  d4T/3TC/NVP 5A – TDF/3TC/EFV.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient 
as eligible for ART and prescribe Regimen 1P -  d4T/3TC/NVP 0P – ABC/3TC+NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART and  prescribe Regimen 5A – TDF/3TC/EFV.
4
iv. For an HIV positive patient that is not on ART, is presenting with Active TB, whose 
weight is less than 35 kg and is aged 6 weeks  to under 3 years, flag patient as 
eligible for ART and  prescribe Regimen 2P – AZT/3TC/NVP.
v. For an HIV positive patient that is not on ART, is presenting with Active TB,  whose 
weight is less than 35 kg and is aged from 3 years up to 14 years, flag patient as 
eligible for ART and  prescribe Regimen 4P – AZT/3TC+EFV.
vi. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient as 
eligible for ART,  prescribe Regimen 4P – AZT/3TC+EFV and Refer to District or 
Central Hospital (Secondary care).
vii. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART,  prescribe Regimen 3A – d4T/3TC+EFV 5A – TDF/3TC/EFV and Refer to 
District or Central Hospital (Secondary care).
viii.For an HIV positive patient that is not on ART and is pregnant and are in their 2nd 
trimester of pregnancy, flag patient as eligible for ART and prescribe Regimen 5A – 
TDF/3TC/EFV.
ix. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 6 weeks up to 14 years, flag patient as eligible for ART,  prescribe Regimen 
2P – AZT/3TC/NVP 0 – ABC/3TC+NVP and Refer to District or Central Hospital 
(Secondary care).
x.  For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 15 years or more, flag patient as eligible for ART,  prescribe Regimen 4A – 
AZT/3TC + EFV and Refer to District or Central Hospital (Secondary care).
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H.3.2 Condition B instructions
Task 1 – Create Guideline Recommendations for Providing Antiretroviral
Therapy (ART) in Special Situations
 1. Open Eclipse IDE using the default workspace
 2. Switch to a new workspace named ‘/second_experiment_part_1/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/second_experiment_part_1/
 3. Create a new general project named ‘task_1’ by using the following menu ‘File > 
New > Project...’ and select project of type general as shown below:
4. Click finish to create the new project
 5. Create a new file named ‘ART_in_special_situations.cig’ using the ‘File > New > 
File’ menu as shown below:
 6. Type in the file name and click finish as shown below:
1
 7. Click ‘Yes’ on the dialogue box similar to the one shown below:
 8. For each itemised encoding sub-task below ( i, ii, iii, ...) :
 8.1. Record your start time on the self reporting form in the corresponding field
 8.2. Encode the guideline recommendation accordingly using Language B. 
 8.3. Record the stop time at the end or when you are unable to complete the task
2
ENCODING SUB-TASKS: Guideline recommendations for providing ART in special 
situations (2011)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia and is 
aged 15 years or more, flag patient as eligible for ART and prescribe Regimen 1A - 
d4T/3TC/NVP.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years, flag patient as eligible for ART and prescribe 
Regimen 1P -  d4T/3TC/NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more, flag patient as eligible for ART and  prescribe Regimen 5A 
– TDF/3TC/EFV.
3
Task 2 – Update Guideline Recommendations for Providing ART in 
Special Situations
 1. Switch to a new workspace named ‘/second_experiment_part_2/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/second_experiment_part_2/
 2. Select the project named ‘task_3’ and double click ‘ART_in_special_situations.cig’ 
in Package Explorer as shown below:
 3. For each itemised update sub-task below ( i, ii, iii, ...) :
 3.1. Record your start time on the self reporting form in the corresponding field
 3.2. Update the guideline recommendation accordingly using Language B. 
 3.3. Record the stop time at the end or when you are unable to complete the task
UPDATE SUB-TASKS: Guideline recommendations for providing ART in 
special situations (2014)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 15 years or more whose weight is 35 kg or more, flag patient as 
eligible for ART and prescribe Regimen 1A -  d4T/3TC/NVP 5A – TDF/3TC/EFV.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient 
as eligible for ART and prescribe Regimen 1P -  d4T/3TC/NVP 0P – ABC/3TC+NVP.
4
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART and  prescribe Regimen 5A – TDF/3TC/EFV.
iv. For an HIV positive patient that is not on ART, is presenting with Active TB, whose 
weight is less than 35 kg and is aged 6 weeks to under 3 years, flag patient as 
eligible for ART and  prescribe Regimen 2P – AZT/3TC/NVP.
v. For an HIV positive patient that is not on ART, is presenting with Active TB,  whose 
weight is less than 35 kg and is aged from 3 years up to 14 years, flag patient as 
eligible for ART and  prescribe Regimen 4P – AZT/3TC+EFV.
vi. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient as 
eligible for ART,  prescribe Regimen 4P – AZT/3TC+EFV and Refer to District or 
Central Hospital (Secondary care).
vii. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART,  prescribe Regimen 3A – d4T/3TC+EFV 5A – TDF/3TC/EFV and Refer to 
District or Central Hospital (Secondary care).
viii.For an HIV positive patient that is not on ART and is pregnant and are in their 2nd 
trimester of pregnancy, flag patient as eligible for ART and prescribe Regimen 5A – 
TDF/3TC/EFV.
ix. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 6 weeks up to 14 years, flag patient as eligible for ART,  prescribe Regimen 
2P – AZT/3TC/NVP 0 – ABC/3TC+NVP and Refer to District or Central Hospital 
(Secondary care).
x. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 15 years or more, flag patient as eligible for ART,  prescribe Regimen 4A – 
AZT/3TC + EFV and Refer to District or Central Hospital (Secondary care).
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H.4 Group two experiment instructions
H.4.1 Condition B instructions
Task 1 – Create Guideline Recommendations for Providing Antiretroviral
Therapy (ART) in Special Situations
 1. Open Eclipse IDE using the default workspace
 2. Switch to a new workspace named ‘/FirstExperimentPart1/’ by using the following 
menu: ‘File > Switch Workspace > Other’ and typing /FirstExperimentPart1/
 3. Create a new general project named ‘task_1’ by using the following menu ‘File > 
New > Project...’ and select project of type general as shown below:
4. Click finish to create the new project
 5. Create a new file named ‘ART_in_special_situations.cig’ using the ‘File > New > 
File’ menu as shown below:
 6. Type in the file name and click finish as shown below:
1
 7. Click ‘Yes’ on the dialogue box similar to the one shown below:
 8. For each itemised encoding sub-task below ( i, ii, iii, ...) :
 8.1. Record your start time on the self reporting form in the corresponding field
 8.2. Encode the guideline recommendation accordingly using Language A. 
 8.3. Record the stop time at the end or when you are unable to complete the task
2
ENCODING SUB-TASKS: Guideline recommendations for providing ART in special 
situations (2011)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia and is 
aged 15 years or more, flag patient as eligible for ART and prescribe Regimen 1A - 
d4T/3TC/NVP.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years, flag patient as eligible for ART and prescribe 
Regimen 1P -  d4T/3TC/NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more, flag patient as eligible for ART and  prescribe Regimen 5A 
– TDF/3TC/EFV.
3
Task 2 – Update Guideline Recommendations for Providing ART in 
Special Situations
 1. Switch to a new workspace named ‘/FirstExperimentPart2/’ by using the following 
menu: ‘File > Switch Workspace > Other’ and typing /FirstExperimentPart2/
 2. Select the project named ‘task_3’ and double click ‘ART_in_special_situations.cig’ 
in Package Explorer as shown below:
 3. For each itemised update sub-task below ( i, ii, iii, ...) :
 3.1. Record your start time on the self reporting form in the corresponding field
 3.2. Update the guideline recommendation accordingly using Language A. 
 3.3. Record the stop time at the end or when you are unable to complete the task
UPDATE SUB-TASKS: Guideline recommendations for providing ART in 
special situations (2014)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 15 years or more whose weight is 35 kg or more, flag patient as 
eligible for ART and prescribe Regimen 1A -  d4T/3TC/NVP 5A – TDF/3TC/EFV.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient 
as eligible for ART and prescribe Regimen 1P -  d4T/3TC/NVP 0P – ABC/3TC+NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART and  prescribe Regimen 5A – TDF/3TC/EFV.
4
iv. For an HIV positive patient that is not on ART, is presenting with Active TB, whose 
weight is less than 35 kg and is aged 6 weeks to under 3 years, flag patient as 
eligible for ART and  prescribe Regimen 2P – AZT/3TC/NVP.
v. For an HIV positive patient that is not on ART, is presenting with Active TB,  whose 
weight is less than 35 kg and is aged from 3 years up to 14 years, flag patient as 
eligible for ART and  prescribe Regimen 4P – AZT/3TC+EFV.
vi. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient as 
eligible for ART,  prescribe Regimen 4P – AZT/3TC+EFV and Refer to District or 
Central Hospital (Secondary care).
vii. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART,  prescribe Regimen 3A – d4T/3TC+EFV 5A – TDF/3TC/EFV and Refer to 
District or Central Hospital (Secondary care).
viii.For an HIV positive patient that is not on ART and is pregnant and are in their 2nd 
trimester of pregnancy, flag patient as eligible for ART and prescribe Regimen 5A – 
TDF/3TC/EFV.
ix. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 6 weeks up to 14 years, flag patient as eligible for ART,  prescribe Regimen 
2P – AZT/3TC/NVP 0 – ABC/3TC+NVP and Refer to District or Central Hospital 
(Secondary care).
x. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 15 years or more, flag patient as eligible for ART,  prescribe Regimen 4A – 
AZT/3TC + EFV and Refer to District or Central Hospital (Secondary care).
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H.4.2 Condition A instructions
Task 1 – Create Guideline Recommendations for Providing Antiretroviral
Therapy (ART) in Special Situations
 1. Open Eclipse IDE using the default workspace
 2. Switch to a new workspace named ‘SecondExperimentPart1/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/SecondExperimentPart1/
 3. Create a new general project named ‘task_1’ by using the following menu ‘File > 
New > Project...’ and select project of type general as shown below:
4. Click finish to create the new project
 5. Create a new file named ‘ART_in_special_situations.mlm’ using the ‘File > New > 
File’ menu as shown below:
 6. Type in the file name and click finish as shown below:
1
 7. Click ‘Yes’ on the dialogue box similar to the one shown below:
 8. For each itemised encoding sub-task below ( i, ii, iii, ...) :
 8.1. Record your start time on the self reporting form in the corresponding field
 8.2. Encode the guideline recommendation accordingly using Language B. 
 8.3. Record the stop time at the end or when you are unable to complete the task
2
ENCODING SUB-TASKS: Guideline recommendations for providing ART in special 
situations (2011)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia and is 
aged 15 years or more, flag patient as eligible for ART and prescribe Regimen 1A - 
d4T/3TC/NVP.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years, flag patient as eligible for ART and prescribe 
Regimen 1P -  d4T/3TC/NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more, flag patient as eligible for ART and  prescribe Regimen 5A 
– TDF/3TC/EFV.
3
Task 2 – Update Guideline Recommendations for Providing ART in 
Special Situations
 1. Switch to a new workspace named ‘/SecondExperimentPart2/’ by using the 
following menu: ‘File > Switch Workspace > Other’ and typing 
/SecondExperimentPart2/
 2. Select the project named ‘task_3’ and double click ‘ART_in_special_situations.mlm’ 
in Package Explorer as shown below:
 3. For each itemised update sub-task below ( i, ii, iii, ...) :
 3.1. Record your start time on the self reporting form in the corresponding field
 3.2. Update the guideline recommendation accordingly using Language B. 
 3.3. Record the stop time at the end or when you are unable to complete the task
UPDATE SUB-TASKS: Guideline recommendations for providing ART in 
special situations (2014)
i. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 15 years or more whose weight is 35 kg or more, flag patient as 
eligible for ART and prescribe Regimen 1A -  d4T/3TC/NVP 5A – TDF/3TC/EFV.
ii. For an HIV positive patient that is not on ART, is presenting with Anaemia (<8g/dl) 
and is aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient 
as eligible for ART and prescribe Regimen 1P -  d4T/3TC/NVP 0P – ABC/3TC+NVP.
iii. For an HIV positive patient that is not on ART, is presenting with Active TB and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART and  prescribe Regimen 5A – TDF/3TC/EFV.
4
iv. For an HIV positive patient that is not on ART, is presenting with Active TB, whose 
weight is less than 35 kg and is aged 6 weeks  to under 3 years, flag patient as 
eligible for ART and  prescribe Regimen 2P – AZT/3TC/NVP.
v. For an HIV positive patient that is not on ART, is presenting with Active TB,  whose 
weight is less than 35 kg and is aged from 3 years up to 14 years, flag patient as 
eligible for ART and  prescribe Regimen 4P – AZT/3TC+EFV.
vi. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 6 weeks up to 14 years whose weight is less than 35 kg, flag patient as 
eligible for ART,  prescribe Regimen 4P – AZT/3TC+EFV and Refer to District or 
Central Hospital (Secondary care).
vii. For an HIV positive patient that is not on ART, is presenting with Jaundice and is 
aged 15 years or more whose weight is 35 kg or more, flag patient as eligible for 
ART,  prescribe Regimen 3A – d4T/3TC+EFV 5A – TDF/3TC/EFV and Refer to 
District or Central Hospital (Secondary care).
viii.For an HIV positive patient that is not on ART and is pregnant and are in their 2nd 
trimester of pregnancy, flag patient as eligible for ART and prescribe Regimen 5A – 
TDF/3TC/EFV.
ix. For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 6 weeks up to 14 years, flag patient as eligible for ART,  prescribe Regimen 
2P – AZT/3TC/NVP 0 – ABC/3TC+NVP and Refer to District or Central Hospital 
(Secondary care).
x.  For an HIV positive patient that is not on ART, is presenting with renal failure and is 
aged 15 years or more, flag patient as eligible for ART,  prescribe Regimen 4A – 
AZT/3TC + EFV and Refer to District or Central Hospital (Secondary care).
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H.5 Experiment posttest questionnaire
Posttest questionnaire
CIG modelling experiment
* Required
1. What is your participant number? *
2. I think that I would like to use this modelling language frequently *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
3. Comments
 
 
 
 
 
4. I found the modelling language unnecessarily complex *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
5. Comments
 
 
 
 
 
6. I thought the modelling language was easy to use *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
7. Comments
 
 
 
 
 
8. I think that I would need the support of a technical person to be able to use this modelling
language *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
9. Comments
 
 
 
 
 
10. I found the various functions in this modelling language were well integrated *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
11. Comments
 
 
 
 
 
12. I thought there was too much inconsistency in this modelling language *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
13. Comments
 
 
 
 
 
14. I would imagine that most people would learn to use this modelling language very quickly
*
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
15. Comments
 
 
 
 
 
16. I found the modelling language very cumbersome to use *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
17. Comments
 
 
 
 
 
18. I felt very confident using the modelling language *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
Powered by
19. Comments
 
 
 
 
 
20. I needed to learn a lot of things before I could get going with this modelling language *
Mark only one oval.
1 2 3 4 5
Strongly disagree Strongly agree
21. Comments
 
 
 
 
 
22. Which modelling features, if any, did you find useful whilst modelling the clinical
guidelines?
 
 
 
 
 
23. Are there any modelling language features that are missing to support modelling of
clinical guidelines?
 
 
 
 
 
Appendix I
Contextual inquiry interview
notes
I.1 Developer semi-structured interview notes
I.2 Health worker semi-structured interview notes
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Table I.1: Developer interview responses - part A
.
Partici-
pant
Can computers
improve H/C
delivery?
How?
Challenges
faced when
developing
e-Health
solutions
Imple-
mented
CPGs in
an EMR
system
before?
How?
d1 Yes
Speed up work,
Medical history
lookup, medical
research
Data gaps Yes
Hard coded into
the EMR
d2
Yes (with well
trained medical
and IT
practitioners)
Record keeping,
diagnosis
support, robotics,
surgery/precision
Unrealistic
demands from
the end-users,
unknown
requirements
Yes
Hard coded IF
. . . THEN . . .
ELSE . . . rules
d3 Yes
Decision support,
minimising
errors, keeping
past medical
history
Knowledge
transfer to the
users
Yes
Reminders and
also depends on
the situation at
hand
d4 Yes
Data systems and
monitoring
Focus is on the
data than the
patient, No way
of introducing
systems
effortlessly
Yes
Spec was straight
forward so the
rules were
hard-coded
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Table I.2: Developer interview responses - part A (continued)
.
Partici-
pant
Can computers
improve H/C
delivery?
How?
Challenges
faced when
developing
e-Health
solutions
Imple-
mented
CPGs in
an EMR
system
before?
How?
d5 Yes
Creating tools
that complement
what health
workers do
Getting the users
to specify what
they actually
need
Yes
Demonstrated by
hard-coding
d6
Yes, when used in
the right context,
for the right
purpose
Record keeping,
decision support,
M & E reports,
drug stocks
management,
automation for
efficiency
Lack of clear
vision for
e-Health
solutions,
conflicting
stakeholder
interests, lack of
technical
know-how on
effective and
efficient technical
solution
implementation
Yes
Encoded in a web
application, as
alerts
d7
Yes, when they
complement the
health worker
Assisting health
workers do their
job e.g.
calculating BMI
Building systems
that match an
individual clinic’s
workflow
Yes
Hard-coding
guidelines/build-
ing EMR
functionality
around guidelines
d8 Yes
collecting,
storing,
transmitting &
presenting
medical data;
automating
CPGs/decision
support; data
analysis &
reporting
Poor
connectivity, high
work load on
users
Yes
Hard
-coded/Integral
part of business
logic of EMR
d9 Yes
Medical history
lookup,
improving access,
decision support
Different user
definitions/speci-
fications of the
same problem,
unrealistic
deadlines by
product owners,
redefinition of
application
features at any
point of the
development
phase
Yes
Hard-coded in
the EMR
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Table I.3: Developer interview responses - Part B
Partici-
pant
What challenges are you
facing when implementing
CPGs in an EMR?
What would be the ideal
way?
d1 Separation of data from logic Separated from other layers
d2
When guidelines change, one needs
to search where to make
corresponding changes in the code
Separate rules from
logic/servlet/controller
d3
Keeping up with changes in the
guideline. Sources of information
are not formal.
Kind of tricky. Depends on
the architecture
d4 Presentation of the guidelines
Guidelines change, separate
guidelines according to areas
d5
Sometimes users do not provide the
guidelines
Separate guidelines from
other layers of the software.
Enable end-user to change
guideline as opposed to the
developer. Consider
practicality of implementing
CPGs
d6
Keeping the systems updated with
latest guidelines
through CPG engines that
execute guidelines in a
standardised form
d7
Adapting guideline -based systems
to a clinic specific workflow
Make sure implementation is
flexible(not needing an expert
to modify) in the system and
allow for health worker to
override recommendations
d8
Changes in guidelines requires deep
understanding of the system
implementation; It is hard
maintain guidelines that apply
across multiple EMRs or versions
of an EMR
Using some type of rule
engine that is integrated with
the EMR
d9
Guideline logic is tedious to
maintain
In a way that they can be
easily used in all EMR
applications/software
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Table I.4: Health worker interview responses - part A
.
Partici-
pant
Loca-
tion
Location
classifica-
tion
Age
(years)
Gender
Highest
qualification
Year
qualifi-
cation
was ob-
tained
h1 Area 18 Peri-urban 33 F
Certificate in
Clinical
Medicine
2009
h2 Area 18 Peri-urban 43 M
Certificate in
Clinical
Medicine
2001
h3 KCH
Tertiary
Hospital
42 M
Internal
Medicine
Fellowship
(Consultant)
2012
h4 KCH
Tertiary
Hospital
27 F
Six year
Medical degree
(MBBS)
2009
h5 KCH
Tertiary
Hospital
27 M
Six year
Medical degree
(MBBS)
2009
h6 Chileka Rural 33 M
Certificate in
Clinical
Medicine
2008
h7
Lum-
badzi
Rural 25 M
BSc Nursing
and Midwifery
2011
h8
Lum-
badzi
Rural 33 F
Diploma in
Nursing
2009
h9
Lum-
badzi
Rural 28 F
Certificate in
Clinical
Medicine
2008
h10
Mten-
thera
Rural 34 M
Certificate in
Clinical
Medicine
2003
h11 Mbabvi Rural 32 M
Diploma in
Nursing and
Midwifery
2009
h12 KCH
Tertiary
Hospital
27 F
Six year
Medical degree
(MBBS)
2009
h13
Man-
gochi
District
Hospital –
Secondary
27 M
Six year
Medical degree
(MBBS)
2010
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Table I.5: Health worker interview responses - part B
.
Par-
tici-
pant
Used
Com-
put-
ers
in
col-
lege
What for?
Use
CDS
tools
during
consul-
tation
Evi-
dence
of CPG
text
Use
digital
devices
for
your
work
What for?
How
long?
Current
challenges?
h1 No N/A Yes No No N/A N/A N/A
h2 No N/A Yes No No N/A N/A N/A
h3 Yes
Research,
Report writing
Yes Yes No N/A N/A N/A
h4 Yes
Research,
Assignments
Yes Yes No N/A N/A N/A
h5 Yes
Email,
research, data
collection
Yes Yes No N/A N/A N/A
h6 Yes
For research
but with very
limited
resources
Yes Yes
Yes, but
not
regularly
Capturing
complaints,
diagnosis and
treatment
2 years
Slows
consultation
process
h7 Yes
Typing
assignments,
listening to
music,
computer
games
Yes Yes No N/A N/A N/A
h8
Yes,
in a
way
Only had one
computer
lesson
Yes Yes No N/A N/A N/A
h9 No N/A Yes Yes
Yes,
partially
Prescribing
and diagnosis
2 years
A limited
system
without full
diagnosis and
prescription
functionality
h10 No N/A Yes Yes
Yes, but
not
regularly
Captures
diagnosis and
treatment
1 year
Slows work
down
h11 No N/A Yes Yes No N/A N/A N/A
h12 Yes
Reading,
searching for
info online,
analysing data
Yes Yes No N/A N/A N/A
h13 Yes
Research,
studying,
assignments
Yes Yes Yes
References
and research
e.g Medskip
4 Years
Most
guidelines that
are
electronically
available are
different to
local
guidelines
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Table I.6: Health worker interview responses - part C
.
Partici-
pant
How often
do you refer
to CPG
text?
Use
digital
devices
for
social
activi-
ties?
Which ones?
Possi-
ble to
use
tech
during
consul-
tation?
How?
h1 Not very often Yes Mobile FB Yes
To store medical history. But
can slow people down, frequent
breakdown of machines for
current system
h2 Not very often Yes Mobile FB Yes
To store medical history. But
Need enough devices and
standard treatment plans in the
systems
h3
Often (2-3
days) per week
Yes FB, E-mail Yes
To store medical history, to
lookup reference material and
guidelines
h4
Often (2-3
days) per week
Yes FB, Twitter, E-mail Yes To store medical history
h5
Often (2-3
days) per week
Yes FB, Twitter, E-mail Yes
To store medical history,
research, retrieve patient info
h6
Very often
(More than 3
times a week)
Yes
Facebook, online
news feeds
Yes
To refer to guidelines for
difficult conditions. Current
system captures very limited
information, not very useful
h7
Very often
(More than 3
times a week)
Yes
Music, games,
digital pictures
Yes
To store data, to search for
diagnostic procedures e.g.
internet references; probable
management of cases
h8
Often (2-3
days) per week
Yes
Facebook, E-mail,
MS Powerpoint,
Access
Yes Keeping medical history
h9
Very often
(More than 3
times a week)
Yes
Saving, copying and
printing text
documents.
Listening and
sharing music and
pictures. Social
networking on
Facebook
Not sure
It may take years as it wouldn’t
help you much. Ideal for data
collection but not for patient
care.
h10
Often (2-3
days) per week
Yes Computer games Yes
To store records, remind them
of guidelines
h11
Very often
(More than 3
times a week)
Yes
FB, e-mail,
Whatsup
Yes
Best practices pulled from
digital devices
h12
Often (2-3
days) per week
Yes
Social networks,
e-mail, video calls
Yes
To store medical records, To
refer to guidelines, Video
conferencing
h13
Very often
(More than 3
times a week)
Yes
Facebook, twitter,
football news
Yes
Used for easy reference of
material as as to prevent
preventable mistakes
Appendix J
CPG change incidents
J.1 Malawi HIV CPG changes in 2011
Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Providing ART in
special situations
ART in case of renal
failure
N Y
Change in
inclusion criteria
additional
decision variable
Prescribing CPT
Any child, aged 6
weeks or more, born
to an HIV-positive
woman
N Y
Change in
inclusion criteria
additional
decision variable
Managing suspected
ART drug failure
Presenting with
suspected ART drug
failure
N Y
Change in
inclusion criteria
additional
decision variable
∼ ∼ ∼ ∼ ∼ 3
Definition of ART
eligibility
Adults [persons aged
15 years and above]
- WHO Clinical
Stage 3 or WHO
Clinical Stage 4
N Y
Change in
inclusion criteria
Change in
decision criteria
value
227
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Adults [persons aged
15 years and above]
- CD4 lymphocyte
below 250/mm3
N Y
Change in
inclusion criteria
Change in
decision criteria
value
Children over the
age of 18 months -
CD4 or TLC counts
(<3 yrs)
N Y
Change in
inclusion criteria
Change in
decision criteria
value
Children over the
age of 18 months -
CD4 or TLC counts
( 3 years to <5 yrs)
N Y
Change in
inclusion criteria
Change in
decision criteria
value
PSHD - OC and SP N Y
Change in
inclusion criteria
Change in
decision criteria
value
PSHD – OC and SS N Y
Change in
inclusion criteria
Change in
decision criteria
value
PSHD – SP and SS N Y
Change in
inclusion criteria
Change in
decision criteria
value
Children over the
age of 18 months -
WHO Paediatric
Clinical Stage 4 or
WHO Paediatric
Clinical Stage 3
N Y
Change in
inclusion criteria
Change in
decision criteria
value
Managing first-line
regimen in children
Triomune-Baby N Y
Change in
inclusion criteria
Change in
decision criteria
value
Determining stan-
dard adult doses of
ART drugs
Zidovudine N Y
Change in
inclusion criteria
Change in
decision criteria
value
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Stavudine N Y
Change in
inclusion criteria
Change in
decision criteria
value
Abacavir N Y
Change in
inclusion criteria
Change in
decision criteria
value
Tenofovir N Y
Change in
inclusion criteria
Change in
decision criteria
value
∼ ∼ ∼ ∼ ∼ 13
Providing ART in
special situations
D4T/3TC/NVP can
be given to lactating
mothers
N Y
Change in
inclusion criteria
drop of decision
variable
Managing suspected
ART drug failure
Suspected ART
failure – new WHO
stage 4
N Y
Change in
inclusion criteria
drop of decision
variable
∼ ∼ ∼ ∼ ∼ 2
Prescribing CPT
Dosages of CPT –
Children aged 6
weeks to 5 months
N Y
Change in
inclusion criteria
new decision
variable
Dosages of CPT –
Children aged 6
months to 4 years
N Y
Change in
inclusion criteria
new decision
variable
Dosages of CPT –
Children aged 5- 14
years
N Y
Change in
inclusion criteria
new decision
variable
Dosages of CPT –
Adults
N Y
Change in
inclusion criteria
new decision
variable
child has stopped
breast- feeding
N Y
Change in
inclusion criteria
new decision
variable
Standard Adult
Doses of Antiretro-
viral Drugs
Zidovudine N Y
Change in
inclusion criteria
new decision
variable
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Stavudine N Y
Change in
inclusion criteria
new decision
variable
Abacavir N Y
Change in
inclusion criteria
new decision
variable
Tenofovir N Y
Change in
inclusion criteria
new decision
variable
Efavirenz N Y
Change in
inclusion criteria
new decision
variable
Lopinavir / ritonavir N Y
Change in
inclusion criteria
new decision
variable
Managing suspected
ART drug failure
Suspected ART
failure – new WHO
stage 4
N Y
Change in
inclusion criteria
new decision
variable
∼ ∼ ∼ ∼ ∼ 12
∼ ∼ ∼ ∼ 30 0
Providing ART in
special situations
ART in case of renal
failure
N Y
Change in
recommended
action
additional
recommended
action
Prescribing CPT
pregnant woman is
on CPT
N Y
Change in
recommended
action
additional
recommended
action
∼ ∼ ∼ ∼ ∼ 2
Determining stan-
dard adult doses of
ART drugs
Zidovudine N Y
Change in
recommended
action
change in action
verb complement
Stavudine N Y
Change in
recommended
action
change in action
verb complement
Abacavir N Y
Change in
recommended
action
change in action
verb complement
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Tenofovir N Y
Change in
recommended
action
change in action
verb complement
∼ ∼ ∼ ∼ ∼ 4
Providing ART in
special situations
D4T/3TC/NVP can
be given to lactating
mothers
N Y
Change in
recommended
action
change in action
verb complement
∼ ∼ ∼ ∼ ∼ 1
Providing ART in
special situations
D4T/3TC/NVP can
be given to lactating
mothers
N Y
Change in
recommended
action
drop of
recommended
action
Providing ART in
special situations
ART in case of renal
failure
N Y
Change in
recommended
action
drop of
recommended
action
∼ ∼ ∼ ∼ ∼ 2
Providing ART in
special situations
Patients with acute
hepatitis
N Y
Change in
recommended
action
new
recommended
action
Managing suspected
ART drug failure
Presenting with
suspected ART drug
failure
N Y
Change in
recommended
action
new
recommended
action
∼ ∼ ∼ ∼ ∼ 2
∼ ∼ ∼ ∼ 11 0
Prescribing CPT
Any child, 6 weeks
or more, who is
HIV-positive
N N ∼ ∼
Definition of ART
eligibility
Infant <12 months -
positive DNA-PCR
N N ∼ ∼
Managing ART
patients who
develop TB
If there is any
suspicion of TB
N N ∼ ∼
∼ ∼ ∼ ∼ ∼ 0
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
∼ ∼ ∼ ∼ 0 0
∼ ∼ 44 ∼ ∼ ∼
Standard Adult
Doses of Antiretro-
viral Drugs
Lamivudine Y N/A ∼ ∼
Nevirapine Y N/A ∼ ∼
Implementing stan-
dardised ART re-
views
Side effects between
reviews
Y N/A ∼ ∼
After 6 months Y N/A ∼ ∼
After one year Y N/A ∼ ∼
Managing first-line
drug reactions
Severe peripheral
neuropathy
Y N/A ∼ ∼
Pancreatitis Y N/A ∼ ∼
lactic acidosis/
Lipodystrophy
syndrome
Y N/A ∼ ∼
Skin reactions Y N/A ∼ ∼
Hepatitis Y N/A ∼ ∼
Adverse reactions to
first line regimen -
child <3 yrs
Y N/A ∼ ∼
Providing ART in
special situations
Contraceptives and
Neverapine
Y N/A ∼ ∼
Contraceptives and
Efavirenz
Y N/A ∼ ∼
d4T/3TC/NVP is
not contraindicated
in pregnancy
Y N/A ∼ ∼
At the onset of
labour - discontinue
NVP
Y N/A ∼ ∼
Child born to HIV
positive mother on
ART
Y N/A ∼ ∼
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Patients with
established stable
chronic liver disease
Y N/A ∼ ∼
ART eligible
patients with
tuberculosis
Y N/A ∼ ∼
initial phase of
anti-TB treatment
Y N/A ∼ ∼
Initial phase of
anti-TB treatment -
severely immuno-
compromised
patients
Y N/A ∼ ∼
continuation phase
of anti-TB
treatment with
rifampicin and
isoniazid
Y N/A ∼ ∼
Prescribing CPT
DNA-PCR- negative
children
Y N/A ∼ ∼
All patients eligible
for ART
Y N/A ∼ ∼
CD4 count
monitoring - Adults
Y N/A ∼ ∼
Discontinuing CPT -
adults - severe
cutaneous reactions
Y N/A ∼ ∼
Discontinuing CPT -
adults - renal or
hepatic toxicity
Y N/A ∼ ∼
Discontinuing CPT -
adults - severe
haematological
Y N/A ∼ ∼
Appendix J. CPG change incidents 234
Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Discontinuing CPT -
severe cutaneous
reactions
Y N/A ∼ ∼
Discontinuing CPT -
renal or hepatic
toxicity
Y N/A ∼ ∼
Discontinuing CPT -
severe
haematological
toxicity
Y N/A ∼ ∼
Person with
symptomatic HIV
disease
Y N/A ∼ ∼
Any person – CD4
count of 500/mm 3
or less
Y N/A ∼ ∼
Pregnant women
irrespective of
duration of
pregnancy
Y N/A ∼ ∼
Definition of ART
eligibility
Presumed severe
HIV disease (PSHD)
- advanced HIV
disease in the
mother
Y N/A ∼ ∼
Presumed severe
HIV disease (PSHD)
- CD4 <20% in
children 12-18
months
Y N/A ∼ ∼
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Presumed severe
HIV disease (PSHD)
- CD4 <25% in
children less than 12
months
Y N/A ∼ ∼
Presumed severe
HIV disease (PSHD)
- recent HIV-related
maternal death
Y N/A ∼ ∼
At 18 months - If
the test is positive -
On ART
Y N/A ∼ ∼
At 18 months - If
the test is negative -
On ART
Y N/A ∼ ∼
Children under the
age of 18 months -
WHO Paediatric
Clinical Stage 3 or 4
( >= 12 months)
Y N/A ∼ ∼
Children under the
age of 18 months -
CD4 or TLC counts
below threshold
values for starting
ART (>= 12
months)
Y N/A ∼ ∼
Children over the
age of 18 months -
CD4 or TLC counts
(5 years to <15
years)
Y N/A ∼ ∼
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Adults [persons aged
15 years and above]
- WHO Clinical
Stage 2 with a total
lymphocyte count
<1200/mm3
Y N/A ∼ ∼
Children under the
age of 18 months -
WHO Paediatric
Clinical Stage 4
Y N/A ∼ ∼
Managing first-line
regimen in children
T30 - Triomune
baby unavailable
Y N/A ∼ ∼
T30 Y N/A ∼ ∼
Managing Kaposi ’s
sarcoma
In patients with
mild to moderate
disease
Y N/A ∼ ∼
For others (severe) Y N/A ∼ ∼
Managing ART pa-
tients who develop
TB
If TB develops when
the patient is on
ART
Y N/A ∼ ∼
If patients on second
line ART (which
contains protease
inhibitors) develop
TB
Y N/A ∼ ∼
If patients on second
line ART develop
drug-resistant TB
Y N/A ∼ ∼
Monitoring and
Managing Drug
Toxicity
Management of
Pancreatitis –
diagnosis
Y N/A ∼ ∼
Appendix J. CPG change incidents 237
Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Management of
peripheral
neuropathy -
diagnosis
Y N/A ∼ ∼
Management of
peripheral
neuropathy -
treatment
Y N/A ∼ ∼
Management of
peripheral
neuropathy -
treatment (No
response after 4
weeks)
Y N/A ∼ ∼
Determining prior-
ity for CD4 count
testing
HIV-positive
pregnant women
Y N/A ∼ ∼
Patients in WHO
stage 2
Y N/A ∼ ∼
HIV-infected
children
Y N/A ∼ ∼
Whenever ART
failure is suspected
Y N/A ∼ ∼
Base-line Y N/A ∼ ∼
Follow-up every 12
months
Y N/A ∼ ∼
Follow-up every 6
months
Y N/A ∼ ∼
Follow-up every 6-12
months
Y N/A ∼ ∼
Standard Adult
Doses of Antiretro-
viral Drugs
Didanosine for
patients >= 60kg
Y N/A ∼ ∼
Didanosine for
patients <60kg
Y N/A ∼ ∼
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Table J.1: Malawi HIV CPG change incidents in 2011 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Zalcitabine Y N/A ∼ ∼
Emtricitabine Y N/A ∼ ∼
Nelfinavir Y N/A ∼ ∼
Saquinavir /
ritonavir
Y N/A ∼ ∼
Indinavir / ritonavir Y N/A ∼ ∼
Atazanavir Y N/A ∼ ∼
Atazanavir/ritonavir Y N/A ∼ ∼
Managing suspected
ART drug failure
Suspected ART
Drug Failure - CD4
count / CD4% -
pre-treatment values
or less
Y N/A ∼ ∼
new or worsening
symptoms since last
visit e.g.(fever,
abnominal pain,
vomiting, diarrhoea,
weight loss, rash,
pain)
Y N/A ∼ ∼
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J.2 Malawi HIV CPG changes in 2014
Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Choosing regimen
and time of starting
in special situations
Anaemia N Y
Change in
inclusion criteria
additional
decision variable
Active TB >= 3yrs
and <15 yrs
N Y
Change in
inclusion criteria
additional
decision variable
∼ ∼ ∼ ∼ ∼ 2
Choosing regimen
and time of starting
in special situations
Active TB >= 3yrs
and <15 yrs
N Y
Change in
inclusion criteria
change in
decision criteria
value
Definition of ART
eligibility
Child 12 to under 24
months – HIV rapid
antibody test or
DNA–PCR
N Y
Change in
inclusion criteria
change in
decision criteria
value
Child or adult 5
years and over –
Pregnant women
N Y
Change in
inclusion criteria
change in
decision criteria
value
Child or adult 5
years and over –
WHO stage 1 or 2
N Y
Change in
inclusion criteria
change in
decision criteria
value
∼ ∼ ∼ ∼ ∼ 4
Choosing regimen
and time of starting
in special situations
Renal failure (6 wks
to <15yrs)
N Y
Change in
inclusion criteria
drop of decision
variable
Renal failure (>15
yrs)
N Y
Change in
inclusion criteria
drop of decision
variable
∼ ∼ ∼ ∼ ∼ 2
CD4 monitoring for
ART eligibility
CD4 monitoring of
patients in HIV
Care Clinic
follow–up – with
confirmed HIV
infection
N Y
Change in
inclusion criteria
new decision
variable
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Choosing regimen
and time of starting
in special situations
Active TB – Under
3 yrs
N Y
Change in
inclusion criteria
new decision
variable
Active TB >= 15
yrs
N Y
Change in
inclusion criteria
new decision
variable
Jaundice - initiation
(6wks to 14 yrs)
N Y
Change in
inclusion criteria
new decision
variable
Jaundice - initiation
(15 yrs+)
N Y
Change in
inclusion criteria
new decision
variable
∼ ∼ ∼ ∼ ∼ 5
∼ ∼ ∼ ∼ 13 ∼
Choosing regimen
and time of starting
in special situations
Anaemia N Y
Change in
recommended
action
change in action
verb complement
Jaundice - initiation
(15 yrs+)
N Y
Change in
recommended
action
change in action
verb complement
Renal failure (6 wks
to <15yrs)
N Y
Change in
recommended
action
change in action
verb complement
Renal failure (>15
yrs)
N Y
Change in
recommended
action
change in action
verb complement
∼ ∼ ∼ ∼ ∼ 4
∼ ∼ ∼ ∼ 4 ∼
ART side-effects -
stopping ART
Yellow eyes /
hepatitis
N N ∼ ∼
Severe stomach pain
and vomiting
N N ∼ ∼
Shortness of breath N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Severe skin rash
with blisters,
involving eyes,
mouth or genitals
N N ∼ ∼
CD4 monitoring for
ART eligibility
CD4 monitoring of
patients in HIV
Care Clinic
follow–up –
Stopping CD4
monitoring
N N ∼ ∼
Choosing regimen
and time of starting
in special situations
Jaundice – referral N N ∼ ∼
In labour (new
HIV+)
N N ∼ ∼
Clinical suspicion
and diagnosis of
treatment failure
suspected ART
failure diagnosis
N N ∼ ∼
suspected ART
failure with good
adherence
N N ∼ ∼
suspected ART
failure with poor
adherence
N N ∼ ∼
VL 5,000 copies/ml
or more
N N ∼ ∼
Combining ART
and TB treatment
Do not combine
without specialist
advice
N N ∼ ∼
Cotrimoxazole pre-
ventive therapy
(CPT)
All infants born to
HIV infected
mothers
N N ∼ ∼
Confirmed HIV
infected children
from age 6 weeks
and adults
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Giving SP to HIV
infected pregnant
women on CPT
N N ∼ ∼
If SP has already
been taken -
pregnant women
N N ∼ ∼
Who and when to
stop on CPT - HIV
exposed children
N N ∼ ∼
Who and when to
stop on CPT -
severe side effects
N N ∼ ∼
Dosage of
Cotrimoxazole
Preventive Therapy
- less than 6kg
N N ∼ ∼
Dosage of
Cotrimoxazole
Preventive Therapy
- 6.0 – 13.9kg
N N ∼ ∼
Dosage of
Cotrimoxazole
Preventive Therapy
- 14.0 – 29.9kg
N N ∼ ∼
Dosage of
Cotrimoxazole
Preventive Therapy
- 30.0kg and above
N N ∼ ∼
Definition of ART
eligibility
Infant under 12
months – Confirmed
HIV infection
(DNA–PCR needed)
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Presumed severe
HIV disease (PSHD)
- oral candidiasis
and severe
pneumonia
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- oral candidiasis
and severe sepsis
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- severe pneumonia
and severe sepsis
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- Pneumocystis
pneumonia
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- Candidiasis of
oesophagus, trachea,
bronchi or lungs
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- Cryptococcal
meningitis
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Presumed severe
HIV disease (PSHD)
- Severe unexplained
wasting /
malnutrition not
responding to
treatment
(weight-for-height/
-age <70% or
MUAC <11cm or
oedema)
N N ∼ ∼
Presumed severe
HIV disease (PSHD)
- Toxoplasmosis of
the brain (from age
1 month)
N N ∼ ∼
Child or adult 5
years and over -
breastfeeding women
N N ∼ ∼
Child or adult 5
years and over -
WHO clinical stage
3 or 4
N N ∼ ∼
Indications for inter-
rupting or stopping
ART
Lactic acidosis N N ∼ ∼
Pancreatitis N N ∼ ∼
chronic poor
adherence
N N ∼ ∼
Isoniazid preventive
therapy (IPT)
Eligibility for IPT N N ∼ ∼
Stopping IPT N N ∼ ∼
Monitoring of nutri-
tional status
Weight–for–height
less than 80% –
Children 0–14 years
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
MUAC less than
12cm – Children
0–14 years
N N ∼ ∼
Start ART if no
response to TF after
3 weeks
N N ∼ ∼
Weight loss >10% –
Non–pregnant
adults 15 years and
above
N N ∼ ∼
BMI under 18.5 –
Non–pregnant
adults 15 years and
above
N N ∼ ∼
BMI under 17 –
Non–pregnant
adults 15 years and
above
N N ∼ ∼
BMI under 16 –
Non–pregnant
adults 15 years and
above
N N ∼ ∼
Universally eligible
for ART – Pregnant
or lactating women
N N ∼ ∼
MUAC less than
22cm
N N ∼ ∼
MUAC less than
19cm
N N ∼ ∼
Use MUAC instead
of BMI
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Provider initiated
family planning
(PIFP)
Implementing
routine PIFP in
HIV clinic - men
N N ∼ ∼
Implementing
routine PIFP in
HIV clinic - women
N N ∼ ∼
Giving
Depo–Provera
N N ∼ ∼
Provider initi-
ated testing and
counselling (PITC)
never tested N N ∼ ∼
tested negative more
than 3 months ago
N N ∼ ∼
claims to have been
tested any time in
the past, but
without
documentation
N N ∼ ∼
Routine ascer-
tainment of HIV
exposure status for
children under 24
months
For the child: If the
mother is not
available / has died
N N ∼ ∼
For the child: If the
mother is not
available / has died
N N ∼ ∼
For the child: If the
child is sick, even if
the mother was
tested negative
during pregnancy or
delivery
N N ∼ ∼
Routine TB
screening
standard screening
questions
N N ∼ ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
Selecting regimen
and formulation for
continuation
All children who
were on the new
standard 1st line
paediatric regimen
(AZT / 3TC / NVP,
Regimen 2)
N N ∼ ∼
Children on 1st line
regimens when their
weight is over 25kg
N N ∼ ∼
Children who were
on paediatric 2nd
line regimen
(Regimen 9P)
N N ∼ ∼
∼ ∼ ∼ ∼ ∼ 0
∼ ∼ ∼ ∼ 0 ∼
∼ ∼ 79 ∼ ∼ ∼
Definition of ART
eligibility
Child 24 months to
under 5 years -
Confirmed HIV
infection (HIV rapid
antibody test) and
WHO stage 1 or 2
Y N/A ∼ ∼
Child 24 months to
under 5 years -
WHO clinical stage
3 or 4
Y N/A ∼ ∼
Selecting regimen
and formulation for
continuation
If a woman became
pregnant while on
an ART regimen
that contains EFV
Y N/A ∼ ∼
∼ ∼ ∼ ∼ ∼ 0
∼ ∼ ∼ ∼ 0 ∼
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Table J.2: Malawi HIV CPG change incidents in 2014 .
Guideline Recommendation
Dis-
con-
tin-
ued
Cha-
nged
Change Type Specific change
∼ ∼ 3 ∼ ∼ ∼
∼ ∼ 82 ∼ ∼ ∼
∼ ∼ ∼ ∼ ∼ ∼
Appendix K
Grammar usability questionnaire
responses
K.1 SUS questionnaire responses
Table K.1: SUS questionnaire responses - Novice CIG modellers .
Par-
tici-
pant
Use
gram-
mar
fre-
quently
Gram-
mar
was
com-
plex
Gram-
mar
easy
to use
Need
sup-
port
of a
tech-
nical
per-
son
Func-
tions
well
inte-
grated
Too
much
incon-
sis-
tency
Learn
to use
gram-
mar
quickly
Gram-
mar
very
cum-
ber-
some
Felt
confi-
dent
Needed
to
learn
a lot
p1 3 3 4 4 4 2 3 2 3 2
p2 3 2 3 2 4 2 4 3 3 2
p3 4 2 3 4 4 2 2 1 4 2
p4 4 1 3 2 3 1 5 1 3 2
p5 4 1 5 5 4 1 5 2 4 1
p6 3 1 5 1 4 1 4 1 1 1
p7 4 1 4 3 5 1 2 1 5 2
p8 3 1 5 1 5 1 2 1 2 1
p9 4 2 5 2 4 1 4 2 5 2
p10 5 2 4 1 4 2 5 1 4 2
p11 5 1 5 1 5 1 5 1 3 3
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Table K.1: SUS questionnaire responses - Novice CIG modellers .
Par-
tici-
pant
Use
gram-
mar
fre-
quently
Gram-
mar
was
com-
plex
Gram-
mar
easy
to use
Need
sup-
port
of a
tech-
nical
per-
son
Func-
tions
well
inte-
grated
Too
much
incon-
sis-
tency
Learn
to use
gram-
mar
quickly
Gram-
mar
very
cum-
ber-
some
Felt
confi-
dent
Needed
to
learn
a lot
p12 5 1 5 1 4 1 3 1 5 1
p13 4 1 5 1 5 1 4 1 5 2
Table K.2: SUS questionnaire responses - Experienced CIG modellers .
Par-
tici-
pant
Use
gram-
mar
fre-
quently
Gram-
mar
was
com-
plex
Gram-
mar
easy
to use
Need
sup-
port
of a
tech-
nical
per-
son
Func-
tions
well
inte-
grated
Too
much
incon-
sis-
tency
Learn
to use
gram-
mar
quickly
Gram-
mar
very
cum-
ber-
some
Felt
confi-
dent
Needed
to
learn
a lot
p1 5 1 3 2 3 1 3 1 4 3
p2 3 1 5 2 4 1 5 1 5 1
p3 3 1 4 1 4 1 5 1 5 1
p4 4 1 5 1 4 1 5 1 4 1
p5 4 1 4 1 5 1 5 1 4 1
p6 5 1 4 1 4 1 5 1 5 1
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K.2 Qualitative questionnaire responses
Table K.3: Qualitative questionnaire responses - Novice CIG Modellers .
Partici-
pant
Which keywords or
concepts/functionality did you find
useful whilst evaluating the
grammar for FCIG?
Are there any features or keywords
that are missing or need to be
improved in the grammar?
p1 No
p2 action, condition, recommendation
p3 conditons, actions N/A
p4 Action Not that I know of
p5
the three constructs -¿ explain the model
well. specifically Condition as it can load
data that’s vital to making an informed
recommendation
A concern is that Recommendation may
have many entries for conditions for very
specific cases making the syntax long an
cumbersome , the possibility of creating
a grouping of conditions may help in
such complex cases. Just from a
readability perspective
p6 Action
RECOMMENDER-to explain where a
recommendation comes from(who/which
body/doctor/nurse/organisation).
Actions should be able to be grouped
(into sets of actions). Actions should.
Also does the order of actions matter?
can I assume actions are sequencial?
CONDITION – HIV STAGE IS
ADVANCED and ACTION
PRESCRIPE-NO HIV MEDICATION,
They both have HIV noun, NOUN
should be extractable in action and
condition for searchability, linking and
possibly other uses of clinical practice
guideline.
p7 confidence/confident
p8 The constructs Not the I’m aware.
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Table K.3: Qualitative questionnaire responses - Novice CIG Modellers .
Partici-
pant
Which keywords or
concepts/functionality did you find
useful whilst evaluating the
grammar for FCIG?
Are there any features or keywords
that are missing or need to be
improved in the grammar?
p9 all of them are necessary
Have the usefulness of concepts such as
pre-conditions, assertions been
investigated?
p10
It was quite idiomatic and the syntax
flows.
What if a reccomendation is based on
another reccommendation? Possibly have
the possiblity for
p11
p12
Conditions, Action and
Recommendations
Choosing between singular and plural
can be tricky.e.g. in case of one
condition, I thought conditions will
change to Condition
p13
Found the condition construct and its
breakdown into units and decision
variable very useful and highly
informative
The UML class diagram initially give me
the impression of two part activity
diagram. It was only after going through
that I understood it as one part. Can
you modify the diagram and have the
Guideline at the top and rest flowing
below so as to avoid this.
Table K.4: Qualitative questionnaire responses - Experienced CIG Modellers .
Partici-
pant
Which keywords or
concepts/functionality did you find
useful whilst evaluating the
grammar for FCIG?
Are there any features or keywords
that are missing or need to be
improved in the grammar?
Participant
Which keywords or
concepts/functionality did you find useful
whilst evaluating the grammar for FCIG?
Are there any features or keywords that
are missing or need to be improved in the
grammar?
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Table K.4: Qualitative questionnaire responses - Experienced CIG Modellers .
Partici-
pant
Which keywords or
concepts/functionality did you find
useful whilst evaluating the
grammar for FCIG?
Are there any features or keywords
that are missing or need to be
improved in the grammar?
p1
condition, action, recommendation.
These really cover the basics one would
need to use in this kind of setup
Not sure if there could be an explanation
later of how the language can be linked
to an interpreting engine and how they
will be expected to work together. I feel
an implementer can easily appreciate the
value of the language if they also have a
view on how the language can be used in
a practical environment but overall this
is a very relevant tool.
p2
clinical practice guideline,
computer-interpretable guidelines, action,
condition, recommendation
where writing a recommendation, are the
action and conditions always compulsory
or are they sometimes optional?
p3
It was all pretty intuitive. I appreciated
the definitions of the key models and how
few of them there were and how well they
fit together.
I think the ability to define more
complex logic might be necessary in
many situations. e.g. this variable =
this other thing + 30 or a = b and c or
(d and e). I understand this is
(somewhat) handled by the concept
dictionary now, but that information
seems like it might need to be in the
grammar/protocol itself
p4
Relator, operators,
condition/action/recommendation names
1. Definition of qualified/authorised
actors/users. 2. Specifying how the
action should be performed
(recommended tools, methods) where
necessary 3. Specifying when
(timeframe) the action should be
performed where necessary. These can be
specified for a group of guidelines
p5
The syntax , CAR for Conditions ,
Actions and Recommendations were easy
to follow
p6 condition None
Appendix L
FCIG against Arden Syntax raw
data
L.1 FCIG against Arden Syntax measurements
Table L.1: FCIG against Arden Syntax measurements - part A .
Time on task 1 (seconds) Time on task 2 (in seconds)
Par-
tici-
pant
Lan-
guage
Sub
task
1
Sub
task
2
Sub
task
3
To-
tal
Mean
Sub
task
1
Sub
task
2
Sub
task
3
Sub
task
4
Sub
task
5
Sub
task
6
Sub
task
7
p2
Arden
Syntax
867 467 346 1680 560 203 158 113 220 154 105 160
p3
Arden
Syntax
489 235 264 988 329.3333333333 123 116 109 190 95 75 79
p4
Arden
Syntax
684 189 209 1082 360.6666666667 183 42 27 71 86 27 34
p5
Arden
Syntax
916 555 229 1700 566.6666666667 288 167 116 270 118 88 58
p6
Arden
Syntax
856 265 192 1313 437.6666666667 237 174 95 184 103 63 118
p8
Arden
Syntax
899 151 205 1255 418.3333333333 94 97 64 118 96 65 90
p9
Arden
Syntax
704 234 273 1211 403.6666666667 174 258 97 159 104 104 87
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Table L.1: FCIG against Arden Syntax measurements - part A .
Time on task 1 (seconds) Time on task 2 (in seconds)
Par-
tici-
pant
Lan-
guage
Sub
task
1
Sub
task
2
Sub
task
3
To-
tal
Mean
Sub
task
1
Sub
task
2
Sub
task
3
Sub
task
4
Sub
task
5
Sub
task
6
Sub
task
7
p10
Arden
Syntax
947 155 163 1265 421.6666666667 159 138 145 66 89 66 83
p11
Arden
Syntax
829 474 302 1605 535 212 168 84 289 89 130 64
p12
Arden
Syntax
900 135 240 1275 425 90 90 60 100 130 90 100
p13
Arden
Syntax 1026
407 244 1677 559 161 122 107 239 102 124 124
p14
Arden
Syntax 1070
363 193 1626 542 204 255 60 266 188 158 107
p15
Arden
Syntax 1212
232 196 1640 546.6666666667 177 164 73 73 124 172 19
p16
Arden
Syntax 1021
237 179 1437 479 131 87 86 261 141 90 85
p17
Arden
Syntax
973 327 258 1558 519.3333333333 230 227 70 194 110 107 103
p18
Arden
Syntax 1700
480 285 2465 821.6666666667 215 218 220 170 123 135 148
p19
Arden
Syntax
715 225 220 1160 386.6666666667 155 132 49 95 194 119 81
p20
Arden
Syntax
917 320 224 1461 487 167 193 262 217 170 157 106
p21
Arden
Syntax 1137
384 248 1769 589.6666666667 211 239 108 429 246 297 180
p23
Arden
Syntax
923 216 214 1353 451 345 55 40 53 141 181 60
p24
Arden
Syntax
908 527 333 1768 589.3333333333 296 361 170 125 109 104 117
p25
Arden
Syntax 1590
470 324 2384 794.6666666667 200 130 102 255 175 128 208
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Table L.1: FCIG against Arden Syntax measurements - part A .
Time on task 1 (seconds) Time on task 2 (in seconds)
Par-
tici-
pant
Lan-
guage
Sub
task
1
Sub
task
2
Sub
task
3
To-
tal
Mean
Sub
task
1
Sub
task
2
Sub
task
3
Sub
task
4
Sub
task
5
Sub
task
6
Sub
task
7
p26
Arden
Syntax
533 330 273 1136 378.6666666667 283 212 54 85 48 127 86
p27
Arden
Syntax
900 397 208 1505 501.6666666667 191 138 315 86 146 126 114
p29
Arden
Syntax
729 269 254 1252 417.3333333333 155 97 138 125 975 157 119
p31
Arden
Syntax
900 168 161 1229 409.6666666667 114 100 32 102 55 71 76
p2 FCIG 438 373 232 1043 347.6666666667 256 265 97 87 56 24 89
p3 FCIG 568 281 214 1063 354.3333333333 257 186 64 126 40 31 60
p4 FCIG 467 257 176 900 300 139 119 14 50 14 31 21
p5 FCIG 570 532 497 1599 533 281 259 142 169 103 114 72
p6 FCIG 379 295 115 789 263 162 153 28 88 26 34 45
p8 FCIG 612 299 170 1081 360.3333333333 177 142 53 39 59 37 46
p9 FCIG 356 283 133 772 257.3333333333 205 157 49 66 57 56 49
p10 FCIG 823 285 187 1295 431.6666666667 252 182 26 72 70 26 41
p11 FCIG 440 360 258 1058 352.6666666667 283 369 61 79 50 65 60
p12 FCIG 437 190 120 747 249 80 85 22 60 25 25 32
p13 FCIG 479 336 277 1092 364 305 267 47 60 35 75 54
p14 FCIG
1112
630 282 2024 674.6666666667 298 185 181 45 67 75 29
p15 FCIG 711 269 141 1121 373.6666666667 176 174 25 43 66 22 39
p16 FCIG 248 288 198 734 244.6666666667 132 151 17 61 56 4 30
p17 FCIG 299 299 214 812 270.6666666667 202 131 40 68 66 75 40
p18 FCIG 782 430 235 1447 482.3333333333 284 142 38 103 108 70 62
p19 FCIG 532 152 163 847 282.3333333333 183 102 32 29 37 32 50
p20 FCIG 616 330 228 1174 391.3333333333 172 218 70 115 99 125 95
p21 FCIG 649 443 204 1296 432 297 258 58 169 168 135 91
p23 FCIG 613 399 336 1348 449.3333333333 137 307 71 183 103 150 72
p24 FCIG 559 528 313 1400 466.6666666667 206 137 117 74 71 49 63
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Table L.1: FCIG against Arden Syntax measurements - part A .
Time on task 1 (seconds) Time on task 2 (in seconds)
Par-
tici-
pant
Lan-
guage
Sub
task
1
Sub
task
2
Sub
task
3
To-
tal
Mean
Sub
task
1
Sub
task
2
Sub
task
3
Sub
task
4
Sub
task
5
Sub
task
6
Sub
task
7
p25 FCIG 985 390 193 1568 522.6666666667 290 368 55 140 150 63 60
p26 FCIG
1034
551 278 1863 621 91 114 75 38 242 64 76
p27 FCIG 589 360 223 1172 390.6666666667 255 261 98 68 48 22 254
p29 FCIG 410 265 156 831 277 134 137 37 55 21 25 41
p31 FCIG 736 287 266 1289 429.6666666667 211 163 46 25 46 91 90
Table L.2: FCIG against Arden Syntax measurements - part B .
Time on task 2 (in seconds) Task 1 Task 2 Efficiency on task
Par-
tic-
i-
pant
Lan-
guage
Sub
task
8
Sub
task
9
Sub
task
10
To-
tal Mean
SUS
Sco-
res
EL-
OC
LOC
EL-
OC
LOC
Task 1 Task 2
p2
Arden
Syntax
551 89 42 1795 179.5 67.5 136 176 447 561 0.000595238095 0.000557103064
p3
Arden
Syntax
33 38 20 878 87.8 35 138 177 449 559 0.001012145749 0.001138952164
p4
Arden
Syntax
21 31 9 531 53.1 60 136 173 453 556 0.000924214418 0.001883239171
p5
Arden
Syntax
104 171 38 3398 339.8 95 136 177 432 549 0.000588235294 0.000294290759
p6
Arden
Syntax
122 209 22 1327 132.7 92.5 130 170 431 541 0.000761614623 0.000753579503
p8
Arden
Syntax
47 61 13 745 74.5 62.5 130 154 433 543 0.000796812749 0.001342281879
p9
Arden
Syntax
41 104 36 1164 116.4 82.5 130 165 432 542 0.000825763832 0.000859106529
p10
Arden
Syntax
49 100 35 930 93 50 127 159 446 557 0.000790513834 0.001075268817
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Table L.2: FCIG against Arden Syntax measurements - part B .
Time on task 2 (in seconds) Task 1 Task 2 Efficiency on task
Par-
tic-
i-
pant
Lan-
guage
Sub
task
8
Sub
task
9
Sub
task
10
To-
tal Mean
SUS
Sco-
res
EL-
OC
LOC
EL-
OC
LOC
Task 1 Task 2
p11
Arden
Syntax
44 141 11 1232 123.2 92.5 139 186 433 545 0.00062305296 0.000811688312
p12
Arden
Syntax
20 68 18 766 76.6 82.5 127 158 432 543 0.000784313725 0.001305483029
p13
Arden
Syntax
57 120 47 1203 120.3 85 139 170 435 547 0.000596302922 0.000831255195
p14
Arden
Syntax
21 108 32 1399 139.9 87.5 137 178 449 560 0.00061500615 0.000714796283
p15
Arden
Syntax
15 20 73 910 91 80 130 162 450 562 0.000609756098 0.001098901099
p16
Arden
Syntax
41 177 28 1127 112.7 80 130 164 435 548 0.000695894224 0.000887311446
p17
Arden
Syntax
100 115 32 1288 128.8 87.5 133 170 432 542 0.000641848524 0.000776397516
p18
Arden
Syntax
98 67 50 1444 144.4 30 140 185 489 616 0.000405679513 0.000692520776
p19
Arden
Syntax
24 77 16 942 94.2 62.5 136 169 432 542 0.000862068966 0.001061571125
p20
Arden
Syntax
65 220 11 1568 156.8 70 139 174 484 605 0.000684462697 0.000637755102
p21
Arden
Syntax
43 116 28 1897 189.7 67.5 136 179 436 548 0.000565291125 0.000527148129
p23
Arden
Syntax
11 38 19 943 94.3 75 132 164 443 553 0.0007390983 0.001060445387
p24
Arden
Syntax
44 207 39 1572 157.2 90 151 198 451 563 0.00056561086 0.000636132316
p25
Arden
Syntax
52 66 14 1330 133 80 135 169 451 563 0.000419463087 0.000751879699
p26
Arden
Syntax
30 149 31 1105 110.5 87.5 140 178 434 547 0.00088028169 0.000904977376
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Table L.2: FCIG against Arden Syntax measurements - part B .
Time on task 2 (in seconds) Task 1 Task 2 Efficiency on task
Par-
tic-
i-
pant
Lan-
guage
Sub
task
8
Sub
task
9
Sub
task
10
To-
tal Mean
SUS
Sco-
res
EL-
OC
LOC
EL-
OC
LOC
Task 1 Task 2
p27
Arden
Syntax
29 65 20 1230 123 70 132 183 447 557 0.000664451827 0.00081300813
p29
Arden
Syntax
18 72 13 1869 186.9 72.5 133 175 432 542 0.000798722045 0.000535045479
p31
Arden
Syntax
44 51 27 672 67.2 47.5 129 160 448 563 0.00081366965 0.001488095238
p2 FCIG 21 100 22 1017 101.7 82.5 34 64 85 164 0.000958772771 0.000983284169
p3 FCIG 26 128 11 929 92.9 55 31 46 84 160 0.000940733772 0.001076426265
p4 FCIG 13 89 12 502 50.2 82.5 31 39 84 153 0.001111111111 0.001992031873
p5 FCIG 22 203 21 1386 138.6 32.5 33 66 79 147 0.000625390869 0.000721500722
p6 FCIG 34 82 7 659 65.9 82.5 34 56 84 155 0.001267427123 0.001517450683
p8 FCIG 23 109 27 712 71.2 85 31 45 84 157 0.00092506938 0.001404494382
p9 FCIG 24 85 8 756 75.6 40 31 52 84 154 0.001295336788 0.001322751323
p10 FCIG 18 137 12 836 83.6 92.5 31 51 84 155 0.000772200772 0.001196172249
p11 FCIG 37 177 12 1193 119.3 97.5 31 58 84 158 0.000945179584 0.000838222967
p12 FCIG 15 33 9 386 38.6 92.5 31 46 82 154 0.001338688086 0.002590673575
p13 FCIG 12 179 6 1460 146 90 34 62 84 157 0.000915750916 0.000684931507
p14 FCIG 5 182 71 1198 119.8 87.5 33 55 84 158 0.000494071146 0.000834724541
p15 FCIG 27 82 31 685 68.5 92.5 31 60 84 164 0.00089206066 0.001459854015
p16 FCIG 44 185 6 686 68.6 80 34 53 84 156 0.00136239782 0.001457725948
p17 FCIG 18 118 15 773 77.3 87.5 31 50 84 155 0.001231527094 0.001293661061
p18 FCIG 30 170 11 1018 101.8 65 31 51 84 155 0.000691085003 0.000982318271
p19 FCIG 28 131 5 629 62.9 82.5 29 43 84 158 0.001180637544 0.001589825119
p20 FCIG 55 183 31 1163 116.3 87.5 34 58 79 147 0.000851788756 0.000859845228
p21 FCIG 68 172 4 4780 478 62.5 31 60 84 159 0.000771604938 0.000209205021
p23 FCIG 25 57 15 1120 112 72.5 31 34 82 148 0.000741839763 0.000892857143
p24 FCIG 29 153 18 917 91.7 87.5 39 72 88 163 0.000714285714 0.001090512541
p25 FCIG 56 110 30 1322 132.2 65 29 42 82 156 0.000637755102 0.000756429652
p26 FCIG 40 100 44 884 88.4 90 32 63 82 152 0.000536768653 0.001131221719
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Table L.2: FCIG against Arden Syntax measurements - part B .
Time on task 2 (in seconds) Task 1 Task 2 Efficiency on task
Par-
tic-
i-
pant
Lan-
guage
Sub
task
8
Sub
task
9
Sub
task
10
To-
tal Mean
SUS
Sco-
res
EL-
OC
LOC
EL-
OC
LOC
Task 1 Task 2
p27 FCIG 16 122 21 1165 116.5 85 31 50 84 155 0.000853242321 0.000858369099
p29 FCIG 14 74 5 543 54.3 90 31 47 84 158 0.001203369434 0.001841620626
p31 FCIG 38 156 31 1497 149.7 75 31 55 84 157 0.00077579519 0.000668002672
Table L.3: Error rates .
Task 1 Task 2
Partici-
pant
Lan-
guage t1 t2 t3
Over-
all t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
Over-
all
p2
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p3
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p4
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p5
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p6
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p8
Arden
Syntax
1 1 1 1 0 0 0 0 0 0 0 0 0 0 0
p9
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p10
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p11
Arden
Syntax
0 0 0 0 0 0 0 0 0 1 0 0 0 0 1
p12
Arden
Syntax
1 1 1 1 0 0 0 0 0 0 0 0 1 0 1
p13
Arden
Syntax
0 0 0 0 0 0 0 0 0 1 0 0 0 0 1
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Table L.3: Error rates .
Task 1 Task 2
Partici-
pant
Lan-
guage t1 t2 t3
Over-
all t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
Over-
all
p14
Arden
Syntax
1 1 0 1 0 0 0 1 1 0 0 0 1 0 1
p15
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p16
Arden
Syntax
1 0 0 1 0 0 0 0 1 0 0 0 0 0 1
p17
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p18
Arden
Syntax
0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
p19
Arden
Syntax
0 1 0 1 0 1 0 1 1 1 0 0 0 0 1
p20
Arden
Syntax
0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
p21
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p23
Arden
Syntax
0 0 0 0 1 1 0 0 0 1 0 0 1 0 1
p24
Arden
Syntax
1 0 0 1 0 1 0 0 0 0 0 0 0 0 1
p25
Arden
Syntax
1 1 1 1 1 0 1 0 0 0 1 0 1 0 1
p26
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 1 0 1
p27
Arden
Syntax
0 1 1 1 0 0 0 0 0 0 0 0 0 0 0
p29
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p31
Arden
Syntax
0 0 0 0 0 0 0 1 0 0 0 0 0 0 1
p2 FCIG 0 1 1 1 1 0 0 0 1 0 1 1 1 0 1
p3 FCIG 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
p4 FCIG 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1
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Table L.3: Error rates .
Task 1 Task 2
Partici-
pant
Lan-
guage t1 t2 t3
Over-
all t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
Over-
all
p5 FCIG 0 0 1 1 0 1 0 1 0 1 1 0 0 0 1
p6 FCIG 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1
p8 FCIG 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0
p9 FCIG 0 1 1 1 0 0 0 0 0 1 0 0 0 0 1
p10 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1
p11 FCIG 0 0 1 1 0 0 0 0 0 1 0 0 0 0 1
p12 FCIG 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1
p13 FCIG 0 0 0 0 0 1 1 0 0 0 0 0 1 0 1
p14 FCIG 1 1 1 1 0 1 1 0 1 1 1 1 1 0 1
p15 FCIG 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0
p16 FCIG 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1
p17 FCIG 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0
p18 FCIG 1 1 1 1 0 0 0 1 0 0 0 0 0 1 1
p19 FCIG 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
p20 FCIG 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1
p21 FCIG 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0
p23 FCIG 1 1 1 1 0 1 1 1 1 1 1 0 1 0 1
p24 FCIG 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1
p25 FCIG 1 1 0 1 0 0 0 1 1 0 0 0 1 0 1
p26 FCIG 0 0 0 0 1 1 0 1 1 1 0 0 0 0 1
p27 FCIG 0 1 1 1 0 0 1 1 1 1 1 0 0 0 1
p29 FCIG 1 1 1 1 0 1 1 0 0 0 1 0 0 0 1
p31 FCIG 1 1 1 1 0 1 1 0 1 1 0 0 0 0 1
Table L.4: Number of errors .
Task 1 Tast 2
Par-
tici-
pant
Lan-
guage t1 t3 t3
to-
tal
avg
t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
to-
tal
avg
p2
Arden
Syntax
0 1 1 2 0.67 1 0 0 0 1 0 1 1 1 0 5 0.5
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Table L.4: Number of errors .
Task 1 Tast 2
Par-
tici-
pant
Lan-
guage t1 t3 t3
to-
tal
avg
t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
to-
tal
avg
p3
Arden
Syntax
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0.1
p4
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0.1
p5
Arden
Syntax
0 0 1 1 0.33 0 1 0 1 0 1 2 0 0 0 5 0.5
p6
Arden
Syntax
0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0.1
p8
Arden
Syntax
0 1 0 1 0.33 0 0 0 0 0 0 0 0 0 0 0 0
p9
Arden
Syntax
0 1 1 2 0.67 0 0 0 0 0 1 0 0 0 0 1 0.1
p10
Arden
Syntax
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.1
p11
Arden
Syntax
0 0 1 1 0.33 0 0 0 0 0 1 0 0 0 0 1 0.1
p12
Arden
Syntax
0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 2 0.2
p13
Arden
Syntax
0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 3 0.3
p14
Arden
Syntax
1 1 2 4 1.33 0 2 2 0 1 1 1 1 1 0 9 0.9
p15
Arden
Syntax
1 0 0 1 0.33 0 0 0 0 0 0 0 0 0 0 0 0
p16
Arden
Syntax
0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 2 0.2
p17
Arden
Syntax
0 1 0 1 0.33 0 0 0 0 0 0 0 0 0 0 0 0
p18
Arden
Syntax
1 1 1 3 1 0 0 0 1 0 0 0 0 0 1 2 0.2
p19
Arden
Syntax
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0.1
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Table L.4: Number of errors .
Task 1 Tast 2
Par-
tici-
pant
Lan-
guage t1 t3 t3
to-
tal
avg
t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
to-
tal
avg
p20
Arden
Syntax
0 1 1 2 0.67 1 1 1 1 1 1 1 1 1 1 10 1
p21
Arden
Syntax
0 1 0 1 0.33 0 0 0 0 0 0 0 0 0 0 0 0
p23
Arden
Syntax
2 2 2 6 2 0 1 1 1 1 1 1 0 1 0 7 0.7
p24
Arden
Syntax
1 0 0 1 0.33 0 0 0 0 0 0 0 0 1 0 1 0.1
p25
Arden
Syntax
1 1 0 2 0.67 0 0 0 1 1 0 0 0 1 0 3 0.3
p26
Arden
Syntax
0 0 0 0 0 1 1 0 1 1 1 0 0 0 0 5 0.5
p27
Arden
Syntax
0 1 1 2 0.67 0 0 1 1 1 1 1 0 0 0 5 0.5
p29
Arden
Syntax
1 1 1 3 1 0 1 1 0 0 0 1 0 0 0 3 0.3
p31
Arden
Syntax
1 1 1 3 1 0 1 1 0 1 1 0 0 0 0 4 0.4
p2 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p3 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p4 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p5 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p6 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p8 FCIG 1 1 1 3 1 0 0 0 0 0 0 0 0 0 0 0 0
p9 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p10 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p11 FCIG 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.1
p12 FCIG 1 1 1 3 1 0 0 0 0 0 0 0 0 1 0 1 0.1
p13 FCIG 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.1
p14 FCIG 1 1 0 2 0.67 0 0 0 1 1 0 0 0 1 0 3 0.3
p15 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p16 FCIG 1 0 0 1 0.33 0 0 0 0 1 0 0 0 0 0 1 0.1
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Table L.4: Number of errors .
Task 1 Tast 2
Par-
tici-
pant
Lan-
guage t1 t3 t3
to-
tal
avg
t1 t2 t3 t4 t5 t6 t7 t8 t9 t10
to-
tal
avg
p17 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p18 FCIG 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0.1
p19 FCIG 0 1 0 1 0.33 0 1 0 1 1 1 0 0 0 0 4 0.4
p20 FCIG 0 0 1 1 0.33 0 0 0 0 0 0 0 0 0 0 0 0
p21 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p23 FCIG 0 0 0 0 0 1 1 0 0 0 1 0 0 2 0 5 0.5
p24 FCIG 1 0 0 1 0.33 0 1 0 0 0 0 0 0 0 0 1 0.1
p25 FCIG 1 1 1 3 1 1 0 1 0 0 0 1 0 1 0 4 0.4
p26 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0.1
p27 FCIG 0 1 1 2 0.67 0 0 0 0 0 0 0 0 0 0 0 0
p29 FCIG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
p31 FCIG 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0.1
L.2 SUS questionnaire responses
Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p2 4 2 4 2
Appendix J. FCIG against Arden Syntax raw data 266
Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p3 2
Not
maintainable. It
would require
fixed meta-labels
on the
recommendations
to recall what
they are. This is
currently done by
the recommenda-
tion’s name but it
is insufficient. A
tool for graphical
editing (with
autocomplete)
would improve
my view.
3 4
It might be
complex for
beginners,
especially ones
with no
programming
experience.
4
A few
training
sessions for
users would
be
necessary.
p4 4
Easy to
understand
2
When the
conditions are all
clamped up it
gets a little bit
disorienting
5 2
p5 1
requires too
much care and
attention to
detail to the user
5
The language
structure seems
ok, but is not
that easy to use
but it could get
better with
practice
2
It takes some
getting used to
3
To get
familiar
with the
bits and
pieces
Appendix J. FCIG against Arden Syntax raw data 267
Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p6 4 2 5 1
p8 5
Flexible, easy to
use and modify
1
Language is very
intuitive
5
Could use
linking words
and
comparators
(¡, ¿) which
make it very
easy to
understand
4
Some
training
would be
necessary,
but I think
anyone
would be
able to use
this
language
p9 3
It would not be
my first choice if
I had to choose.
4
It is a bit hard to
understand at
first.
2
It took me
sometime to
get started.
4
Only in the
beginning.
p10 5
Takes some time
to wrap mind
around the
syntax but once
one gets going its
a peace of cake
1 5 2
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Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p11 4 1
It is very simple
and easy to use
5
I thought it
was extremely
easy to use,
with the
exception of
not knowing
exactly what
the prescribed
variables are.
I knew age
was a
prescribe
variable, but I
didn’t know if
height was, or
what qualified
a variable to
be a variable
to be a
variable.
1
p12 5 2 5 1
p13 5 1 4 2
p14 4 2 5 2
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Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p15 4
straight forward,
pleasant enough.
1
The language
quite natural.
nothing confusing
about it for me. I
was overly
concerned with
form.
5 1
I am very
familiar
with the
technical
aspects of
such
languages
p16 4
yes, editing this
language i think
was a bit easier
since you reused
conditions a lot
2
there was a lot of
work to be done
in the beginning,
with setting up
conditions and
actions, but after
that it was quite
easy
4 2
p17 5 1 5 1
p18 2 2 3 4
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Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p19 4
It was very quick
to understand, a
person with no
programming
experience can
adapt to this
language easily, I
wish there was a
library to avoid
spending time on
typing words.
1
The only thing
complex was
keeping track to
the numbering of
recommenda-
tion/condi-
tion/action as if i
had to edit a
recommendation
i would take a
huge time trying
to find the
particular
recommendation
5
Very quick to
understand as
it does not
require any
programming
experience
2
I would
need
someone
only in the
first few
minutes to
understand
the syntax
of the
language
otherwise
p20 5 very reusable 1 4 2
p21 4 2 2 3
p22 5
It’s very is to
understand and
use
1
It’s very easy to
understand
5 1
p23 5 3
The editing of
the conditions is
a bit tricky
2 1
Only a
person who
understand
the
language is
needed for
first time
use expla-
nation.
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Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p24 5
feels natural and
informal
1
only what is
required is
written
5
has high code
reusability
1
easy to pick
up
p25 3
It was a learning
curve at first, but
after a while it
became easier to
use and made
more sense.
2
It seemed so at
first, but it’s
actually fairly
simple.
3 2
I may need
help but
not all the
time.
p26 5
The language is
straight forward
using simple
sentences to
describe a
function or
method
1 3
I had a bit of
trouble at first
getting the
concept but as
i went on i
managed to
get a better
idea of how to
go on
3
Just a bit
of help in
getting a
better idea
on what to
do next
and when
p27 2 2 4 1
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Table L.5: SUS questionnaire responses - FCIG (part A)
Par-
tici-
pant
Use
lan-
guage
fre-
quently
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p29 5
The language is
extremely
intuitive and has
the potential to
significantly
improve clinical
recommendation
systems.
2
The language is
fairly easy to pick
up and get used
to at first glance.
4
The language
syntax is very
intuitive and
fairly simple.
1
I think that
if you don’t
have
experience
in program-
ming, you
could need
some help
at first but
as you
continue
using the
program-
ming
language, it
becomes
intuitive
and simple
to use.
p31 4 2 4 2
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p2 5 1 4 2
p3 4 1 3
Health
workers in
rural areas
might have a
difficult time
using it. It
then depends
on the training
offered.
4
p4 4
the
recommendation,
action and
condition
structure is
simple
1 4
very high level
language
1
p5 3
Everything was
too clustered
3
the language was
fairly consistend
2 A Big No No 4
Very cum-
bersome
even
though it
might not
seem that
way
p6 4 2 4 1
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p8 5
Autocomplete
functions really
helped with
finding conditions
etc. This
language was well
integrated with
Eclipse
2
The wide range
of naming
freedom such as
5
Those with
basic
computer
literacy would
not struggle
with this
language. It is
very intuitive.
1
The
separation
of
conditions,
actions and
recommen-
dations
makes it a
very
succinct
language
that is easy
to modify
p9 2
When the code is
large enough, It
will be hard to
keep track of
your actions,
recommendations
and conditions.
2
You can use the
same variable
many times.
3 4
Everything
is all in one
place and
you can not
group
things
together.
p10 5 1 4 1
p11 5 1 5 1
p12 4 1 5 1
p13 4 1 4 1
p14 4 2 5 1
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p15 4
I kind of want a
way to quickly go
back to the
Recommendation
after Ctrl+Click
ing on the condi-
tions/actions
1 5 2
Descriptive
variable
names are
cumber-
some in any
language
p16 4 1 4 1
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p17 4 2 5
There are very
few keywords
to learn and
the document
follows an
intuitive,
simple
structure
4
Conditions
cannot
have
multiple
clauses. If
we could
use ”and’
and ’or’
operators
to compose
conditions,
it might
declutter
the list of
conditions
a little.
having to
workaround
this
limitation
by using 2
conditions
is a little
cumber-
some
p18 4 1
Well-structured,
though it is
technical
4
People with
some
knowledge of
programming
can pick it up
quickly
2
Structure is
simple
enough to
understand
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p19 3
Having being told
that who the
language is
designed for, I
would have
expected
functions and
libraries for the
particular target.
2 5 2
p20 5 1 3 1
p21 3 2 4
Although the
language has
limitations in
capturing
recommenda-
tions, it is
easy to use
and learn.
2
p22 5 2 5 1
p23 5 2 3 2
p24 4
reading patients
info is well
integrated
5
found if very
consistent
5 1
it’s
function
orientated.
not much
structural
code is
needed
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Table L.6: SUS questionnaire responses - FCIG (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p25 5 4
Because things
could be defined
differently, it
could be
confusing when
using the
different names.
4 3
p26 5 1 5
The language
is way easier
then language
A once you
get a good
idea of it and
how it works
1
p27 4 1 5 1
p29 5 1
The language is
very consistent in
terms of its
structure and it
will be fairly
simple to read
other people’s
program
structure.
5 1
p31 5 2 4 2
Table L.7: SUS questionnaire responses - FCIG (part C)
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Par-
tici-
pant
Felt
con-
fi-
dent
Comments
Needed
to
learn
a lot
Comments
Any useful
feautures?
Any missing
features?
p2 5 2 code re-use
p3 4 3
p4 4
Not sure what
the drug names
were until the
end
2
The python like
structure, use of
semicolons with no
constrains on the
positions of the
leading white
spaces
composite
conditions (having
conditions within
conditions) may
make it compact
p5 3
My confidence
dropped a bit
3 The syntax All Not really
p6 4 2 Reusability None
p8 4
After some
practise, it
became very easy
to use
2
With the help of
the wiki and the
spreadsheet, I
didn’t need to
know anything
about the
medical
conditions in
order to get to
grips with it.
Autocomplete was
very helpful, the
outline allowed me
to see what
conditions had
already been
created.
Not that I can
think of
p9 2 I was confused. 2
There isn’t a lot
to learn to use
this language.
Using variables
you define once
and use multiple
times
Code grouping.
Group Conditions
together, Group
Recommendations
together and
Group Actions
together.
p10 5 2 The outline
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p11 5 1
The actions are
very simple to use
and the fact that
it only has
conditions, actions
and
recommendations
makes it even
easier to use.
No.
p12 5 2
Reuse of
conditions in
different
recommendations
the ability to
select ranges (eg
1¡x¡5)
p13 5 1
p14 5 1
scripting from the
same file/page
all the basic
mathematical
operands should
be catered for as
widely know. eg.
the between x and
y as one expression
as opposed to
separate entity
p15 5 1
all of them.
Although I did not
use the Ctrl+hover
feature, and chose
to Ctrl+click (see
above). That
would have been
wiser. Silly me for
not paying
attention
I don’t know :—
p16 5 3
The reusing of
conditions and
actions was very
helpful
no
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p17 5 1
Extremely
simple,
straightforward
syntax was easy
to learn. Very
few keywords
that were
intuitive and
easy-to-learn
document
structure
Reusing the
conditions and
actions was a
really good feature
that saved a lot of
time. It also made
the
recommendations
very easy to parse
(I could
completely
understand what
was going on even
when reading the
example cig file for
the first time).
Being able to
compose
conditions and/or
use multiple
clauses to define a
condition would be
nice.
p18 4 2
References to
certain conditions,
statements
Being able to put
the list of
conditions and list
of
recommendations
in the different
sections
p19 5
Very easy to
understand
2
Only to get
started otherwise,
after the
experiment i feel
as if i can use
this language on
my own
the shortcuts as it
prevented me to
type the
redundant text
It needed a sort of
library for clinical
guidelines to avoid
typing, for
example, instead
of typing positive
or negative it
could already be
installed in the
language.
p20 4 1
The fact that we
could reuse the
conditions
Not that I can
think of
p21 4 3
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p22 5 2
Separating the
conditions and the
actions. It made
the modelling easy
to understand.
Nothing I can
think of
p23 4 2
Having outlined
variable links on
the IDE makes it
easy to navigate to
the actual
definitions of the
variables hence
making it easy and
fast to use.
p24 5
tag names helps
with navigation
1
it’s function
orientated. not
much structural
code is needed
p25 3
At first no, but
after a while I
became more
confident
1
The
auto-completion
and suggestions
when filling in
conditions and
actions
Not to my
knowledge
p26 5
Easy to
understand and
implement
1
All the features
are useful like in
language A
p27 5 1
Ease of use in
adding various
conditions or
actions to guide a
patients
recommendation
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p29 4 2
I needed to learn
a few medical
jargon and the
basic syntax of
the programming
language,
however, it
becomes intuitive
even with
minimum medical
knowledge.
Referencing
Condition and
Action constructs
to make
recommendations
is a very useful
feature, and
significantly
minimizes human
error in my
opinion.
p31 4 3
Autocomplete very
useful, Overview
also helpful
Consistency with
condition variables
could be better. I
know for example
Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p2 3 2 4 5
p3 2
Maintenance is
easier. However,
the language is
too verbose. It is
also hard to keep
track of
individual mlm’s
since they are all
in a single file.
4 2 4
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p4 2
The detailed
information is
appreciated
however the use
of threshold
values for each
recommendation
is redundant.
4 3 2
p5 5
The language is
easy to use
1
Once you become
familiar with the
syntax everything
starts to fall in
place
5
The language
is straight
forward
1
p6 5 1 5 1
p8 4
More complex
than Language
A, but allows for
reading from a
record which I
think would be
very useful.
2 Some fields like 4
Again it was
fairly intuitive
but separating
the data
(variable
declaration)
and logic
components
made it
slightly less
intuitive
5
I definitely
needed
guidance to
begin using
this
language.
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p9 5
The language is
straight forward.
It is easy to
follow whats
happening.
1
The language is
easy to
understand and I
did not find it
complex.
5
It has the
basic concepts
of other
programming
languages and
that makes it
easy.
5
This
experiment
got me
interesting
in working
with this
program-
ming
language.
p10 3 3 3 4
p11 5
It’s very easy to
use and learn as
well.
1 5 1
p12 4 2
Not complex but
repetitive, would
be nice to define
some variables
once and use in
multiple places.
5 1
p13 4 2 4 1
p14 4 1 4 2
p15 3
I’d prefer the
other one, but I
got used to the
MLM towards
the end
2
It seems complex
in relation to the
CIG. But it isn’t
really.
4
Simple enough
once I got the
hang of it.
And I got the
hang of it very
fast
1
Once again,
it was easy
after I got
the hang of
it
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p16 4
It was very easy
to learn after
reading the wiki
1 5
the wiki and
spreadsheet
really helped
in making
things easy
3
p17 5 1 5 1
p18 2 4 1 4
Very
technical,
would need
some
guidance in
explaining
the syntax
used
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p19 3
Its a good
language for a
programmer but
someone who has
never done
programming will
definitely find it
difficult to
understand
2
It was very easy
and fast to edit
the document
although if i
wasn’t given a
template at first,
i would’ve
struggled
3
If i wasn’t
given a
template of
how to do one
patient I
would’ve had
a lot of errors
and difficulty
4
It would be
unfair for a
person who
has never
pro-
grammed
to use this
language as
they would
struggle to
fix serious
errors if
they mess
up the
template or
they don’t
know the
value of a
semicolon.
p20 4 1 4 3
p21 5 4 4 2
p23 5 1 3 3
Technical
support
will be
needed for
people not
familiar
with pro-
gramming
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p24 5 easy to pickup 2
the use of semi
colons can be
tricky at first
5
tags on the
side help with
navigation,
syntax is close
to english
1
might need
some help
with
variable
names for
data access
p25 5
I’d use this more
often because it
is nicely
structured and
more readable. It
also gives more
information
under the
different sections.
2 4 2
p26 4
The language is
straight forward
and easy to
implement with
little back ground
knowledge.
1 4
It took only
one example
to get the
basic idea of
how the
language
should be
done.
1
p27 3 1 5 3
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Table L.8: SUS questionnaire responses - Arden Syntax (part A)
Par-
tici-
pant
Use
lan-
guage
freque-
ntly
Comments
Lan-
guage
com-
plex
Comments
Lan-
guage
easy
to
use
Comments
Need
sup-
port
of a
tech-
nical
per-
son
Com-
ments
p29 4 2
The language is
fairly intuitive.
4
The language
uses an easy-
to-understand
syntax.
2
A technical
person
could be
required
when first
trying out
the
language.
It will be
fairly easy
to use
without
additional
assistance
on a
day-to-day
basis.
p31 3 4 3 2
Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p2 3 2 3 1
p3 3 1 1 5
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Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p4 5
The if construct
is well integrated
in the logic
section.
1 2
takes some
time to getting
used to.
3
p5 4
They get the job
done
1 5
The language
is not complex
1
p6 4 1 4 1
p8 5
Once again the
autocomplete
function was very
useful. This
language would
have been far
more challenging
and
time-consuming
to use without it.
1
I felt that
Language B is
more consistent
than Language
A, at the expense
of its flexibility.
1
I think this
system would
take some
time to get
used to,
especially
when
executing
complex
functions.
3
A little
cumber-
some
p9 3
It feels easy to
use already.
1 5 1
p10 4 1 2 3
p11 5
I found they were
integrated in a
way that
contributed to
the efficiency of
the language.
1 5 1
p12 5 2 5 2
p13 5 1 5 2
p14 4 1 5 1
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Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p15 5 1 2
The language
is more
technical than
most, and
closely
resembles
other
programming
languages.
These always
take users
some time to
learn,
particularly if
they are
unfamiliar
with languages
such as these
2
At first yes,
but very
quickly it
became
light and
easy to use
p16 4 1 4 1
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Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p17 5 4
Case insensitivity
can be a little
confusing
5 2
I’m not
sure why
logic and
action were
separated.
Why not
just add
the action
where we
currently
write
’conclude
TRUE’ -¿
this is
boilerplate
code that
doesn’t
really
encode any
valuable in-
formation.
p18 4 2 2 4
Very
technical,
with a lot
of detail
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Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p19 4
It was a lot
quicker to edit
although I kept
losing track of
where to edit.
1
It was well
consistent, there
was very little to
edit
3
This language
could be good
for people who
are interested
in learning
programming
but it would
definitely take
time to
understand
especially if i
wasn’t given a
template.
1
It was very
fast to use
especially
in editing
p20 3
Did not really
notice functions
and integration
1 2
If the person
does not have
a
programming
background, it
may not be
easy
2
p21 5 4 4 2
p23 4 2 3 2
p24 3 1
the same, simple
structure is used
throughout
5
the structure
is intuitive
2
p25 4 2 3 1
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Table L.9: SUS questionnaire responses - Arden Syntax (part B)
Par-
tici-
pant
Func-
tions
well
inte-
grated
Comments
Too
much
in-
con-
sis-
tency
Comments
Learn
lan-
guage
very
quickly
Comments
Very
cum-
ber-
some
Com-
ments
p26 4
The functions
were similar to
other
programming
languages which
made it simple to
implement.
1 5
As long as you
get told how
the language
works and go
through an
example of the
language than
the language
is easy to
learn quickly
1
p27 4 2 1 2
p29 4 1
The language was
consistent and
has a specific
programming
structure that
makes it easy to
get used to it.
3
It would take
a reasonable
amount of
time to get
used to the
programming
language if
you are a
beginner at
programming,
however it can
be very
intuitive in
due time even
with the most
inexperienced
programmer.
2
It is easy to
debug if
errors have
occurred
because the
structure of
the
language is
intuitive.
p31 3 2 2 4
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Table L.10: SUS questionnaire responses - Arden Syntax (part C)
Par-
tici-
pant
Felt
con-
fi-
dent
Comments
Needed
to
learn
a lot
Comments
Any useful
feautures?
Any missing
features?
p2 5 1
object oriented
approach to some
of th data types
p3 4 4
p4 5
The detail
provided in the
language
increased my
confidence in the
language
3
The if statement
in the logic
section.
linking
recommendations
together.
p5 4
As a first time
user I have to say
that it was not
that bad, it was
actually easy to
use.
1 No All
I think the
language has what
it is needed for the
task at hand.
p6 5 2
The language uses
commonly used
operators for logic
None
p8 4
After some time I
became
comfortable,
especially with
the editing
section.
Descriptions such
as purpose and
explanation
sections make it
time consuming
to edit
2
It took longer to
get to grips with
than language A,
but was fairly
intuitive once I
became familiar
with the layout.
Autocomplete,
referring to the
wiki for examples
Possibly an
autocomplete for
reference record
database names to
make it easier to
refer to the
records.
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p9 5 2
Having separate
blocks. e.g
maintenance,
Library and
Knowledge
Not that I can
think of.
p10 2 3 The outline
p11 5 4
You just have to
know the
operators and
have working
knowledge of
variables and
variable
declaration.
I found the
description very
useful, and it made
navigating the
code easy together
with the outline.
No.
p12 4 3 Autocomplete
None come to
mind
p13 4 2
p14 5 2
p15 5
At first not, but
then yes
1 Ctrl+space Not sure
p16 5 4
Even though was
a lot to learn, the
documentation
helped make the
process easy
the auto-complete
made filling in the
blocks
(maintenance etc)
very easy.
None, that i can
think of
p17 4
May have been
more confident
with better
domain
knowledge
1
Having multiple
mlm’s in the same
file was useful -¿
made it easier to
keep related
modules together.
Allowing
comments helped
clarify complex
bits.
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p18 2 5
library section for
referencing
patients
Explanation of
how to refer to
medical records in
the data section
p19 4
If i was given
plenty of time to
practice i would
eventually be
good at it
4
I like how you can
move from record
to record using the
outline toolbar.
I wish there was
an interface that
would display the
output of the
code. And i wish
there I was a
p20 4 2
the readability and
having many mlm
in one file
Not that I can
think of
p21 4 3
use of variables
and a more flexible
way of specifying
logic rules.
Re-use of data
across slots.
p23 4 1
Defining constants
before using them
and reading data
from spreadsheet
p24 5
auto complete +
underlining errors
helps you code
quickly
1
all it takes is a 10
min read through
and a reference
manual handy
The tag structure
and easy to read
syntax
p25 5 2
There was not
much to learn,
very simple and
easy operations
The descriptions
and variable
assigning.
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p26 5
It’s straight
forward and easy
to pick up
3
I might need a bit
more information
on what i can
and can not do in
the language just
to see what i can
do with it
I find keywords
very useful in
specifying values
or data to use
once i head to the
logic part of the
program to run
the actual
instruction i want.
p27 4 1
p29 4 3
There is a
reasonable
amount of
knowledge
regarding the
program
language
structure that is
required in order
to get going with
the language, but
it is intuitive.
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p31 4 4
Again the
standard IDE
Jumping and
autocomplete were
useful.
However the
rewriting of
conditions was
frustrating and the
overall feel of the
language felt too
verbose. The
Jumping via the
overview also took
you to the end of
the relevant
module after
which you needed
to scroll up which
was a little
confusing. Syntax
was also slightly
over complicated.
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